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CHAPTER 1
The brain is a highly complex organ consisting of  an array of  different cell types that 
are strictly organized into specialized regions. One of  the largest regions within the 
human brain is the cerebral cortex, which is responsible for processing of  sensory 
information, cognitive functioning and consciousness. Brain tissue contains two major 
classes of  cells, namely neurons and glia. These cells are extensively connected with 
each other to form intricate networks through which information flows in the form 
of  electrochemical signals. Electrical signals are transduced by the release of  chemical 
messenger molecules from the axon fibers into the synaptic cleft. These chemical sig-
nals, or neurotransmitters/neuropeptides, activate receptors located on dendritic spines 
of  the receiving cell and carried over the dendritic trees and axon to the next cell. The 
capacity of  a neuron to receive, process and transmit information is thus highly depen-
dent on the correct development of  its axons, dendrites and synaptic connections. It is 
therefore no surprise that the formation of  these neural networks is strictly regulated, 
and dependent on the cooperative expression and regulatory control of  a large number 
of  genes. Key regulators of  genes governing these neurodevelopmental processes are 
microRNAs (miRs). As the name implies, miRs are small non-coding RNA molecules 
of  typically 22 nucleotides long, which have the capacity to bind to short complemen-
tary sequences within target RNA transcripts. Interaction of  a miR with a target tran-
script can lead to translational attenuation and/or transcript destabilization. Due to the 
relatively limited sequence complementarity needed for these interactions to take place, 
miRs have a vast regulatory potential and it is estimated that more than half  of  the 
genes contain miR regulation sites [1-5]. In the past several years a large body of  work 
has shown that regulation by miRs plays an essential role in a diverse set of  biological 
processes, including the control of  various aspects of  brain development. Currently 
> 1800 miR loci are known, coding for an even larger number of  functional miRs [6]. 
Many of  these are expressed at high abundance within the developing brain, suggesting 
important regulatory roles in neuronal development and function. 
miR history          
The nucleus of  a cell contains the genetic material (DNA), which harbours vital in-
structions for proper cell growth, development and function. Historically, research has 
largely focused on uncovering functions for genes encoding proteins, fueled by the 
classical dogma that genes are transcribed into RNA messages which are subsequently 
translated into proteins that fulfill particular cellular functions. However, the human 
genome project has revealed that only a relatively small number of  the genes translate 
into proteins [7,8]. In the following years it became clear that a significant portion of  
the genome produces non-protein-coding RNA sequences which have important reg-
ulatory functions [8]. One such pivotal class of  genes encoding non-coding regulatory 
RNAs and described around that time were genes that produce miRs [9,10]. The very 
first miR, named lin-4, was described in 1993 in the nematode Caenorhabditis elegans 
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(C. elegans) by the laboratories of  Ambros and Ruvkun [11,12]. They found that lin-4 
produces short non-coding sequences capable of  repressing the protein-coding gene 
lin-14 by complementary binding to the 3’-untranslated region (3’-UTR) of  its mRNA. 
The second C. elegans miR named let-7 was discovered a few years later in Ruvkun’s 
laboratory. They described the capacity of  let-7 to regulate the L4-to-adult transition 
of  larval development by inhibiting the function of  the target gene lin-41 [13]. While 
initially this novel regulatory mechanism was thought to be restricted to C. elegans, later 
findings showed that let-7 is part of  a family of  miRs that is highly conserved across 
species from flies to humans [14]. These groundbreaking studies prompted intense re-
search towards the identification of  miRs in other species and marked the beginning of  
the miR field in which novel miR genes were discovered in rapid succession [15]. Due 
to the development of  powerful tools to screen for cellular expression profiles, such as 
deep transcriptome sequencing, the number of  identified miRs regulating a myriad of  
biological functions has exponentially grown.
miR biogenesis and function       
The expression of  miRs begins in the nucleus, where they are encoded as long primary 
(pri) transcripts in a number of  different genetic contexts. miRs can be located in in-
tergenic or intragenic regions of  the genome. Typically, miRs are imbedded in intronic 
regions of  coding or non-coding genes, while a fewer number of  exonic miRs exist. 
Most of  these intragenic miRs are under the transcriptional control of  the host gene in 
which it is embedded, whereas only some miRs possess their own promoter site [16]. 
miRs are often clustered and expressed as polycistronic transcripts from which multiple 
different miR sequences are generated. The pri-miR is transcribed by RNA polymerase 
II, resulting in the expression of  a several kilobases large transcript and through a series 
of  processing steps the functional mature miR is formed (Figure 1). Within the nucle-
us, the pri-miR transcript is folded in a stem-loop which is recognized by the RNase III 
domain containing protein DROSHA. Under the guidance of  DiGeorge syndrome crit-
ical region 8 (DGCR8)-protein, DROSHA cleaves the pri-miR into an ~70 nucleotide 
long precursor (pre) miR sequence [17,18]. While the majority of  miRs are processed in 
a DROSHA/DGCR8-dependent manner, a subclass of  miR genes named “miRtrons”, 
are processed independent from DROSHA/DGCR8. These miRtrons are encoded in 
introns of  protein-coding genes and by splicing they form pre-miR transcripts which 
are further processed through the regular miR biogenesis pathway [19-22]. Pre-miRs 
have a characteristic stem-loop conformation which is approximately 22 nucleotide 
long containing the mature miR transcript. Exportin5 recognizes the 3’ overhang and 
the stem-loop of  the pre-miR transcript, and shuttles it to the cytoplasm through the 
nuclear pore in a Ran/GTP-dependent manner [23,24]. In the cytoplasm the pre-miR is 
recognized by the RNase III DICER that cleaves it into its mature form. These mature 
miRs are incorporated into the miR silencing complex (miRISC), where they serve as 
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Figure 1. Pathway of  miR biogenesis. Pri-miRs are transcribed from intergenic genes, capped 
and polyadenylated. Alternatively, miRs transcription can occur from genes coded within in-
trons of  coding or non-coding genes. Pri-miR transcripts are processed into a pre-miR by the 
DROSHA/DGCR8 complex, creating a ~70–80 nucleotide, hairpin-looped molecule, which is 
then shuttled out of  the nucleus via the exportin-5 mediated transport. Some intronic-encoded 
miRs evade nuclear processing prior to nuclear export. Cytoplasmatic digestion of  the pre-miR 
is facilitated by DICER, resulting in double-stranded mature miRs. Mature miRs modulate gene 
expression by associating with Argonaute-containing complexes to form the RNA induced si-
lencing complex (RISC). By imperfectly or near-perfectly base pairing with sequences in the 3’ 
UTRs of  target mRNAs, miRs modulate gene expression through transcript destabilization and 
translational attenuation. Alternatively, mRNA deadenylation and decapping precedes mRNA 
cleavage, a process depending on the degree of  base-pairing [25]. Some miRs can enhance trans-
lation of  target mRNAs [26]. (Image from Olde Loohuis et al 2012)
primers that can target downstream RNA transcripts. The miRISC complex consists 
of  several proteins such as Argonaute1 (AGO), AGO2, Pumilio2 (PUM2), and the 
probable RNA helicase moloney leukemia virus 10 (MOV10), which collectively direct 
the targeting and regulation process. By imperfect or near-perfect base pairing of  miR 
with target mRNA transcripts, either translation inhibition or mRNA cleavage will take 
place [25], while in rare cases translational upregulation may also occur [26-28]. The 
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level of  miR and mRNA transcript complementarity determines whether the mRNA is 
degraded or translation is inhibited [29]. However, recent studies have shown that while 
initially miR regulation will inhibit translation; such non-translated mRNA transcripts 
are turned over more rapidly than translated transcripts, ultimately resulting in their 
degradation [30].
miR regulation of  gene networks      
Once a mature miR transcript is incorporated into the RISC complex, it acts like a 
primer where sequence complementarity determines the ability to bind and regulate a 
target transcript. Of  essential importance is the seed sequence that is typically located 
at positions 2-7 at the 5’-end of  a miR transcript and largely determines whether initial 
binding takes place [31,32]. Structural investigations have shown that the RISC protein 
AGO2 positions this sequence outward to maximally support target binding [33-36]. 
The remaining nucleotides, residing outside the seed sequence are thought to play an 
important role in facilitating regulation efficiency [32]. Although a large number of  
studies have described the regulation of  a single mRNA transcript by various miRs, an 
increasing body of  evidence has shown that a single miR has the potential to simulta-
neously target and regulate many downstream RNA transcripts and conversely a single 
mRNA can be regulated by multiple miRs [4,37-39]. This regulatory capacity is attribut-
ed to the relative limited lengths of  the mature miR sequences resulting in the presence 
of  numerous complementary binding sequences within RNA transcripts. Recent stud-
ies have shown that a miR can regulate multiple transcripts that act in overlapping gene 
networks with an enrichment of  gene targets functioning in specific cellular processes 
[40,41]. Moreover, miRs and their binding sites within target genes tend to be highly 
conserved [2], indicating their evolutionary importance. The inhibitory effects of  miRs 
are generally modest [42,43]. Although some miRs can function as regulatory switches 
which completely shut down expression, they more often tend to function as fine tun-
ers of  gene expression [42,44,45]. This has culminated in the idea that miRs function 
as network regulators which convey robustness to gene networks to ensure their stable 
expression during perturbations [46,47]. For miR-7 it was experimentally determined 
that it has the capacity to stabilize the expression of  a number of  neurodevelopmental 
networks controlling photoreceptor determination and the development of  the sensory 
organ in Drosophila during temperature fluctuations [48]. The miR-mediated fine tuning 
of  gene expression is also important in other neurodevelopmental processes. For ex-
ample, altering the expression of  miR-9a in Drosophila led to generation of  an aberrant 
number of  neuronal precursors, revealing that correct dosage of  miR-9a ensures precise 
development of  these cells [49]. These regulatory mechanisms also play an important 
role in cortical neurodevelopmental processes, where miR-20a/b and miR-23a control 
a gene network critically important for progenitor fate decisions during cortical neuro-
genesis through regulation of  cyclin D1 [50]. The capacity to accurately regulate gene 
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transcripts is especially important during development where synchronized expression 
of  miRs and their targets helps to dampen potentially deleterious gene expression [51]. 
miR regulation of  localized gene expression     
For regulation by a miR to take place, it needs to be co-expressed with its target tran-
scripts. miR expression can be spatially restricted to specific brain regions such as the 
cortex, hippocampus or amygdala or within specific cell types [52-54]. It is thought 
that these cell- and tissue-specific expression patterns help to regulate the expression 
of  transcripts important for development or differentiation of  cell populations within 
these tissues. For the proper growth and function of  their extensive network of  neurites 
which can span great distances, neurons need a constant supply of  proteins. Some of  
these proteins are produced near the soma of  the cell, and translocated to distal parts 
of  the dendrites and axons. However, a large body of  evidence has shown that mRNA 
transcripts can be transported large distances and translated at sites when and where 
they are needed [55,56]. Similarly, a number of  studies have identified a considerable 
number of  miRs within the dendrites and axons of  neurons [57-59], suggesting a po-
tential local regulation of  mRNA translation. 
miR in the dendrite         
In a landmark study by Schratt and others, the brain-specific miR-134 was shown to be 
expressed in the synaptodendritic compartment of  hippocampal neurons. Inhibition 
of  miR-134 negatively regulated dendritic spine development through regulation of  
LIM domain kinase 1 (Limk1) [60]. Later studies using isolated dendritic compartments 
from the hippocampus revealed a number of  synaptic miRs with miR-26a being the 
most significantly enriched. Inhibition of  miR-26a showed its ability to regulate micro-
tubule-associated protein 2 (MAP2) mRNA [58]. More recent large-scale screening studies 
using isolated synaptic fractions from various brain regions [61], including the hippo-
campus [62], forebrain [57] and nucleus accumbens [63] have identified numerous miRs 
enriched at the synapse. Furthermore, many of  these miRs tend to be present in their 
precursor form, indicating that these immature miRs are transported to the synapse and 
locally processed [57,64]. This is supported by the finding that the pre-miR processing 
enzyme DICER is highly enriched within the post synaptic fraction of  neurons [57]. 
miR in the axon         
An abundant repertoire of  miRs, including critical components for their processing and 
function, has also been identified in axonal compartments where they control the trans-
lation of  the locally present mRNAs [65]. Sasaki and colleagues performed a quantita-
tive polymerase chain reaction (qPCR) screen on RNA derived from cortical neuronal 
axons, and found a number of  enriched miRs at the growth cone [66]. By employing 
compartmentalized Campenot cell chambers, Natera-Naranjo and colleagues could 
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grow axons from superior cervical ganglia (SCG) neurons separately from their cell 
body [59]. This culture system allowed the isolation of  RNAs from the axonal compart-
ment. miR microarray analysis revealed 130 axonal-expressed miRs with a large number 
enriched at these distal sites. miR-338 was one of  the miRs identified as being axonally 
enriched, and in a later study using the same compartmentalized cell culture platform, 
Aschrafi et al. showed the capacity of  this miR to locally regulate nuclear-encoded cy-
tochrome c oxidase IV (COXIV) mRNA [67]. The majority of  these miRs are thought 
to be transported to these distal sites in their premature form and processed locally 
upon a stimulus [68]. Within the miR precursor the miR loop sequence is critical for 
its directed transport to distal parts of  the neuron [69,70]. One of  the specialized miR 
binding proteins identified is the DEAH-box helicase DHX36 which binds to the loop 
structure of  miRs [70]. However, it is currently not known whether the loop sequence 
or its structure is responsible for the binding DHX36 to miRs. The identification of  
miR processing enzymes within growing axons further supports the idea that these pre-
miR sequences can be locally activated, although the exact underlying mechanism is still 
unknown [64,71]. The discovery of  the abundant presence of  numerous miRs at the 
sites of  dendritic spines and in growing axons put forward the idea that specific stimuli 
rapidly activate the miR machinery resulting in the regulation of  downstream target 
transcripts ultimately impacting the availability of  proteins at these distal sites. 
miR regulation of  neuronal development     
The cortex constitutes the largest area of  the mammalian brain and plays an import-
ant role in many of  the higher cognitive functions such as sensory perception, con-
sciousness, working memory and attention. During evolution, the mammalian cortex 
has grown disproportionately large compared to other brain areas [72]. Although the 
human cortex is unique in size relative to other parts of  the brain, many of  the basic 
features are conserved in other mammals. Much of  what we know about the molecular 
basis of  its development, cellular makeup and fundamental functions of  its neural net-
works is based on experimental data obtained from rodent models. Although the rodent 
cortex is relatively small and lacks the folds present in the human cortex, it does pos-
sess a number of  key features present within the human brain, including a six-layered 
organization and regionalization into specialized areas with specific functions (Figure 
2). The cells comprising these cortical layers are formed from neuronal stem cell pop-
ulations residing within two germinal layers which line the cerebral ventricles, namely 
the ventricular zone (VZ) and the subventricular zone (SVZ). A key finding by the lab-
oratory of  Kriegstein resulted in the acknowledgement of  radial glia cells which divide 
to form neuronal cells. These newly formed cells subsequently migrate via radial glial 
fibres that guide them to form the layers of  the cortex [73]. The cortical the layers are 
formed in an inside-out order, where the deeper layers are generated first and upper 
layers are subsequently organized on top. 
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Figure 2. miRs controlling corticogenesis. A schematic representation of  a developing cor-
tical wall from E10.5 to E18.5 and its various layers representing the boxed area in the coronal 
section (upper left). From E10.5 to 11.5 the neuroepithelial cells divide symmetrically to increase 
the stem cell pool (light grey). Neurogenesis initiates after E11.5 in the ventricular zone (VZ) 
where some of  the radial glial cells (blue) divide asymmetrically generating both more redial 
glial cells (dark blue) and neuronal precursor cells (orange). Redial glial cells can also generate 
neurons indirectly through basal progenitor cells (purple) within the subventricular zone (SVZ). 
Basal progenitor cells can divide both asymmetrically for self-renewal or symmetrically forming 
expanding the neuronal cell pool. Neurogenesis is regulated by a number of  miRs: Let-7b, miR-
9, miR-124 and miR-134 (arrows 1 and 2). Following neurogenesis the neurons further differen-
tiate and migrate through the intermediate zone (IZ) integrating in the cortical plate (CP) which 
requires Let-7b, miR-9, miR-34a and miR-137 (arrow 3). Neurite formation and differentiation 
to generate dendrites and synapses requires the expression of  miR-34a, mir-132, mir-125b and 
miR-134 (arrow 4) to form functional neural networks. The right panel highlights the inside-out 
formation of  the cortical layers. miR-134 and miR-137 (arrow 6) regulate the migration of  
neurons along the radial glial cells (blue) towards the upper cortical plate layer. The migrating 
neurons stop under the Cajal–Retzius cells (CR) (blue turquoise) within the marginal zone (MZ). 
Formation of  CR cells is regulated by miR-9 (arrow 5). MGE, medial ganglionic eminence, LGE, 
lateral ganglionic eminence, LV, lateral ventricle. (Image adapted from ML Volvert et al. 2012)
miR control of  corticogenesis        
A number of  studies have suggested that cell fate is determined after neurogenesis, but 
before neuronal migration is initiated [74]. The combinatorial interplay of  both extrin-
sic and intrinsic factors cooperates to determine the cell fate of  the postmitotic neu-
rons [75,76]. During and after the migrating neurons position themselves in the correct 
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cortical layer under influence of  membrane-bound signaling molecules, the cells start 
to differentiate their neural processes [77]. Initially an immature axon projects tangen-
tially, afterwards the remaining neurites transform to become the dendrites. These early 
neurites will further grow and develop to form networks connecting the cells within the 
cortical areas as well as connecting with other brain regions. Corticogenesis is highly 
controlled by the timely expression of  a repertoire of  genes [78-80]. An increasing 
body of  studies have identified miRs which regulate the various processes involved in 
the developing cortex. In an effort to elucidate the miR regulation programs important 
for brain development and in particular corticogenesis, some of  the initial experiments 
used cloning or microarray platforms to screen miR expression patterns. These exper-
iments identified a number of  brain and cortex-specific miRs, which showed abundant 
and dynamic expression patterns during corticogenesis [81-84]. The critical functions 
of  these miRs in cortical development was shown through the use of  cortex-specific 
Cre lines in order to block miR maturation by deleting Dicer, a central miR biogenesis 
enzyme (for review, see [85-88]. Selective Dicer deletion in cortical neural progenitors 
(NPs) resulted in smaller cortices because of  reductions in the sizes of  the neural stem 
cells (NSCs) and NP pools, and increased apoptosis and impaired neuronal differen-
tiation. Furthermore, Dicer deletion from post-mitotic neurons in the cortex using a 
calcium/calmodulin protein kinase II promoter-driven Cre line also caused reduced 
cortical size, possibly through impairment of  neurite outgrowth and increased neuronal 
packing density in the cortical plate [89,90]. Moreover, specific miRs have been impli-
cated in neuronal differentiation and maintenance of  neuronal phenotype. For example, 
the miR-17-92 cluster controls cortical size by regulating radial glial cell proliferation 
[91,92]. In addition, the cortex-enriched miR-9 regulates NSC expansion by targeting 
the nuclear receptor gene tailless (Tlx) [93]. Interestingly, TLX also represses the expres-
sion of  the miR-9 primary transcript, suggesting a feedback loop by which TLX and 
miR-9 control the size of  the NSC pool. Recently, miR-22 and miR-124 were found 
to control neuronal polarization and radial migration by targeting the CoREST/REST 
(Repressor element 1 silencing transcription factor) complex, which transcriptionally regulates 
doublecortin (DCX) [94]. Interestingly, a study by Gaughwin and colleagues revealed that 
miR-134 can control multiple stages of  corticogenesis [95]. miR-134 regulates DCX and 
Chrdl-1, and as such promote cell proliferation of  neuronal progenitors. While during 
migration, miR-134 inhibited the movement of  neurons towards the upper cortical lay-
ers in a DCX-dependent manner. At later stages, miR-134 inhibited neurite growth in 
differentiating neurons. These results suggest that a single miR can regulate a multitude 
of  neurodevelopmental processes, depending on the expression pattern of  its down-
stream targets. 
miR regulation of  neurite development      
Neurite growth and development is crucial for the formation of  a functional neural net-
18
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work and a number of  miRs have been identified to be important for the regulation of  
genes that control this process. miR-132 regulates both the development of  dendrites 
of  newborn neurons within the olfactory bulb [96] and hippocampus [97]. In dorsal 
root ganglion neurons, miR-132 is expressed within developing axons and through local 
regulation of  Rasa1 mRNA it promotes axon extension [98]. Similarly, miR-338 is ex-
pressed in the axons of  dorsal root ganglion neurons where it regulates the expression 
of  nuclear-encoded COXIV mRNA [67]. Consequently, the knock-down of  COXIV 
mRNA decreases axonal respiration and adenosine triphosphate (ATP) levels, resulting 
in decreased axon function. Furthermore, in a later study miR-338 was shown to atten-
uate axon growth possibly by the regulation of  a number of  mitochondrial genes [99]. 
miR-9 is abundantly expressed in cortical regions and more specifically in the axons of  
cortical neurons. By making use of  microfluidic culture devises, allowing the isolated 
growth of  axonal processes, miR-9 was identified as a local regulator of  microtubule-as-
sociated protein 1b (Map1b) mRNA, and the axonal expression of  miR-9 increases upon 
brain-derived neurotrophic factor (BDNF) stimulation [100]. miRs are frequently en-
coded by clusters and transcription of  these polycistronic units results in the generation 
of  multiple mature miR sequences. Several miRs expressed from these miR clusters 
can be jointly transported to a specific neuronal compartment, including the axon. Na-
tera-Naranjo and colleagues identified several of  these miR clusters within the axons of  
sympathetic neurons [59]. In a study by Zhang et al, the miR-17-92 cluster consisting of  
six miR transcripts, was found to be abundantly present in the distal axons of  mature 
cortical neurons [101]. Interestingly, they observed that these miRs collectively enhance 
the growth and development of  axons by reducing phosphatase and tensin homolog 
(PTEN) proteins. These studies show that miR regulation is important for neurogene-
sis, migration and differentiation as well as neurite development of  cortical cells. 
miR regulation of  the synapse       
Besides important functions in the development of  neuronal structures, miRs play criti-
cal roles in the functioning of  neurons, such as synaptic function and synaptic plasticity 
which is the capacity of  synapses to strengthen or weaken over time, in response to 
increased or decreased synaptic activity. Notably, miRs can affect synaptic plasticity 
by several not mutually exclusive mechanisms: (a) direct targeting synaptic receptors 
or their downstream targets [63,102], (b) influencing α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR) trafficking by targeting long-term depres-
sion (LTD) proteins such as activity-regulated cytoskeleton-associated protein (ARC) 
and MAP1b [103,104], and (c) modulating key actin-regulating proteins [60,105]. These 
reports suggest that variation in miR expression levels will affect synaptic protein levels 
and consequently synaptic plasticity by controlling the translation of  many mRNA en-
coding synaptic proteins. 
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Dysregulated miR function and neurodevelopmental disorders   
Since miRs have indispensable functions during early development of  the brain, it is 
not surprising that perturbations in miR expression can lead to neurodevelopmental 
disorders. Indeed, a steady accumulation of  experimental data argues that disruption 
of  miR expression and down-stream signaling pathways can impair the formation of  
neural structures and function, including synaptic formation and function [106,107] 
and has been associated with cognitive impairment in mice [108] and humans [109,110]. 
miR malfunction has been associated with neurodevelopmental disorders, such as intel-
lectual disability (ID), autism spectrum disorder (ASD) and schizophrenia (SZ) [111].
miR in ID         
ID is a prevalent heterogeneous collection of  mental disorders estimated to affect 1-3% 
of  the population [112]. It is commonly associated with a severe decrease in cognitive 
abilities and adaptive behaviors. Clinically, ID is defined as having an intelligence quo-
tient (IQ) score below 70 occurring before the age of  18 and deficits in two or more 
adaptive behaviors, such as communication, self-care, social skills, community access 
skills, self-direction, health, and safety [113]. ID can be caused by genetic and/or envi-
ronmental factors which perturb the normal development and function of  the nervous 
system. Severe forms of  ID are often caused by genomic aberrations and monogenic 
mutations, whereas milder forms of  ID can be multifactorial, triggered by combina-
tions of  genetic and environmental cues [114]. However, for up to 60% of  the cases 
there is no identifiable underlying cause [115]. Recently, several studies have revealed 
miR expression changes occurring in a number of  ID disorders [116]. Patients with 
Down syndrome, also known as Trisomy 21, are particularly well studied in this context. 
This chromosomal disorder is characterised by the gain of  an extra whole or part of  
chromosome 21 and a range of  tissues have been screened for miR expression changes 
including placenta [117], maternal plasma [118], fetal cord blood [119], and at older 
ages in lymphocytes [120] and brain tissue [121,122]. These studies revealed extensive 
expression changes in many miRs, suggesting their potential role in modulating disease 
progression. miR-137 has recently gained increased attention because common genetic 
variants and rare genomic deletions associated this miR with severe cognitive impair-
ments in the context of  SZ and ID [123-126]. Willemsen and others identified overlap-
ping genomic 1p21.3 deletions comprising dihydropyrimidine dehydrogenase (DPYD) 
and MIR137 in lymphocyte cell lines of  three siblings and two unrelated patients with 
mild to moderate ID using genome-wide array analysis. These patients displayed signifi-
cantly decreased miR-137 levels, as well as altered expression of  validated targets of  this 
miR [110]. Combined with evidence showing miR-137 as a regulator of  synaptic trans-
mission and plasticity, indicates that alteration in miR-137 levels is a likely explanation 
for the ID phenotype [127-129].
20
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miR in ASD         
ASD is a heterogeneous group of  neurodevelopmental disorders. It is diagnosed on 
the basis of  several shared behavioral dysfunctions namely, impairments in social inter-
action, delays in verbal and non-verbal communication, and presence of  restricted and 
repetitive interests and behaviors [130]. Although a number of  environmental factors 
can trigger the development of  ASD, twin and family studies indicate that susceptibility 
for the disorder has a high heritability [131], with the latest estimates suggesting a heri-
tability of  50% [132]. A number of  studies have started to explore the miR expression 
landscape in a variety of  tissues derived from ASD patients. Transcriptome analysis of  
blood [133], lymphoblastoid cell lines [134-137], and isolated post-mortem brain tissue 
[138,139] revealed extensive miR expression changes potentially contributing to ASD 
susceptibility and development. 
miR in SZ          
SZ is a common psychiatric disorder with an estimated prevalence of  1% worldwide 
[140]. Patients can manifest a wide range of  symptoms and cognitive impairments. 
Some of  the common characteristics are hallucinations, delusions, disorganized behav-
ior, social withdrawal and apathy. Some of  the cognitive deficits include impairments 
in attention, executive function and working memory [141]. miR profiling studies per-
formed on post-mortem brain material revealed considerable expression changes in 
several brain regions [142-148]. Furthermore, studies have screened blood samples 
from SZ patients for miR expression changes and potential biomarkers [133,149-151]. 
At the DNA level, genome-wide association studies (GWAS) have strongly implicated 
the single nucleotide polymorphism (SNP) rs1625579 located in an intron of  MIR137 
in the etiology of  SZ [152,153]. Later studies have confirmed that SNPs resulting in 
lower miR-137 expression might confer risk to SZ [129,154-156]. 
Aim and outline of  this thesis       
The essential role that miRs play in the regulation of  neuronal development has been 
revealed in many studies. There is an emerging understanding that subtle changes in 
miR regulatory pathways controlling neurodevelopment can contribute to neuropsy-
chiatric disorders. However, while a large number of  miRs have been identified, the 
underlying molecular mechanisms that are regulated by individual miRs are still poorly 
understood. The research described in this thesis aims to elucidate the role of  specific 
miRs in the control of  neurodevelopment, with a particular focus on corticogenesis. 
In the first part of  the thesis, I investigate the role and the underlying molecular mecha-
nisms of  the brain-enriched miR-338 in cortical development (chapters 2-4). In chap-
ter 2, I perform an expression study on miR-338 and its host gene AATK in primary 
neurons. While miR-338 is under the control of  the AATK promoter, I find that at 
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specific stages of  neurodevelopment miR-338 and AATK show an unexpected inversed 
expression pattern. Analysis of  the mRNA sequence of  AATK results in the identifica-
tion of  miR-338 binding sites within its 3’ UTR. miR-338 overexpression experiments 
reveal that miR-338 has the capacity to regulate AATK mRNA levels. Further analysis 
of  the 3’ UTR of  AATK shows that miR-338 has the capacity to regulate its transla-
tion. These findings suggest that miR-338 can exert its neurodevelopmental function 
partially through regulating its host gene AATK. In chapters 3 and 4, I investigate 
the capacity of  miR-338 to control various aspects of  cortical development. Using a 
combination of  in vitro (chapter 3) and in vivo (chapter 4) models, I show that miR-
338 controls axon growth, dendrite development and dendritic spine morphology in 
dissociated cortical neurons and cortical neuron migration and neuronal polarity in the 
developing cortex. miR-338 inhibition and subsequent large-scale screening of  down-
stream mRNA targets in chapter 3 results in the identification of  gene targets involved 
in the axon guidance pathway. Bioinformatics analysis of  the 3’ UTR of  transcripts 
with altered expression upon miR-338 inhibition reveals regulation sites in a few of  the 
affected transcripts. Further validation leads to the identification of  Robo2 as one of  
the direct targets of  miR-338. Collectively, these results establish miR-338 as a critical 
gene in cortical neuronal development through modulating gene pathways involved in 
axon development. In chapter 5, I explore the role of  the autism-associated miR-181c 
in cortical development. Transcriptome analysis of  cortical neurons in which miR-181c 
is downregulated results in altered expression patterns of  a large number of  transcripts. 
Subsequent gene clustering analysis reveals a number of  affected gene networks with 
the most significant functioning in neurodevelopmental processes such as neurite and 
spine development. Neuromorphological analysis of  cortical cells shows that long-term 
reduction of  miR-181c levels causes increased dendritic branching and complexity, de-
creased spine development and increased axon growth. The results demonstrate that 
miR-181c is a critical modulator of  cortical neuronal development through modulating 
the expression of  gene sets involved in nervous system development and function.   
In chapter 6, I describe the use of  microfluidic chambers combined with a nascent 
protein labeling technique to investigate local protein synthesis dynamics in distal neu-
ronal compartments. The results show that these techniques allow the visualisation of  
nascent proteins in growing axons and synaptic compartments which could be applied 
to study the impact of  miRs on local protein synthesis.    
Finally, in chapter 7 the results presented in this thesis are summarised, discussed and 
placed in a broader context.
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Abstract
MicroRNAs (miRNAs) are important gene regulators that are abundantly expressed in 
both the developing and adult mammalian brain. These non-coding gene transcripts 
are involved in post-transcriptional regulatory processes by binding to specific target 
mRNAs. Approximately one third of  known miRNA genes are located within intronic 
regions of  protein coding and non-coding regions, and previous studies have suggest-
ed a role for intronic miRNAs as negative feedback regulators of  their host genes. In 
the present study, we monitored the dynamic gene expression changes of  the intronic 
miR-338-3p and miR-338-5p and their host gene Apoptosis-associated Tyrosine Kinase 
(AATK) during the maturation of  rat hippocampal neurons. This revealed an uncor-
related expression pattern of  mature miR-338 strands with their host gene. Sequence 
analysis of  the 3’ untranslated region (UTR) of  rat AATK mRNA revealed the presence 
of  two putative binding sites for miR-338-3p. Thus, miR-338-3p may have the capacity 
to modulate AATK mRNA levels in neurons. Transfection of  miR-338-3p mimics into 
rat B35 neuroblastoma cells resulted in a significant decrease of  AATK mRNA levels, 
while the transfection of  synthetic miR-338-5p mimics did not alter AATK levels. Our 
results point to a possible molecular mechanism by which miR-338-3p participates in 
the regulation of  its host gene by modulating the levels of  AATK mRNA, a kinase 
which plays a role during differentiation, apoptosis and possibly in neuronal degener-
ation.
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Introduction
MicroRNAs (miRNAs) constitute a novel class of  small 21–23 nucleotides long, 
non-coding RNAs that act as post-transcriptional regulators of  gene expression. They 
are highly conserved during evolution, and involved in a wide variety of  biological pro-
cesses. For example in developmental processes, apoptosis, metabolism, cell differen-
tiation, and morphogenesis [1,2,3,4]. In animals, miRNAs regulate gene expression by 
base pairing imperfectly to the 3’ untranslated region (UTR) of  target mRNAs, thereby 
inhibiting protein synthesis or causing mRNA degradation [5]. Although most miRNAs 
are encoded in intergenic regions or within exonic loci, approximately one-third of  the 
mammalian miRNA genes are located in introns of  non-coding RNA genes, or within 
introns of  protein-coding genes [6]. They are referred to as intronic or intragenic miR-
NAs [7]. While the majority of  the mammalian intronic miRNAs are transcriptionally 
linked to their host gene expression and are processed from the same primary transcript, 
computational surveys suggested that one fourth of  intronic miRNAs are transcribed 
from their own promoters [8]. The precursor miR-338 sequence is intronically encod-
ed within the Apoptosis-associated Tyrosine Kinase (AATK, also known as AATYK) 
host gene [9]. This gene is upregulated during apoptosis of  myeloid precursor cells 
induced by interleukin-3 deprivation [10,11], and in cultured cerebellar granule neurons 
undergoing apoptosis induced by exposure to a low K+ environment [12]. Transcrip-
tion, splicing and further processing will produce mature miR-338-3p and miR-338-5p 
from the seventh intron of  the AATK gene (Figure 1A). For most miRNAs, only one 
strand (the guide strand) of  the double-stranded miRNA duplex is loaded into RISC, 
while the other (*) strand is destroyed rapidly [13]. However, in some cases such as for 
miR-338, both strands (5p and 3p) are selected, and can function as post-transcriptional 
repressors [14]. Both AATK and miR-338 are highly conserved genes, and prominently 
expressed within the vertebrate central nervous system (CNS) [12,15]. Little is known 
about the role of  miR-338 in maintaining neuronal function. Recent studies have in-
dicated a role for miR-338-3p in oligodendrocyte differentiation and maturation [16]. 
In addition, miR-338-3p is enriched in distal axons, where it modulates mitochondrial 
function, and consequently oxygen dependent metabolic pathways in sympathetic neu-
rons by regulating the expression levels of  cytochrome c oxidase, subunit IV [17,18]. 
Since previous studies have also demonstrated a role for AATK in stimulating neuronal 
differentiation [19], we here monitored the gene expression changes of  precursor (pre-) 
and mature miR-338 strands and their host gene (AATK) during the first 21 days in vitro 
(DIV) neuronal differentiation. This investigation revealed an uncorrelated expression 
pattern of  the intronic miR-338-3p, and -5p with their host gene. Follow-up bioinfor-
matic surveys identified that the 3’ UTR of  rat AATK mRNA contains two putative 
binding sites for miR-338-3p, suggesting that this miRNA may regulate the expression 
of  its host gene during neuronal differentiation or degeneration. In the current study, 
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gene expression analysis was combined with luciferase-based gene activity assay, to fur-
ther examine the functional association of  miR-338-3p and miR-338-5p in relation to 
their host gene.
Materials and Methods
Bioinformatic analysis        
The Targetscan algorithm [33] was used to interrogate the 3’ UTR sequence of  AATK 
mRNA for putative binding sites of  miR-338. The context scores indicated in Figure 2 
were calculated by the TargetScan algorithm [34]. In short, the context score combines 
the 3’ pairing score, local AU content and distance from the nearest 3’ UTR terminus 
to provide an interaction prediction in which a lower context score indicates a higher 
targeting preference by a miRNA.
Transfection of  DNA constructs and miR-338 mimics     
The miRNASelect pEGP-mmu-mir-338 and its corresponding negative control vector 
pEFP-mir-null expression vectors were commercially obtained from Cell Biolabs (San 
Diego). The 3’ UTR from the AATK gene was amplified from a rat cDNA library 
using the following primers incorporating the SacI and Xbal restriction sites: AATK 
3’ UTR forward, AAAAAAAAGAGCTCTGAGACCCAGGTTATCCCAC; AATK 3’ 
UTR reverse, AAAAAAAATCTAGAGGAACAAGAAAATCATTGCA. The AATK 
3’ UTR amplicon was ligated into the pmirGLO Dual-Luciferase miRNA target ex-
pression vector (promega) between the SacI and XbaI restriction sites. Transfection 
of  DNA constructs into cell lines was performed using Lipofectamin 2000 reagent 
(Life Technologies) according to the manufacturer’s instructions. The double-stranded 
RNA that mimics endogenous rat miR-338-3p [UCCAGCAUCAGUGAUUUUGUU-
GA], rat miR-338-5p [AACAAUAUCCUGGUGCUGAGUG], and miR-NT, used as a 
non-targeting control, were obtained from Qiagen. The introduction of  miRNA mim-
ics was accomplished by lipofection using siPORT NeoFX (Life Technologies), with a 
30 nM miRNA mimic concentration per condition.
Reverse transcription and Real-Time PCR      
Total RNA was isolated using TRIzol (Life Technologies), according to the protocol 
provided by the manufacturer. The purity of  all isolated RNA samples was determined 
by agarose gel electrophoresis and UV-spectrophotometric analysis, respectively. The 
mean ± S.D. of  the 260/280 nm ratios was 2.0±0.05. Contamination by genomic DNA 
was removed by treating 1 mg of  each RNA sample with 2 U deoxyribonuclease (DNase) 
(Sigma Aldrich, D7691) for 1 hr at 37˚C, followed by DNase inactivation at 65˚C for 10 
min. cDNA was synthesized from 0.5–1 mg RNA according to the protocol provided 
with the revertAid First Strand cDNA Synthesis Kit (Fermentas). For detection of  
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mature miR-338 (-3p, and -5p), the miScript reverse transcription kit (Qiagen) was uti-
lized. Real-time PCR was performed with 1:10 diluted cDNA using the Maxima SYBR 
Green/ROX qPCR master mix (Fermentas) or the miScript SYBR green PCR kit (Qia-
gen) for detection of  mature miR-338 (-3p, and -5p). The following gene-specific prim-
ers were used: AATK forward, ATGCTGGCCTGCCTGTGTTGT; AATK reverse, 
AGGGGCAGGACATACACATCGG; pre-miR-338 forward, AACAATATCCTG-
GTGCTGAGTG; pre-miR-338 reverse, CAACAAAATCACTGATGCTGGA; mature 
miR-338-3p forward, TCCAGCATCAGTGATTTTGTTG; mature miR-338-5p for-
ward AACAATATCCTGGTGCTGAGTG; β-Actin forward, CCAGATCATGTTT-
GAGACCTTC; β-Actin reverse, AGGATCTTCATGAGGTAGTCTG; U6 forward, 
GCTTCGGCAGCACATATA; U6 reverse, CGCTTCACGAATTTGCGT. Relative 
gene expression differences were calculated by applying the delta C
T
 method [35]. DNA 
band intensities on an agarose gel were quantified using LabWorks image acquisition 
software provided with an EpiChemi II Darkroom gel documentation system (UVP). 
Equal regions of  interest were selected to obtain the band intensities after background 
subtraction. U6 band intensities were used to normalize pre-miR-338 measurements.
Luciferase assay         
Three days after transfection, the cells were lysed and processed for luciferase lumines-
cence measurements. For detection of  luciferase activity the Dual-Glo luciferase assay 
system (Promega) was performed as previously described [36]. Briefly, an appropriate 
amount of  Dual-Glo reagent was added to the cell medium enabling cell lysis and 
subsequent detection of  firefly luminescence in a luminometer. Normalization of  the 
samples was performed by addition of  the Dual-Glo Stop & Glo reagent enabling the 
detection of  renilla luminescence, and the luciferase activity in relative light units (RLU) 
was subsequently calculated.
Cell culture         
Rat neuroblastoma B35 cells (rat CNS derived) were obtained from American Type 
Culture Collection (Manassas, VA, USA), and were cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) high glucose (4.5 g/L)supplemented with pyruvate (10 mg/
mL), penicillin/streptomycin antibiotics (20 mg/mL) and 10% fetal calf  serum. The 
cells were maintained at 37˚C and 5% CO2. Primary cultures of  hippocampal neurons 
were prepared from embryonic day 18 rats as described [37], and maintained in a neuro-
basal medium supplemented with B27 (Invitrogen, Carlsbad, CA, USA) and 2 mmol/L 
GlutaMax (Life Technologies).
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Statistics          
Quantitative data are presented as the mean ± SEM. Student’s t test was used to deter-
mine significant differences between two groups. One-way ANOVA with Bonferroni’s 
multiple comparison test was used to analyze significant differences among multiple 
groups; p≤0.05 was considered significant.
Results
Profiling miR-338 and AATK Expression in Hippocampal Neurons during Dif-
ferentiation in vitro         
Previous reports have demonstrated that retinoic acid-mediated neuronal differentia-
tion of  human neuroblastoma cells results in the synchronized induction of  expression 
levels of  miR-338-3p and its host gene AATK [9]. Although both miR-338 and AATK 
are known to be specifically expressed in neuronal tissue [15,19,20], little is known 
about their relative abundance during neuronal maturation and neurite outgrowth. To 
examine whether the onset of  miR-338 expression in hippocampal neurons in culture 
was correlated with the expression of  AATK, the expression levels of  the pre- and ma-
ture miR-338 strands, as well as AATK during in vitro differentiation of  these neurons 
were investigated. A comparative qRT-PCR experiment was performed on dissociated 
embryonic day 18 (E18) hippocampal neurons at eight different maturational stages 
(Days in vitro (DIV) 0, 1, 3, 6, 10, 14, 18, and 21; Figure 1B). In rat hippocampal neurons, 
the expression levels for pre-, and mature miR-338 strands remained at significantly 
lower levels as compared to AATK mRNA levels. While the levels of  miR-338-5p, con-
tinuously elevated within the assessment period (ten-fold until DIV 21), miR-338-3p 
levels increased only during early neuronal differentiation (fifteen-fold until DIV 6). Af-
terwards until DIV10, miR-338-3p expression levels decreased slightly, and remained at 
a relatively low level throughout the differentiation period (measured up until DIV 21). 
In addition, pre-miR-338 levels increased slightly within the first day in culture, followed 
by gradually decreased levels between DIV 3 and DIV 14, when pre-miR levels resumed 
to DIV 1 levels. Conversely, the relative levels of  AATK mRNA increased considerably 
during the onset of  neuronal differentiation (up to DIV 6), and AATK expression lev-
els increased approximately sixty-fold within the first 21 days of  in vitro differentiation 
(Figure 1B). The outcome of  this experiment strongly suggests that the AATK mRNA 
levels and the levels of  the (pre, -3p, -5p) miR-338 in rat hippocampal neurons are not 
coordinately regulated.
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Figure 1. MiR-338 is encoded within the AATK gene and is expressed during matu-
ration of  hippocampal neurons. (A) A schematic overview of  rat miR-338 encoded within 
the seventh intron (depicted in blue) of  the AATK gene located on chromosome 11, with the 
exons shown in red. The depicted genes are Rattus norvegicus AATK (rno-AATK) and miR-338 
(rno-miR-338). (B) qPCR assay was used to assess levels of  pre-miR-338, mature miR-338-3p 
and miR-338-5p, and AATK mRNA in cultured rat hippocampal neurons (DIV 0–21). The data 
represents relative fold change in AATK and miR-338 expression levels to DIV 0.
AATK Is a Target of  miR-338 in Neurons     
To evaluate whether the expression of  miR-338 and AATK mRNA is functionally re-
lated, the possibility that miR-338 has the capacity to regulate AATK mRNA expression 
was considered. To initially explore this postulate, the TargetScan algorithm [21,22] 
was used to search for miR-338 binding sites in the 3’ UTR of  AATK mRNA. This in 
silicio analysis identified two 7-mer binding sequences within the 3’ UTR of  rat AATK 
mRNA which have the potential to function as a putative binding site for miR-338-3p 
(Figure 2). Furthermore, the 3’ UTR of  mouse AATK mRNA was found to contain 
two putative cis-acting binding sites for miR-338-3p, and one putative binding site for 
miR-338-5p. 
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Gene Target sequence Context score
-0.02
-0.19
-0.04
-0.11
-0.10  
-0.14
hsa-AATK
mmu-AATK
rno-AATK
AATK 3' UTR        941: 5'  ...AAAGACAUGUAAAGUAUAUUGUU...  3' 947
mmu-miR-338-5p      3'       GUGAGUCGUGGUCCUAUAACAA      5'
AATK 3' UTR        1576: 5'  ...GGCGGGAGUGAGCUCUGCUGGAG...  3' 1582
hsa-miR-338-3p            3'     GUUGUUUUAGUGACUACGACCU         5'
AATK 3' UTR        222: 5'  ...AUGUGUCCCGAGUGGAUGCUGGG...  3' 228
mmu-miR-338-3p      3'        GUUGUUUUAGUGACUACGACCU     5'
AATK 3' UTR        882: 5'   ...AAUAUUUUUGUAACUUGCUGGAG...  3' 888
mmu-miR-338-3p      3'      GUUGUUUUAGUGACUACGACCU        5'
AATK 3' UTR        998: 5'   ...AGUUUGAGGCUUAGGAUGCUGGU...  3' 1004
rno-miR-338-3p         3'       AGUUGUUUUAGUGACUACGACCU     5'
AATK 3' UTR        873: 5'   ...AGUAUUUUUGUAACUUGCUGGAG...  3' 879
rno-miR-338-3p         3'    AGUUGUUUUAGUGACUACGACCU        5'
Figure 2. An overview of  in silico identified putative miR-338 target sites within the 
AATK 3’ UTR. Three AATK genes are depicted namely Homo sapiens AATK (hsa-AATK), 
Mus musculus AATK (mmu-AATK) and Rattus norvegicus AATK (rno-AATK). The miR-338 seed 
sequence is indicated in red.
Moreover, the 3’ UTR of  human AATK mRNA contained a conserved sequence com-
plementary to the seed target region of  miR-338-3p (Figure 2). To explore whether 
miR-338 regulates AATK mRNA levels in neurons, AATK mRNA levels were moni-
tored after transfecting rat B35 neuroblastoma cells with a miR-338 expression vector. 
MiR-338 transfection resulted in a significant increase in the levels of  pre-miR-338, 
and mature miR-338-3p levels as compared with the endogenous miR-338 levels in null 
vector-transfected neuroblastoma cells (Figure 3A). In miR-338 overexpressing cells, 
AATK mRNA levels decreased by 30% when compared with null vector-transfected 
neurons (Figure 3B). To assess whether miR-338 can specifically target AATK mRNAs, 
B35 cells were co-transfected with the miR-338 expression vector and a luciferase re-
porter plasmid containing the rat AATK 3’ UTR. The presence of  the miR-338 expres-
sion vector significantly reduced luciferase activity by 15% in B35 cells as compared to 
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Figure 3. MiR-338 targets AATK. (A) Pre-miR-338, and miR-338-3p levels in B35 cells (trans-
fected with pmiR-338 or pmiR-null plasmids) were quantified following PCR. Pre-miR-338 lev-
els are visualized on 4% agarose gels containing ethidium bromide using UV absorption (254 
nm wavelength), and pre-miR-338 band intensities are expressed relative to U6 snRNA. Further-
more qRT-PCR assessment of  miR-338-3p levels, expressed relative to U6 snRNA following 
pmiR-338 overexpression versus the null condition. (B) Quantification of  AATK mRNA levels 
in B35 cells transfected with pmiR-338 or pmiR-null vectors, as determined 72 hrs following 
transfection using qRT-PCR. (C) Relative firefly luciferase activity in B35 cells measured in light 
units. Cells were co-transfected with luciferase encoding the 3’ UTR of  rat AATK (indicated as 
3’ AATK) and either with the pmiR-null control vector, or the pmiR-338 overexpression vector. 
Luciferase activity was normalized to Renilla luciferase activity. Error bars represent the SEM 
for n = 3 independent experiments, * is p<0.05 with pmiR-null vs. pmiR-338 (Student’s t test).
null-vector co-transfected neurons, indicating that 3’ UTR of  AATK mRNA is targeted 
by miR-338 (Figure 3C). The initial results derived from B35 cells transfected with the 
miR-338 vector suggest that miR-338 has the capacity to modulate AATK mRNA lev-
els. To specifically delineate the contribution of  mature miR-338-3p, or miR-338-5p in 
reducing AATK mRNA levels, we individually lipofected double-stranded miR-338-3p 
and miR-338-5p mimics into B35 cells. Transfection of  miR-338-3p and -5p resulted in 
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Figure 4. Regulation of  AATK by mature miR-338 Strands. (A) Relative mature miR-338 
levels in B35 cells transfected with either miR-338-3p, or miR-338-5p mimics, as compared 
to endogenous miR-338 (-3p, and -5p) levels in miR-NT transfected control cells. (B) AATK 
mRNA levels in B35 cells following transfection with mature miR-338 mimics (-3p, or 5p), as 
compared to host gene levels in miR-NT transfected B35 cells. Mature miR-338 levels are ex-
pressed relative to U6 snRNA, whereas AATK levels are normalized to the levels of  b-actin. 
Error bars represent the SEM for n = 3 independent experiments. (C) Relative firefly luciferase 
activity in B35 cells measured in light units. B35 Cells were co-transfected with luciferase en-
coding the 3’ UTR of  rat AATK (indicated as 3’ AATK) and either miR-338-3p, miR-338-5p 
mimics, or with miR-NT serving as non-targeting control ribo-oligonucleotides. Error bars rep-
resent the SEM for n = 8, * is p<0.05 and *** is p<0.0001 (one-way ANOVA with Bonferroni 
multiple comparison test).
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an approximately hundredfold increase in mature miR-338 levels, as compared to the 
endogenous miR-338 levels in non-target miRNA (miR-NT)-transfected neuroblasto-
ma cells (Figure 4A). As shown in Figure 4B, in miR-338-3p transfected cells a signif-
icant reduction of  AATK mRNA levels was achieved. Conversely, overexpression of  
miR-338-5p did not alter AATK levels significantly, as compared to the AATK mRNA 
levels of  miR-NT transfected control samples. To further substantiate this finding, we 
co-transfected B35 cells with the luciferase reporter plasmid containing the AATK 
3’ UTR combined with either miR-338-3p, or with miR-338-5p. When compared to 
the control conditions, the introduction of  the miR-338-3p reduced luciferase activity, 
~50% (Figure 4C). In contrast, luciferase levels did not change significantly when the 
miR-338-5p mimic was co-transfected with this reporter plasmid, indicating that rat 
AATK mRNA is specifically targeted by miR-338-3p. The outcome of  these studies 
indicate that while overexpression of  miR-338-5p may have modest, although not sig-
nificant, effects on AATK mRNA levels, most pronounced reduction of  the host gene 
mRNA levels is observed following the overexpression of  miR-338-3p in B35 cells.
Discussion
The outcome of  this study puts forward the idea that an intronic miRNA may have the 
capacity to regulate the expression of  its host gene. In agreement with previous mea-
surements, we find that the average level of  AATK repression is modest. Interestingly, 
van Oudenaarden and associates recently demonstrated that regulation by miRNAs es-
tablishes a threshold level of  target mRNA below which protein production is highly 
repressed. Near this threshold, protein expression responds sensitively to target mRNA 
input, consistent with a mathematical model of  molecular titration, suggesting that 
miRNAs can act both as a switch and as a fine-tuner of  gene expression [23]. Previous 
studies revealed an increased expression of  AATK mRNA and protein during postnatal 
brain development, and elevated levels of  AATK have been demonstrated to enhance 
neurite outgrowth [24]. Interestingly, it has been shown that AATK up-regulation is also 
associated with cultured apoptotic cerebellar granule neurons [11]. These findings sug-
gest that specific amounts of  AATK may be important for proper neuronal growth and 
homeostasis. A recent paper has suggested that miR-338 is involved in the control of  
neuroblast apoptosis and in neuroblastoma pathogenesis [25]. Thus, miR-338 mediated 
fine-tuning of  AATK expression levels during the onset of  neuronal differentiation and 
apoptosis may be an important physiological mechanism to control differentiation and 
the number of  neurons. Previous studies have suggested that approximately 20% of  in-
tragenic miRNAs have the capacity to target their host mRNA transcript [26]. Further, 
Kyoto Encyclopedia of  Genes and Genomes (KEGG) pathway analysis revealed that 
22 out of  74 pathways implicated the association of  host genes, demonstrated 
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Figure 5. Proposed model of  AATK regulation by its intronic miR-338. MiR-338 encoded 
within the seventh intron of  the AATK gene is transcribed from the genome (blue block). Sub-
sequent splicing generates the miR-338 precursor hairpin followed by Dicer-mediated matura-
tion, leading to the incorporation of  the mature miR-338-3p strand into the RISC complex. This 
ribonucleoprotein complex targets cis-acting binding sites for miR-338-3p (red blocks) located 
on the 3’ UTR of  AATK mRNA, resulting in the degradation of  the transcript (orange block).
significant over-representation of  proteins encoded by the mRNA targets of  associ-
ated intragenic miRNAs [7]. Similar to many intronic miRNAs, miR-338 lacks its own 
promoter and is therefore processed out of  its intronic sequence [27,28]. Previous in-
vestigations have revealed that the proportion of  intronic miRNAs whose expression 
profiles are synchronized with their host genes ranges between 34%–71% [29,30]. Here 
we propose a model, in which one of  the two complementary versions of  mature miR-
338, namely miR-338-3p, generated through splicing and Dicer-mediated maturation, 
has the capacity to modulate the expression level of  its host gene AATK in rat neuro-
blastoma cell lines (Figure 5). This outcome is in agreement with bioinformatics analy-
ses shown in Figure 2, in which the miR-338-5p binding site is restricted to the 3’ UTR 
of  the mouse homologue of  AATK mRNA, and is very poorly conserved evolutionary. 
For example, the -5p binding site is absent in the 3’ UTRs of  rat and human versions 
of  AATK mRNA. Despite the lack of  a cis-acting binding site for miR-338-5p in rat 
AATK mRNA, our studies indicate that overexpression of  this mature miRNA resulted 
in a modest reduction of  host gene mRNA levels in rat neuroblastoma cell lines. While 
the exact mechanism for this observation is not clear, we presume that reduced AATK 
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levels could be explained by secondary effects inherent with the overexpression of  this 
mature miRNA. This notion is further supported by our observation that luciferase ac-
tivity upon miR-338-5p introduction remained unchanged, suggesting that miR-338-5p 
lacks the capacity to directly modulate AATK levels through interacting with its 3’ UTR. 
A detailed survey of  miR-338-5p targets using the in silico TargetScan tool reveals that 
this miRNA has number of  transcription regulators (such as SP3, and SP2 transcription 
factors) as putative targets, which could be modulated in their expression and subse-
quent function upon miR-338-5p overexpression, resulting in altered AATK mRNA 
transcription. Recent studies have suggested a potential regulatory role of  co-expressed 
intronic miRNAs with their host gene. Furthermore, a few studies have suggested a 
functional relationship between miRNA host genes and putative targets of  correspond-
ing intronic miRNAs. For example, the heart-specific host gene Myh6 is co-expressed 
with the intronic miR-208a, the latter of  which has the capacity to regulate thyroid hor-
mone associated protein 1 and myostatin, both negative regulators of  muscle growth 
and hypertrophy [31]. Furthermore, the intron of  the schizophrenia-susceptibility gene 
GRID1 encodes miR-346 which is downregulated in schizophrenia, and based on target 
prediction algorithms preferentially targets genes which may be involved in the patho-
physiology of  this disorder [32].       
In conclusion, the current investigations have determined the expression pattern of  
miR-338 and its host gene AATK during in vitro differentiation of  primary hippocampal 
neurons and assessed the possible regulation of  AATK by miR-338-3p. Collectively, 
these results suggest that miR-338-3p has the capacity to modulate rat AATK mRNA 
levels. MiR-338-3p-dependent regulation of  AATK mRNA would thus offer a mecha-
nism to control availability of  this neuronal mRNA during neuronal differentiation and 
degeneration. This conjecture is presented here, as a testable hypothesis that we suggest 
should be subject to future experimental examination.
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Abstract
MicroRNAs (miRs) are small non-coding RNAs that confer robustness to gene net-
works through post-transcriptional gene regulation. Previously, we identified miR-338 
as a modulator of  axonal outgrowth in sympathetic neurons. In the current study, we 
examined the role of  miR-338 in the development of  cortical neurons and uncovered 
its downstream mRNA targets. Long-term inhibition of  miR-338 during neuronal dif-
ferentiation resulted in reduced dendritic complexity and altered dendritic spine mor-
phology. Furthermore, monitoring axon outgrowth in cortical cells revealed that miR-
338 overexpression decreased, while inhibition of  miR-338 increased axonal length. To 
identify targets mediating the observed phenotype, we inhibited miR-338 in cortical 
neurons and performed whole-transcriptome analysis. Bioinformatics-based pathway 
analysis revealed that miR-338 modulates a subset of  transcripts involved in the ax-
onal guidance machinery by means of  direct and indirect gene targeting. Collectively, 
our results implicate miR-338 as a novel regulator of  cortical neuronal maturation by 
fine-tuning the expression of  gene networks governing cortical outgrowth.
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Introduction
The cerebral cortex is a highly laminated and parcellated brain structure harbouring 
an intricate network of  neuronal circuitries. The correct functioning of  the cortex de-
pends on the precise formation of  its neural network architecture. In addition, several 
neurological disorders such as intellectual disability, schizophrenia and epilepsy display 
distinct alterations in cortical structure and circuitry [1-5]. One critical step in the neu-
rodevelopmental processes which underlie the formation of  the cortex, involves the 
outgrowth of  dendrites and axons to form functional cortical networks [6]. Neural 
network formation is tightly regulated by a set of  both intrinsic and extrinsic factors and 
understanding how these factors are involved in modulating the gene networks during 
cortical development is key for understanding neurodevelopmental disorders. 
MicroRNAs (miRs) have emerged as a class of  evolutionarily conserved small non-cod-
ing RNAs (ncRNAs) that regulate gene expression post-transcriptionally. Due to their 
relatively small binding sequence, a single miR can interact with multiple downstream 
mRNAs, while a single mRNA can be regulated by several miRs, enabling a single miR 
to convey robustness to an entire gene network with shared physiological roles [7-10]. 
Due to these assets, miRs represent a particularly vital group of  gene network regula-
tors. Importantly, a growing number of  experiments have thus far identified a critical 
role for individual miRs in orchestrating the tightly regulated gene expression required 
to direct cortical development. These investigations have shown that the activity of  sin-
gle miRs can be critical in controlling neurodevelopmental aspects such as neurogenesis 
[11], neuronal migration [12], axon and dendrite development [13,14], and ultimately 
synapse formation [15] and neuronal plasticity [16,17]. Furthermore, a growing body 
of  evidence suggests that even slight aberrations in miR activity can be detrimental to 
neuronal function [18-20].       
Previously, miR-338 has been shown to play a critical role in a number of  cell differen-
tiation processes [21,22]. For example, miR-338 is encoded intronically within its host 
gene, the apoptosis-associated tyrosine kinase (AATK), a gene implicated in neuroblas-
toma differentiation and the control of  axon and dendrite outgrowth in cortical neu-
rons [23-25]. In addition, miR-338 is enriched in the axons of  sympathetic neurons [26] 
and is capable of  locally modulating mitochondrial activity by regulating cytochrome c 
oxidase, subunit IV (COXIV) in the distal parts of  axons [27]. Since neurite outgrowth 
is crucial for regeneration, miR-338 may be of  critical importance in the treatment of  
neurological diseases. Notably, miR-338 was upregulated in blood leukocytes as well as 
in cerebrospinal fluid, serum, and spinal cord of  amyotrophic lateral sclerosis (ALS) 
patients [28]. Furthermore, its genomic region is frequently altered in neuroblastoma 
with mRNA targets encoding proteins involved in cell proliferation, neuroblast differ-
entiation, neuroblast migration and apoptosis [29].
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While most of  the studies on miR-338 have been reported in cells from the peripher-
al nervous system, miR-338 is known to be broadly expressed in the central nervous 
system (CNS) including the cortex [30]. Accumulating evidence indicates that this miR 
and its host gene AATK are involved in axonal outgrowth and differentiation [24,27]. 
However, little is known about its role in the differentiation and development of  cor-
tical neurons. In the present study, we examined the role of  miR-338 in acting as a 
modulator of  differentiation of  cortical neuronal cells. Collectively, our results reveal 
the impact of  miR-338 on normal cortical neuronal development, and identify miR-338 
as a controller of  genes within the axon guidance pathway through direct or non-ca-
nonical targeting of  downstream transcripts. Among these we found Roundabout, axon 
guidance receptor, homolog 2 (Robo2) as one of  the direct miR-338 targets. Through 
collective regulation of  these axon guidance genes, we place miR-338 as a vital regulator 
of  dendrite development and axonal growth.
Material and methods
Animals          
Embryonic day 18 (E18) embryos from timed-pregnant Wistar rats (Harlan labora-
tories B.V., Boxmeer, The Netherlands) were used as a resource for the isolation of  
primary cortical neurons. Animals were housed 2-3 per cage with ad libitum food and 
water access with a 12 h light cycle at controlled ambient temperature (21 ± 1°C). All 
animal use, care and experiments were performed according to protocols approved by 
the Committee for Animal Experiments of  the Radboud University Nijmegen Medical 
Centre, Nijmegen, The Netherlands.
Cell culture.          
HEK-293T cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) high 
glucose (4.5 g/L) (Life Technology, Grand Island, NY) supplemented with 10% fetal 
bovine serum (FBS) (Life Technology, Grand Island, NY) and penicillin-streptomycin 
(Pen/Strep) antibiotic mixture (Life Technology, Grand Island, NY). The cells were 
maintained at 37°C and 10% CO2. Primary cortical neurons were isolated from E18 rat 
embryonic brains. The cortical region was isolated and placed in ice-cold Hanks’ Bal-
anced Salt solution (HBSS) containing 2 mmol/L GlutaMAX (Life Technology, Grand 
Island, NY) and Pen/Strep antibiotics. Cortical tissue was washed two times with the 
HBSS washing buffer before adding a 0.025% trypsin in HBSS solution followed by 
incubation at 37°C for 15 minutes. After incubation, the tissue was washed 3 times with 
the HBSS washing buffer before adding Neurobasal (NB) medium (Life Technology, 
Grand Island, NY) supplemented with 10% FBS and 2 mmol/L GlutaMAX. The tis-
sue was titrated several times with a glass Pasteur pipette, this treatment was repeated 
with a fire-polished tip glass Pasteur pipette to obtain fully dissociated cells. Separated 
52
CHAPTER 3
cells were seeded in cell culture plates, which were coated overnight with 0.1 g/L, mol 
wt 70,000-150,000 poly-D-lysine (PDL) (Sigma–Aldrich, St. Louis, MO). For the first 
5 h, the cells were cultured in medium containing NB medium with 10% FBS and 
2 mmol/L glutaMAX. Afterwards, the medium was replaced with culturing medium 
containing NB with the serum free neural supplement B27 (Life Technology, Grand 
Island, NY) and 2 mmol/L glutaMAX. For culturing pure axonal fractions, microfluidic 
chambers were prepared by firstly ethanol cleaning the chambers. After the chambers 
were completely dry, they were placed on PDL coated coverglasses (Hecht Assistent, 
Sondheim von der Rhön, Germany). The chambers were subsequently filled with 100 
µl of  NB medium containing 10% FBS and 2 mmol/L GlutaMAX. This was done at 
least one day before seeding the cells such that any formed bubbles will be removed. A 
seeding density of  100,000 cells per chamber was used. All neuronal cell preparations 
were maintained at 37°C and with 5 % CO2. 
DNA constructs and transfection.        
The miR-338-sponge vectors were made by designing DNA oligonucleotides (Sigma–
Aldrich, St. Louis, MO) as previously described [16,31]. miR Sponge sequences were de-
signed to contain four complementary artificial binding sites for miR-338-3p (Table 1). 
Presynthesized DNA oligonucleotides were ligated 3’ to the stop codon of  the cDNA 
encoding eGFP of  the lentiviral pFUGW vector (Addgene, Cambridge, MA) using 
restriction sites BsrGI and EcoRI. Luciferase vectors containing the 3’ UTRs of  puta-
tive miR-338 targets were generated by cloning long DNA oligonucleotides (so-called 
gBlock fragments) (IDT, Leuven, Belgium) (Table 2) between the SacI and SalI restric-
tion sites of  the pmirGLO Dual-Luciferase miRNA target expression vector (Prome-
ga, Madison, WI). For Argonaute2 (Ago2) pulldown assays the pIRESneo-FLAG/HA 
Ago2 vector (Addgene, Cambridge, MA) was used (plasmid # 10822, previously de-
scribed [32]). All DNA constructs were sequenced to validate their correct identity. 
Table 1: pFUGW lentiviral miR-338 sponge oligonucleotides 
miR-338-sp-
Fw
5’GTACACAACAAAATGGAGATGCTGGAATCGCAACAAAATG-
GAGATGCTGGAATCGCAACAAAATGGAGATGCTGGAATCGCAA-
CAAAATGGAGATGCTGGAG 3’
miR-338-sp-
Rv
5’AATTCTCCAGCATCTCCATTTTGTTGCGATTCCAGCATCTC-
CATTTTGTTGCGATTCCAGCATCTCCATTTTGTTGCGATTCCAG-
CATCTCCATTTTGTTGT 3’
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Transfection of  primary neurons and mammalian cells was performed using the Screen-
fect A transfection agent (Genaxxon, Ulm, Germany), following the protocol provided 
by the manufacturer. In brief, Screenfect A together with either the anti-miR-338 (Ex-
iqon, Vedbaek, Denmark), miR-338 mimic (Qiagen, Germantown, MD) or a corre-
sponding non-targeting (NT) scrambled control were diluted in the provided dilution 
buffer in order to achieve a final concentration of  30-60 nM. The mixture was applied 
to the adherent primary neurons and left to incubate at 37°C for no longer than 24 
h. For transfection of  HEK-293T cells, ± 50000 cells / cm2 were first trypsinized, 
mixed with nucleotide/Screenfect A complexes, and after incubating for 20 mins, the 
cells were seeded on cell culture plates. For lentivirus production HEK-293T cells were 
transfected using the CaCl2 method. The viral particles were produced and purified as 
previously described [33]. The purified viral pellets were resuspended in 100 µl calcium- 
and magnesium-free HBSS. For infecting primary neurons, ± 0.5 µl/cm2 of  concentrat-
ed virus was added to the cultures. If  a lower infection rate was needed the virus was 
diluted 10-20 times before adding to the primary neuronal cultures. 
Luciferase assay          
HEK-293T cells were detached using trypsin and transfected with 75ng Dual-Glo lucif-
erase vector carrying the appropriate gene 3’ UTR together with 30nM or 60nM miR-
338 mimic, anti-miR-338 or a NT control. After addition of  the transfection mixture 
the cells were seeded in 96 wells plates. 24 hrs after transfection the cells were used 
for detection of  the luciferase bioluminescence using the Dual-Glo luciferase assay 
system (Promega, Madison, WI) according to the provided protocol and as previously 
described [34]. The cells and all the reagents were placed at room temperature to ensure 
a stable luciferase signal before measuring. For bioluminescence detection, a Victor2 
multi-label plate reader (Perkin Elmer, Waltham, MA) was used. Luciferase data was 
normalized by measurement of  renilla luminescence activity (encoded within the pmir-
GLO Dual-Luciferase miRNA target expression vector) by addition of  the Dual-Glo 
Stop & Glo reagent. 
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Table 2: 3’UTR gBlock gene fragments from selected genes (5’ → 3’)
Robo2 GCATCCGAGCTCAGCTCACTCTTTTTAACTCTGTTCATAT-
TATTGTCTGTTCTGATTGGTCTGTTGTACTATATGTGAAT-
TAATGGGCTGTGGTGCCATATATTAACTTTTAATTGTGTA-
ACTTTTTATGTTTAAATTTTGCACTGCGATTTTATTTGGTGA-
TAAGCACAAATCTCTACTCCTCATGACATGAAGAAAAGATT-
GAATGTGAAGGGAGTTTTCTGTACTGTAAGTTAGGTTGGA-
TAATGCTGGTGTAACCAATCCAGTTAGATGGTTTTCAGTTG-
GGGGTGTAGAAATAGGAAGATCGAAGGAATGATGGTGTTG-
GCAAAGTCTTCTTGAAACAACAGATATTGAGACAATTTTA-
AGAAGCAGAAAGATGGATACTATTGACTAAAGCAGGGGT-
CAAAAGAAGGGGGTTTAAGTCTAGACAGAGTATGTAATAAAG-
TATGGTGGTAGCAAAGATGTACTAACTTGCTTTAAAAATAGTC-
GACGGGACT 
Robo2 mutant GCATCCGAGCTCAGCTCACTCTTTTTAACTCTGTTCATAT-
TATTGTCTGTTCTGATTGGTCTGTTGTACTATATGTGAAT-
TAATGGGCTGTGGTGCCATATATTAACTTTTAATTGTGTA-
ACTTTTTATGTTTAAATTTTGCACTGCGATTTTATTTGGTGA-
TAAGCACAAATCTCTACTCCTCATGACATGAAGAAAAGATT-
GAATGTGAAGGGAGTTTTCTGTACTGTAAGTTAGGTTG-
GATATGTAACCAATCCAGTTAGATGGTTTTCAGTTGGGG-
GTGTAGAAATAGGAAGATCGAAGGAATGATGGTGTTGG-
CAAAGTCTTCTTGAAACAACAGATATTGAGACAATTTTAA-
GAAGCAGAAAGATGGATACTATTGACTAAAGCAGGGGT-
CAAAAGAAGGGGGTTTAAGTCTAGACAGAGTATGTAATAAAG-
TATGGTGGTAGCAAAGATGTACTAACTTGCTTTAAAAATAGTC-
GACGGGACT
RNA isolation, reverse transcription and real-time PCR      
Total RNA from primary neurons was isolated using the miRNAeasy kit (Qiagen, Ger-
mantown, MD), according to the manufacturer’s manual which allows for the preser-
vation of  both the small RNA and mRNA fraction. RNA purity was determined using 
the Nanodrop ND1000 (Thermo Scientific, Waltham, MA) UV-spectrophotometer. 
The 260/280 nm ratios were measured and samples with ratios of  2.0 ± 0.05 were 
considered pure. This was followed by RNA integrity assessment with a 1% agarose gel 
imaged with the Gel doc XR system (Bio-Rad, Hercules, CA). Samples showing clearly 
visible S28 and S18 ribosomal RNA bands were considered to be intact. cDNA was 
synthesized from isolated RNA according to the protocol provided with the revertAid 
First Strand cDNA Synthesis Kit (Fermentas, Life Technologies, Waltham, MA). To 
reverse transcribe small RNAs, the miScript reverse transcription kit (Qiagen, German-
town, MD) was used. Following cDNA synthesis, samples were diluted 1/10 with water. 
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Quantitative real-time PCR (QRT-PCR) detection of  mRNA transcripts was performed 
using the SensiFAST SYBR No-ROX kit (Bioline, London, United Kingdom) or the 
miScript SYBR green PCR kit (Qiagen, Germantown, MD) for the detection of  mature 
miRs according to the manufacturer’s manual. See Table 3 for the gene-specific primers 
that were used. Data were normalized to housekeeping genes (β-actin and U6) using 
GeNorm software [35]. 
Table 3: List of  qPCR primers (5’ → 3’)
Gene Forward-primer Reverse-primer
ROBO2 TCCGAGCTCCTCCACAGTTT CGGGAAAAGTAGGTTCTGGCT
ROCK2 GACCACAAAAGCACGACTAG-
CG
TTCTCGGCTTCCAGGAGTAGGT
PAK1 TCCTCTCGGCTATTACCGGC AGCAGCTACTTCTGCGCTCG
PAK6 GGCTCGACCACAATCTTGC AATTGAGCTTGTTCTGTGGCA
UNC5C TTTCTCAGGACTGCCTGGCG AAAAGTCATCATCTTGAGCGGC
ABLIM3 GGACGAAGCACCTGAGTCCT TAAGGCGAGTGGACGAACAG
NEGF CACTCGCTTGCTTACACACT GGTGGTTACCTTCCACCTCC
U6 GCTTCGGCAGCA CATATA CGCTTCACGAATTTGCGT
Β-Actin CGTGAAAAGATGACCCAGAT-
CA
AGAGGCATACAGGGACAACACA
miR-338-3p TCCAGCATCAGTGATTTTGTT 
G
Universal reverse primer (Exiqon)
Immunoprecipitation         
HEK-293T cells were detached and 500,000 cells were transfected with 1µg pIRES-
neo-FLAG/HA Ago2 vector together with either 30nM miR-338 mimic, 30nM an-
ti-miR-338 or 30nM of  a NT control. The transfected cells were seeded in 6 wells culture 
plates. The Ago2 immunoprecipitation assay was performed largely as described pre-
viously [36], with some minor differences. After 2-3 days of  culture, cells were lysed at 
-80°C for 1 h with 0,5 ml lysis buffer (10% glycerol, 20mM Tris (pH 8), 0.2mM EDTA, 
0.5% NP-40, 0.5M KCl, 1mM DTT, supplemented with Complete mini EDTA-free 
protease inhibitors (Sigma–Aldrich, St. Louis, MO) and 1 u/µl RiboLock RNase inhib-
itor (Thermo Scientific, Waltham, MA)). Cell lysates were centrifuged for 10 minutes 
at 12,000 x g. To the supernatant 20 µl anti-Flag M2 agarose beads (Sigma–Aldrich, St. 
Louis, MO) was added and incubated for 2 h at 4°C under gentle agitation. The beads 
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were washed 3 times with lysis buffer followed by elution with 1 mg/ml Flag peptide 
(sequence DYKDDDDK) (Sigma–Aldrich, St. Louis, MO) in 10% glycerol, 20mM Tris 
(pH 8), 0.2mM EDTA, 0.5% NP-40, 0.1M KCl, 1mM DTT supplemented with prote-
ase and RNAase inhibitors. RNA was isolated from the eluate using the miRNeasy kit 
as described above. Equal concentrations of  RNA were used for cDNA synthesis. 
RNA sequencing and bioinformatics analyses       
RNA sequencing (RNA-seq) was performed on samples obtained from primary corti-
cal neurons transfected with either an anti-miR-338 or a NT scrambled control RNA 
(Exiqon, Vedbaek, Denmark) at days in vitro (DIV) 2. RNA was isolated at DIV 6 from 
three separately generated samples and subsequently pooled to generate one sample for 
each condition. RNA quality was determined by acquiring the ribosomal integrity num-
ber (RIN) using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), revealing 
a RIN of  above 9.0 for all samples. The samples were subsequently processed further 
by Hudson Alpha Institute for Biotechnology (Huntsville, AL, USA). Sequencing was 
performed on two separate flow cells with a total of  more than 30 million 50 bp reads 
per sample. The generated sequencing data was mapped, assembled into genes and an-
alysed using the Genesifter genetic analysis software (Geospiza, Perkin Elmer, Seattle, 
WA). Normalization was based on the total number of  mapped reads and the RPKM 
(reads per kilobase per million mapped reads) expression threshold was set at 10. Gene 
expression changes would be considered statistically significant with a p-value ≤ 0.001 
determined with the likelihood ratio test and Benjamini and Hochberg correction for 
multiple testing. Gene ontology (GO) and clustering analysis was performed on sig-
nificantly up and down regulated genes using the DAVID database for functional gene 
annotation and KEGG pathway mapping [37,38]. For GO term clustering of  the an-
notated genes a high stringency setting was used. MiR-338 binding sites were identified 
within the 3’ UTR of  genes using DIANA-microT v5.0 algorithm [39]. This program 
combines both conserved and nonconserved binding sites for each target transcript and 
combines it to calculate a final prediction score. The higher the prediction scores the 
lower the likelihood for a false positive target. For our analysis we used a threshold of  
0.6. 
Immunolabeling and imaging        
For immunocytochemistry, cells were fixed with warm (37°C) 4% PFA and 16% su-
crose in PBS for 30 min. After washing with PBS (3 x 5 min at RT) cells were incubated 
for 15 min at RT with 50 mM NH
4
Cl to quench residual aldehydes. Cells were washed 
(3 x 5 min at RT), permeabilized with 0.1% Trixon X-100 for 5 minutes at RT, incu-
bated with 2% BSA (ICN Biomedicals Inc., Santa Ana, CA) in PBS for 30 min at RT 
to block nonspecific staining, and were incubated with the primary antibodies in 2% 
BSA in PBS. Incubation in primary antibodies was done overnight at 4°C. Subsequent-
57
MIR-338 CONTROLS CORTICAL NEURONAL OUTGRWOTH 
3
ly, cells were washed in 2% BSA in PBS (3 x 5 min) and incubated in species-specific, 
Alexa-conjugated secondary antibodies in 2% BSA in PBS for 30-60 min at RT, washed 
in 2% BSA in PBS (3 x 5 min), and washed (3 x 5 min) in PBS containing fluores-
cent DAPI (Sigma–Aldrich, St. Louis, MO at 1:3000). The coverslips were mounted 
in Prolong Gold (Invitrogen). Primary antibodies included chicken anti-GFP (Abcam, 
Cambridge, UK at 1:500), mouse anti-MAP2 (Sigma–Aldrich, St. Louis, MO at 1:1000), 
rabbit anti-Robo2 (Sigma–Aldrich, St. Louis, MO at 1:500). Secondary antibodies in-
cluded Alexa488 goat anti-chicken (Molecular Probes, Life Technologies, Grand Island, 
NY at 1:500), Alexa568 goat anti-mouse (Molecular Probes, 1:500) and Alexa488 goat 
anti-rabbit (Molecular Probes, Life Technologies, Grand Island, NY at 1:500). Staining 
of  DIV 3 or DIV 6 neurons cultured in microfluidic chambers was done with acti-stain 
488 fluorescent phalloidin according to the provided manufacturer’s protocol (Cyto-
skeleton Inc., Denver, CO). The microfluidic chambers were removed before staining. 
Images from axon chambers were made by capturing multiple higher magnification 
micrographs followed by matching and stitching together individual images to generate 
overview panels of  large sections from each chamber. Fluorescent images of  the neu-
rons and brain slices were obtained using a Leica DMRA fluorescence microscope fitted 
with a DFC340 FX CCD camera (Leica, Wetzlar, Germany) or a Leica TCS SP2 AOBS 
Confocal Laser Scanning Microscope (CLSM) (Leica, Wetzlar, Germany).
Western blot           
Primary cortical neurons were transfected at DIV 2 with NT control, miR-338 mimic or 
anti-miR-338 RNA. Cells were homogenized at DIV 6 with ice-cold lysis buffer (50 mM 
Tris [pH 8.0], 150 mM NaCl, 1% Triton X-100, and protease inhibitors). Samples were 
subjected to Western blot analysis and specific bands were detected using rabbit an-
ti-Robo2 (Sigma–Aldrich, St. Louis, MO at 1:1000) and mouse anti-TUBB3 (Covance, 
Princeton, NJ at 1:4000).
Neuronal morphology analysis    
The fluorescent images were randomized and analysed in a blinded fashion. For Sholl 
analysis, images of  DIV 21 cortical neurons infected at DIV 6 were taken with a Leica 
DMRA fluorescent microscope using a 20x optical zoom. One pixel wide concentric 
circles originating from the somatic centre were placed over fluorescent neurons using 
ImageJ software. The intersecting dendrites with each circle were quantified. Axons 
were measured from panels consisting of  stitched together images using the ImageJ 
plugin, NeuronJ [40]. All axons from an entire chamber were measured from the dotted 
white line depicted in Figure 3c-d and averaged. For dendritic spine analysis, spines 
were imaged using a CLSM with an optical zoom of  63x. Secondary dendritic segments, 
branching of  primary dendrites (originating from the soma) were selected for analysis. 
Neuronstudio software was used to quantify spine density per dendritic segment and 
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determine the spine head length and diameter [41].
Statistical analysis         
Quantitative data are presented as the mean ± s.e.m. Non-paired two-tailed Student’s 
t-test was used to determine significant differences between two groups. One-way 
ANOVA with Bonferroni’s multiple comparison testing was used to analyse significant 
differences between multiple groups. P ≤ 0.05 was considered significant. 
Results
MiR-338 affects dendritic complexity and axon outgrowth in rat cortical neurons 
in vitro
To investigate the extend of  miR-338 to modulate cortical neuronal differentiation, 
we first examined its expression levels in rat cortical neurons growing in vitro. In a 
previous study, we have shown that the expression of  this miR in developing primary 
hippocampal neurons is dynamically regulated [34], however, little is known about miR-
338 expression in cortical neurons. To determine this, total RNA was isolated from 
dissociated primary cortical cultures at eight different neuronal maturation time points, 
namely DIV 0, 1, 3, 6, 10, 14, 18, and 21 (Fig. 1a). qPCR analysis revealed that miR-338 
is expressed relatively early at DIV 0 and 1. Two distinct peaks in miR-338 expression 
levels were detected at DIV 3 and DIV 18, when the level of  this miR increased approx-
imately four-fold as compared to miR-338 expression at DIV 0. After miR-338 levels 
peaked, its expression returned to significantly lower levels at DIV 6 and DIV 21 to ap-
proximately 1.8 fold of  DIV 0 levels. These results suggest that miR-338 is abundantly 
and dynamically expressed during the growth of  cultured cortical neurons. Since these 
expression peaks correspond to extensive neurite growth and spine development in vi-
tro, we studied whether miR-338 is involved in these processes. We generated a miR-338 
repressing (sponge) lentivirus allowing long-term and efficient repression of  miR-338 
(Fig. 1b). The construct contains four complementary miR-338 sequences within the 
3’ UTR of  a GFP gene, with each binding site having a central mismatch previously 
shown to increase the efficiency of  miR repression [31,42]. qPCR analysis of  RNAs 
from primary cortical neurons infected with this miR-338 sponge revealed a significant 
reduction of  miR-338 (Fig. 1c). To test whether endogenous miR-338 has the capacity 
to modulate dendrite development, we performed Sholl analysis on mature DIV 21 cor-
tical neurons infected with the miR-338 sponge lentivirus (Fig. 1d-e). Neurons in which 
miR-338 was inhibited showed a significant decrease in dendritic sprouting (mean 5.344 
± 0.240 versus 6.7 ± 0.333 number of  intersections at 20 µm distance from the soma; 
p=0.0015), as compared to neurons expressing only GFP (Fig. 1e).
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Fig. 1 miR-338 inhibition reduces dendritic complexity in primary rat cortical neurons. a Rela-
tive expression of  miR-338-3p levels determined by qPCR in primary cortical neurons isolated 
at several developmental time points starting from 0 days in vitro (DIV 0) to DIV 21. Data 
represents relative fold change as compared to miR-338-3p expression at DIV 0, with error 
bars ± s.e.m. One-way ANOVA with Bonferroni multiple comparison test, n = 3 independent 
experiments with 3 different samples each; ** P < 0.001, *** P < 0.0001. b Schematic overview 
of  the miR-338 sponge design to allow for long-term specific sequestering of  miR-338-3p. 
The human ubiquitin c promoter (UbC) promoter driven lentiviral miR-338 sponge construct 
contains 4 complementary binding sites for miR-338-3p (highlighted in green blocks) within the 
3’ UTR the GFP gene. Here, it is also shown how the sponge sequence is designed to interact 
with the mature miR-338-3p, containing a three-nucleotide bulge to prevent the degradation 
of  the sponge mRNA and an arbitrary 4 nucleotide long linker region between each miR-338 
binding site. c qPCR analysis of  miR-338-3p levels of  DIV 8 primary cortical neurons infected 
with a GFP control or the miR-338 sponge at DIV 1. miR-338-3p expression levels were nor-
malized to U6 with the control set to one. Two-tailed unpaired students t test, n = 3 samples 
from independent experiments; * P = 0.0282. d Representative micrographs of  DIV 21 primary 
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cortical neurons used for the Sholl analysis infected with either control GFP or miR-338-sponge 
lentivirus at DIV 6. e Quantification of  dendritic arborisation using Sholl analysis of  neurons 
infected with either control (black line) or miR-338 sponge (blue line) lentivirus. Data represents 
the mean with error bars ± s.e.m. Two-tailed unpaired students t test, n = 30-33 cells collected 
from 3 independent experiments.
Furthermore, cortical neurons infected with a miR-338 sponge exhibited a decrease in 
dendritic arborisation as revealed by an exacerbated decrease in the number of  inter-
secting dendrites at 40 µm and 60 µm distance from the soma compared to control-in-
fected neurons. miR-338’s capacity to influence dendrite development led us to analyse 
the number and morphology of  dendritic spines of  DIV 21 cortical cells infected with 
the miR-338 sponge. Morphological analysis of  the dendritic spines revealed that miR-
338 inhibition failed to alter spine density (mean 0.77 ± 0.06 control versus 0.75 ± 0.07 
miR-338 sponge spines per µm; p=0.8254) (Fig. 2a,b), while it increased spine head 
diameter (mean 0.52 ± 0.008 control versus 0.68 ± 0.016 miR-338 sponge µm wide 
spines; p=<0.0001) (Fig. 2c) and spine length (mean 1.287 ± 0.03 control versus 1.596 
± 0.05 miR-338 sponge µm long spines; p=<0.0001) as compared to control-GFP 
infected neurons (Fig. 2d). miR-338 was previously observed to attenuate axon growth 
and function in sympathetic superior cervical ganglia neurons [21]. Furthermore, our 
qPCR expression study showed that miR-338 has an expression peak in cortical cells af-
ter 3 days in culture (Fig. 1a), which coincides with extensive morphological maturation, 
including increased axon growth and development [43]. To assess the role of  miR-338 
on axonal outgrowth in cortical cells, we aimed at rapidly and acutely altering miR-338 
expression levels in young cortical cells. Since the lentiviral miR-338 sponge acts too 
slow for sufficient expression inhibition to take place at these earlier time points, we 
opted to use short miR-338 mimics and anti-miR-338 locked nucleic acid (LNA) oligo-
nucleotides to acutely alter miR-338 levels in developing cortical neurons. In previous 
studies we revealed that miR-338 mimics and inhibitors are able to significantly increase 
or decrease miR-338 expression levels within 48-72 hrs after transfection, respectively 
[21,34]. To complement these findings, human embryonic kidney (HEK) 293 cells were 
transfected with FLAG-tagged Ago2 together with miR-338 mimic or anti-miR-338. 
Immunoprecipitation of  the RNA bound to FLAG tagged Ago2 two days after trans-
fection, followed by RNA isolation and qPCR analysis revealed that miR-338 mimic 
increases whereas anti-miR-338 decreases Ago2 bound miR-338 as compared to a NT 
scrambled control oligonucleotide  (Fig. 3a-b). This finding suggests that transfection 
of  cells with the miR-338 mimic increases, whereas the anti-miR-338 decreases incor-
poration of  mature miR-338 into the RNA induced silencing complex (RISC). To study 
axon growth in cortical neurons, we used microfluidic chambers, 
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Fig. 2 MiR-338 inhibition alters spine morphology in cortical neurons. a Images of  whole cells 
(upper panels) and high-magnification spiny dendrite images (lower panels) of  GFP control or 
miR-338-sponge expressing DIV 21 primary cortical neurons infected at DIV 6. The inserted 
boxes in the upper whole-cell panels represent the magnified areas shown below. Quantifications 
of  b Average spine density, c spine head diameter and d spine length are shown for control or 
miR-338 sponge infected neurons. Error bars represent s.e.m. Two-tailed unpaired students t 
test, n = 3 independent experiments with 8-10 cells per experiment; *** P < 0.0001.
which allowed us to readily trace the extensive network of  growing axons [44]. Primary 
cortical cells were transfected at DIV 2 with miR-338 mimic or anti-miR-338, and after 
phalloidin staining, axon length was measured at DIV 3 and DIV 6 (Fig. 3c-d). Com-
pared to a NT control, miR-338 overexpressing neurons exhibited an attenuated axon 
growth at DIV 3 and DIV 6 (mean of  25.5% decrease at DIV3 and a mean of  39.3% 
decrease at DIV6, p=<0.0001; Fig. 3e,f), whereas inhibiting miR-338 increased axon 
outgrowth (mean of  54.2% increase at DIV 3 and a mean of  31.7% increase at DIV 6, 
p=<0.0001; Fig. 3e,f). Together, these results emphasize previous observations on the 
impact of  miR-338 alterations on axonal outgrowth in sympathetic superior cervical 
ganglia neurons [21]. 
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Fig. 3 MiR-338 attenuates axonal outgrowth in cultured cortical neurons. a-b qPCR analysis 
of  miR-338-3p levels in FLAG-tagged Ago2 pulldown samples isolated from HEK-293T cells 
co-transfected with a miR-338 mimic or b anti-miR-338 compared to non-targeting (NT) con-
trols. c, d Representative images of  growing axons stained with phalloidin from DIV 6 cor-
tical neurons cultured in microfluidic chambers transfected at DIV 2 with miR-338 mimics, 
anti-miR-338 or NT controls. Axon bundles were measured from the white dotted line. e-f 
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Quantified average axonal length of  e DIV 3 and f DIV 6 neurons during overexpression (30 
nM miR-338 mimic) or inhibition (30 nM anti-miR-338) of  miR-338 relative to a NT transfected 
control (30 nM). Bars represent mean relative values to control with error bars ± s.e.m. Two-
tailed unpaired students t test, axons measured from n = 3 chambers per condition; **** P < 
0.0001.
miR-338 regulates the expression of  axon guidance genes   
miRs have the capacity to regulate multiple downstream mRNA transcripts, enabling 
them to refine specific gene networks that control a variety of  cellular functions [45,46]. 
Previous findings have suggested that regulation by a miR results in mRNA degradation 
of  the vast majority of  its target genes [47]. To identify the miR-338 regulated down-
stream gene networks controlling neuronal development, we performed deep-sequenc-
ing of  the transcriptome of  primary cortical neurons in which miR-338 was inhibited 
(Fig. 4a). In light of  our in vitro neurite outgrowth findings, we opted for the use of  DIV 
6 primary cortical neurons since there is a high degree of  ongoing neurite outgrowth at 
this time point. To rapidly and acutely inhibit miR-338 function, DIV 2 cortical neurons 
were transfected with the anti-miR-338. Anti-miR-338-mediated inhibition resulted in 
the differential expression of  854 genes with 536 down-regulated and 318 up-regulat-
ed transcripts at DIV 6 using a p-value cut-off  of  0.001 (Fig. 4b). To reveal the cor-
responding gene networks associated with the inhibition of  miR-338, we performed 
functional gene annotation and clustering analysis using DAVID on the total pool of  
significantly altered genes. This gene ontology (GO) analysis revealed a large number 
of  miR-338 modulated genes involved in neurite development. The annotation cluster 
with the highest score (8.64, using a high clustering stringency) consists of  six GO 
terms with the most significant being neuron projection development, with a p-value 
of  3.70E-07 (Fig. 4c). This finding suggests that miR-338 has the capacity to control a 
set of  neurodevelopmental genes either by directly binding to these transcripts or by 
secondary downstream regulation. Based on previous findings that miRs can regulate 
sets of  genes functionally connected within a single pathway [48,49], we employed a 
KEGG (Kyoto Encyclopedia of  Genes and Genomes) analysis to map altered miR-
338 mediated transcripts into distinct gene pathways. This inquiry identified several en-
riched canonical pathways as summarized in Fig. 4d. Among the putative miR-338 me-
diated gene pathways identified, the axon guidance pathway was found to be the most 
significant with a calculated p-value of  4.40E-4, containing 17 up- or down-regulated 
axon guidance genes. To further identify direct miR-338 targets within this pathway, we 
filtered out the eight (of  the total of  17) significantly upregulated axon guidance genes 
as a consequence of  miR-338 inhibition (Fig 4e). 
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Fig. 4 Transcriptome analysis shows that miR-338 regulates a subset of  genes involved in axon 
growth. a An experimental outline of  the transcriptome analysis in cortical neurons transfected 
with anti-miR-338, or NT control oligonucleotides followed by RNA sequencing (RNAseq) 3 
days post transfection. The sequencing data was analysed using DAVID functional annotation 
and GO term clustering. b A pie diagram depicting the number of  significantly (P < 0.001) up 
(blue) and down (orange) regulated genes. c Gene ontology based clustering by DAVID show-
ing the annotation cluster with the highest enrichment score (8.64). Presented are the GO term 
processes, the number of  assorted genes clustered within each category and the corresponding 
p-value. d Top 10 significant canonical KEGG pathways with the number of  associated mole-
cules. e A list of  significantly upregulated axon guidance genes identified with the KEGG path-
way analysis. It shows the gene symbol, full gene name, the fold change increase, the associated 
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65
MIR-338 CONTROLS CORTICAL NEURONAL OUTGRWOTH 
3
p-value identified with RNA sequencing and whether or not it has a putative miR-338 binding 
site identified by DIANA. f qPCR validation of  the upregulated axon guidance genes identified 
by RNA sequencing. Data represents the relative to control mean fold change with error bars ± 
s.e.m. Two-tailed unpaired students t test, n = 3 samples from independent experiments; ** P < 
0.01, *** P < 0.001 and **** P < 0.0001.
To further define miR-338 regulated transcripts, the computational miR seed prediction 
algorithm DIANA-microT v5.0 was utilized to identify putative miR-338 binding sites 
within the eight axon guidance genes. A cut-off  threshold of  at least 0.6 or higher was 
used, where a higher score means a lower amount of  false positives [50]. Furthermore, 
the identified binding sites needed to be conserved between mouse and rat. This anal-
ysis resulted in the identification of  one binding site within the 3’ UTR of  Robo2 and 
two binding sites in Rock2 (Rho-associated protein kinase 2) (Fig. 4e). qPCR validation 
confirmed the upregulation of  all of  the selected axon guidance genes (control vs, Pak6 
p=0.0046, Robo2 p=<0.0001, Ucn5c p=0.0002, Ablim3 p=0.002, Rock2 p=<0.0001, Ngef 
p=0.002 and Pak1 p=0.0046) identified by RNA sequencing (Fig. 4f). These results 
suggest that miR-338 has the capacity to alter the expression of  several axon guidance 
genes either by directly or indirectly interacting with downstream target transcripts.
miR-338 regulates Robo2 gene expression     
To further pinpoint miR-338 targets responsible for the miR-338 induced neurodevel-
opmental phenotypes, we set out to identify consensus miR-338 regulatory sequences 
within the 3’ UTRs of  the RNA sequencing determined putative target genes. Although 
initial luciferase reporter assays revealed that the 3’ UTR of  Rock2 is not directly reg-
ulated by miR-338 (data not shown), we further examined Robo2 as a potential direct 
miR-338 target since it contains a conserved miR-338 binding site within its 3’ UTR 
(Fig. 5a) and its mRNA levels were upregulated in miR-338 repressed cortical cells, as 
identified by RNA sequencing and qPCR (Fig. 4e,f). In order to pinpoint miR-338 reg-
ulation sites within the 3’ UTR of  Robo2, we performed luciferase gene activity assays 
using a luciferase vector carrying the 3’ UTR of  Robo2 containing the putative miR-338 
binding site. The Robo2 3’ UTR luciferase reporter construct was co-transfected with a 
miR-338 mimic or a NT control into HEK cells to assess whether increased miR-338 
levels result in decreased luciferase activity. Adding the 3’ UTR of  Robo2 led to a sig-
nificant 24% decrease in luciferase activity compared to NT transfected control (Robo2 
3’ UTR NT control vs miR-338 mimic, p=<0.0001) (Fig. 4b). Furthermore, miR-338 
inhibition by transfection of  anti-miR-338 inhibitor caused an increase of  13% (NT 
control vs anti-miR-338 30nM, p=<0.0001) and 40% (NT control vs anti-miR-338 
60nM, p=<0.0001) in luciferase activity in a dose-dependent manner as compared to 
the NT-transfected control (Fig. 5b). To show that this modulation by miR-338 is due to 
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direct association with the binding site residing in the 3’ UTR of  Robo2, we generated a 
luciferase reporter construct in which the 7-mer seed sequence for miR-338 was entirely 
deleted. This mutation abolished miR-338-induced regulation both during overexpres-
sion and inhibition of  miR-338 (Fig. 5b), showing that miR-338 can directly bind to the 
3’ UTR of  Robo2 and that the seed sequence located at nucleotide positions 542-548 is 
essential for regulation to take place. To examine whether miR-338 can regulate Robo2 
mRNA levels, primary cortical neurons were transfected with 50 nM miR-338 mimic 
or 50 nM anti-miR-338 inhibitor at DIV 2 followed by RNA isolation at DIV6 and 
subsequently qPCR analysed. This analysis revealed a bi-directional regulation of  Robo2 
during miR-338 modulation (Fig. 5c). Overexpression of  miR-338 resulted in a signif-
icant decrease of  28% in Robo2 mRNA levels, compared to a NT-transfected control 
(NT control vs miR-338 mimic, p=0.0106), while inhibition of  miR-338 led to a sig-
nificant 40% increase in Robo2 mRNA levels (NT control vs anti-miR-338, p=0.0023). 
This outcome indicates that miR-338 regulation of  Robo2 is due to mRNA destabili-
zation resulting in the degradation of  the transcript. To investigate whether the effect 
of  this regulation is also detectable at the protein level, protein samples were extracted 
from DIV 6 primary cortical cells either overexpressing or underexpressing miR-338 
(transfected at DIV 2). As expected, a bidirectional regulation was observed with a 27% 
decrease (NT control vs miR-338 mimic, p=0.0037) and 48% increase (NT control vs 
anti-miR-338, p=0.0003) in Robo2 protein during miR-338 overexpression and inhibi-
tion compared to the control, respectively (Fig. 5d). To further examine the regulation 
of  Robo2 by miR-338, we asked whether gain- or loss-of-function of  miR-338 could 
modulate Robo2 protein expression. To study this, we utilized the same protocol used 
in the experiments described above where DIV 6 cortical cells were transfected with 
an NT control, miR-338 mimic or anti-miR-338 inhibitor, followed by fluorescently 
labelling Robo2 protein. Overexpression of  miR-338 resulted in a significant 26% de-
crease (NT control vs miR-338 mimic, p=0.0146), while inhibition of  miR-338 led to 
a 32% increase of  Robo2 protein (NT control vs anti-miR-338, p=0.015) (Fig. 8d). In 
conclusion, these data show that miR-338 targets the 3’ UTR of  Robo2 and post-tran-
scriptionally regulates its expression in cortical neurons. 
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Fig. 5 MiR-338 regulates Robo2. a In silico identified miR-338-3p binding site in the 3’ UTR of  
Robo2 conserved in mouse and rat. Both the type of  seed sequence binding and the nucleotide 
position within the 3’ UTR are shown. Nucleotides depicted in blue are complementary (con-
nected with a blue line), while nucleotides in red are not complementary to miR-338-3p. Nucle-
otides forming a wobble base pair are connected with a blue dot. b HEK-293T cells transfected 
with luciferase reporter constructs containing the 3’ UTR fragment of  Robo2 (black bars), in 
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which overexpression led to a decrease, while a dose-dependent inhibition of  miR-338 increases 
the luciferase activity compared to the NT control (dotted black line). A miR-338 seed mutant 
(red bars) did not respond to miR-338 modulation. n = 4 independent experiments with 4-8 
samples per repetition. c-e Cortical neurons were transfected with 50 mM NT control, miR-338 
mimic or an anti-miR-338 at DIV 2 and analysed at DIV 6. b Relative Robo2 mRNA levels in 
cortical neurons assessed by qPCR during miR-338 overexpression and inhibition, compared to 
a NT control. n = 4 samples from independent experiments. c Immunoblot of  Robo2 protein 
of  samples isolated from cortical neurons transfected with NT control, miR-338 mimic or an-
ti-miR-338 with its corresponding band intensity quantification. For Robo2, the intensity of  the 
lower ~150 kDa band was measured, indicated with the red arrow. TUBB3 (tubulin, beta 3 class 
III) served as loading control. n = 3 samples from independent experiments. d Immunostaining 
of  MAP2 (red), Robo2 (green) and the overlay in primary cortical neurons transfected with NT 
control, miR-338 mimic and anti-miR-338. Average cell intensities collected from n = 3 samples 
from independent experiments. Data represents mean fold change with error bars ± s.e.m. One-
way ANOVA with Bonferroni multiple comparison test; * P < 0.05, ** P < 0.01, *** P < 0.001.
Discussion
This study provides evidence that miR-388 is important for dendrite formation and 
axon outgrowth during cortical neuronal development. The dendrites of  cultured corti-
cal neurons were significantly less complex when miR-338 activity was inhibited, while 
the length and diameter of  the dendritic spines were increased. Furthermore, miR-338 
inhibition in cortical neurons resulted in longer axons, while increasing miR-338 levels 
reduced axon growth. In addition, whole-transcriptome analysis of  cultured cortical 
neurons in which miR-338 activity was inhibited identified a large set of  upregulated 
transcripts involved in neuronal development. Pathway-based gene clustering pointed 
towards a significant enrichment of  axon guidance genes, of  which we found Robo2 
to be a direct miR-338 target. Together, our observations support the idea that ma-
nipulating miR-338 expression levels induces changes in neurite outgrowth of  cortical 
neurons, suggesting that this miR actively participates in the promotion of  neuronal 
development.          
We assessed the underlying mechanism of  miR-338 regulation in neuronal cortical de-
velopment by identifying its target genes. This approach provided a global view of  alter-
ations to the transcriptome during miR-338 inhibition. Our studies suggest that miR-338 
is involved in the posttranscriptional regulation of  neurite growth by steering cortical 
neurons towards dendritic growth while decreasing axon growth. Indeed, our analysis 
of  miR-338 targets identified a large number of  genes involved in axon or dendrite 
growth and development pathways. In keeping with these findings, we have previously 
demonstrated that miR-338 is involved in controlling axonal outgrowth in sympathetic 
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neurons by regulating the local levels of  a number of  nuclear-encoded mitochondrial 
proteins in the axons, such as COXIV and ATP5G1 [27,21]. Moreover, we have shown 
that miR-338 can directly target the 3′ UTR of  its host gene, encoding AATK [34], a 
kinase that plays a critical role in neuronal differentiation and axon outgrowth [23,24]. 
The study presented here suggests that miR-338’s action to modulate neuronal out-
growth and differentiation is mediated by direct and indirect regulation of  several axonal 
guidance pathway genes, such as Robo2, since miR-338 overexpression results in Robo2 
mRNA degradation and its subsequent translational diminution. Previously, Robo2 has 
been identified as a receptor important in stimulating axon growth [51]. Furthermore, 
Robo2 knock-out studies have shown exacerbated neuronal progenitor cell division 
and enhanced neuronal migration towards the cortical plate, as well as an increase in 
the outgrowth of  neurite processes of  migrating neurons [52,53]. These findings are 
largely in line with the observed effect of  miR-338 on process growth and branching, 
and may at least be partly attributed to the modulation of  Robo2 levels. This and other 
studies suggest that miR-338 has multiple downstream targets with converging roles in 
neural growth and development. Furthermore, it has also become increasingly clear that 
miRs can modulate gene expression in an indirect manner [54,55]. This non-canonical 
gene regulation could be facilitated by directly regulating the expression of  transcription 
factors, RNA binding molecules, components of  the nonsense-mediated mRNA decay 
pathway or modulate the activity of  the RNA translation system [56,54,57]. In light of  
this, we predict that direct and indirect regulation of  axon guidance genes, including 
Robo2, contribute to miR-338’s guided control of  cortical development.    
Accumulating evidence indicates that post-transcriptional mechanisms involving miRs 
are essential for the regulation of  cortical development. Our data demonstrate a critical 
role of  miR-338 during neurite development of  cortical neurons, and further supports 
the notion for a tight temporal regulation of  this miR’s expression for proper function 
in this process. Nevertheless, due to the extensive expression of  miR-338 throughout 
the development of  cortical cells, we suspect that miR-338 modulates gene expression 
at multiple steps of  cortical development which could be indicative of  a multitude of  
neurodevelopmental functions for this miR.      
The miR-338 target Robo2 is cooperatively involved with other axon guidance genes in 
axon development and could be responsible for the observed miR-338 cellular pheno-
types. However, additional direct and indirect targets of  miR-388 are likely to contribute 
as well. Indeed, miR-338 inhibition resulted in the altered expression of  a relatively large 
number of  axon guidance genes. This emphasizes the need to delineate the significance 
of  the full spectrum of  genes regulated by miR-338 at a particular time and place in 
order to understand how these targets collectively contribute to the assigned function 
of  miR-338 in cortical neuronal development. 
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Abstract
The precise spatial and temporal regulation of  gene expression is vital for development 
and overall functioning of  the brain. MicroRNAs (miRs) are small non-coding RNAs 
that control gene targets through post-transcriptional gene regulation. miR-338 was 
recently identified as a modulator of  axon maturation and function in superior cervical 
ganglia (SCG) neurons. Here, we show that reduction of  miR-338 levels in the develop-
ing mouse cortex, using a sequence-specific miR-sponge, resulted in a loss of  neuronal 
polarity in the cortical plate and significantly reduced the number of  neurons within this 
cortical layer. Conversely, miR-338 overexpression increased the number of  neurons 
in the developing mouse cortex, which exhibited a multipolar morphology. Together, 
these observations uncover a putative role for miR-338 in the regulation of  cortical 
neuronal polarity and layer placement.
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Introduction 
The cerebral cortex is responsible for a plethora of  critical brain functions, including 
the processing of  sensory information, cognitive function and consciousness. Prolif-
eration, migration, and differentiation of  cortical progenitor cells during development 
generate intricate neural networks important for these tasks (Lui et al., 2011;Franco 
and Muller, 2013). The formation of  these neural structures is tightly regulated and 
depends on the coordinated expression of  a large number of  genes (Schubert et al., 
2015). Moreover, accumulating evidence has implicated specific aberrant temporal and/
or spatial gene expression patterns underlying the etiology of  neurodevelopmental dis-
orders. Moreover, accumulating evidence has implicated aberrant temporal or spatial 
gene expression patterns underlying the etiology of  various neurodevelopmental disor-
ders, such as autism spectrum disorder, schizophrenia and intellectual disability (Stark 
et al., 2008;van Bokhoven, 2011;Willemsen et al., 2011;Schubert et al., 2015). MicroR-
NAs (miRs) have emerged as a powerful class of  evolutionarily conserved non-coding 
RNAs (ncRNAs) that bind to complementary sequences within target transcripts fol-
lowed by post-transcriptional regulation of  mRNA stability and/or translation. miRs 
are expressed at high levels in the developing nervous system, and their expression has 
been found essential for the correct development of  the brain, including the cortex 
(Krichevsky et al., 2003;De Pietri Tonelli et al., 2008;Kawase-Koga et al., 2009;Yao et 
al., 2012). miR-dependent regulation of  gene networks in the brain affects a wide set 
of  cellular processes, which are critical for cortical neurogenesis, neuronal survival and 
differentiation (Sempere et al., 2004;Cheng et al., 2009;Zhao et al., 2009;Olde Loohuis 
et al., 2012;Volvert et al., 2012).       
Previous studies have identified miR-338 as a regulator of  oligodendrocyte maturation 
and differentiation by repressing the transcription factors SOX6 and HES5 (Zhao et 
al., 2010). Furthermore, miR-338 controls the growth and development of  axons of  
superior cervical ganglion (SCG) neurons through local regulation of  COXIV expres-
sion (Aschrafi et al., 2008). The repression of  COXIV mRNA by miR-338 decreased 
mitochondrial function and resulted in reduced axonal respiration and diminished ATP 
levels in distal axons (Aschrafi et al., 2008;Aschrafi et al., 2012). miR-338 is encoded 
within the intron of  the AATK gene. Previously, we showed that miR-338 has the 
capacity to regulate the mRNA levels of  its host-gene by binding to the AATK 3’ 
untranslated region (3’ UTR) (Kos et al., 2012). Interestingly, AATK was identified as 
a regulator of  axon growth, as well as dendrite formation and arborisation in cortical 
neurons (Takano et al., 2012;Takano et al., 2014). Furthermore, miR profiling has im-
plicated a potential role for miR-338 in neurological disorders. For example, miR-338 
was overexpressed in blood leukocytes, as well in cerebrospinal fluid from amyotrophic 
lateral sclerosis (ALS) patients (De Felice et al., 2012;De Felice et al., 2014). Moreover, 
miR screening of  white matter isolated from MS patients revealed an enhanced miR-
338 function in these patients (Noorbakhsh et al., 2011).      
Thus far, studies on miR-338’s role in neuronal development have been conducted in 
cell lines and in cultured primary neurons from the peripheral nervous system. Howev-
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er, miR-338 is also abundantly expressed within the central nervous system, including 
the cortex (He et al., 2012). In the present study, we aimed at delineating the function in 
vivo of  miR-338 in early corticogenesis by modulating miR-338 expression using in utero 
electroporation (IUE)-mediated gene transfer. This investigation revealed that over-
expression of  miR-338 resulted in an enhanced number of  multipolar neurons within 
the upper layers of  the cerebral cortex. Inhibition of  miR-338 decreased the number 
of  neurons within the upper cortical layers, which displayed a non-polar phenotype. 
Collectively, these findings suggest that miR-338 functions as a novel regulator of  early 
cortical neurodevelopment.
Material and methods
Animals          
For the IUE experiments, timed-pregnant C57BL/6 JolaHSD mice (Harlan Labora-
tories B.V., Boxmeer, The Netherlands) were used. Embryonic day 18 (E18) embryos 
from timed-pregnant Wistar rats (Harlan laboratories B.V., Boxmeer, The Netherlands) 
were used for the isolation of  primary cortical neurons. Animals were housed 2-3 per 
cage with ad libitum food and water access with a 12 hr light cycle at controlled ambient 
temperature (21 ± 1°C). All animal use, care and experiments were performed accord-
ing to protocols approved by the Committee for Animal Experiments of  the Radboud 
university medical center, Nijmegen, The Netherlands.
Cell culture          
Primary cortical neurons were isolated from E18 rat embryonic brains. The cortical 
region was isolated and placed in ice-cold Hanks’ Balanced Salt Solution (HBSS) con-
taining 2 mmol/L GlutaMAX (Life Technology, Grand Island, NY) supplemented with 
Pen/Strep antibiotics (Life Technology, Grand Island, NY). Cortical tissue was washed 
two times using supplemented HBSS before adding 0.025% trypsin in HBSS solution 
followed by incubation at 37°C for 15 minutes. After incubation, the tissue was washed 
3 times with the supplemented HBSS before adding Neurobasal (NB) medium (Life 
Technology, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) (Life 
Technology, Grand Island, NY) and 2 mmol/L GlutaMAX. Cells were dissociated with 
a glass Pasteur pipette, this treatment was repeated with a fire-polished glass Pasteur 
pipette to obtain fully dissociated cells. Separated neurons were seeded in cell culture 
plates, which were coated overnight with 0.1 g/L, mol wt 70,000-150,000 Poly-D-Ly-
sine (PDL) (Sigma–Aldrich, St. Louis, MO). For the first 5 hours, the neurons were 
cultured in medium containing NB medium with 10% FBS and 2 mmol/L glutaMAX. 
Afterwards, the medium was replaced with culturing medium containing NB with the 
serum free neural supplement B27 (Life Technology, Grand Island, NY) and 2 mmol/L 
glutaMAX. Neuronal cell preparations were maintained at 37°C and with 5 % CO2. 
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DNA constructs and transfection        
The mammalian miR-338 overexpression vector and its corresponding control vector 
were previously used and described (Kos et al., 2012). The miR-338-sponge plasmid 
vector was generated by designing DNA oligonucleotides (Sigma–Aldrich, St. Louis, 
MO) as previously described (Lin et al., 2011;Mellios et al., 2011). miR Sponge sequenc-
es were designed to contain four complementary artificial binding sites for miR-338-3p 
(Table 1), as previously described (Lin et al., 2011;Mellios et al., 2011). Presynthesized 
DNA oligonucleotides were ligated 3’ to the stop codon of  the cDNA mCherry. For 
cloning miR sponges into the pmR-mCherry vector (Clontech, Mountain View, CA), 
the restriction sites HindIII and BamHI were used. All DNA constructs were sequenced 
to confirm their correct sequence orientation and identity. Electroporation of  primary 
neurons was performed using the Amaxa Nucleofector II combined with the Amaxa 
rat neuron Nucleofector kit (Lonza, Basel, Switzerland) according to the manufacturers’ 
protocol. 
Table 1: pmCherry miR-338 sponge oligonucleotides 
miR-338-sp-
Fw
5’AGCTTCAACAAAATGGAGATGCTGGAATCGCAACAAAATG-
GAGATGCTGGAATCGCAACAAAATGGAGATGCTGGAATCGCAA-
CAAAATGGAGATGCTGGAG 3’
miR-338-sp-
Rv
5’GATCCTCCAGCATCTCCATTTTGTTGCGATTCCAGCATCTC-
CATTTTGTTGCGATTCCAGCATCTCCATTTTGTTGCGATTCCAG-
CATCTCCATTTTGTTGA 3’
RNA isolation, reverse transcription and real-time PCR      
RNA was isolated using the following two methods. Total RNA from brain tissue was 
isolated using TRIzol reagent (Life Technology, Grand Island, NY), according to the 
supplied manufacturer’s manual. Alternatively, total RNA from primary neurons was 
isolated using the miRNAeasy kit (Qiagen, Germantown, MD), according to the manu-
facturer’s manual, which allows for the preservation of  both the small RNA and mRNA 
fraction. RNA purity was determined using the Nanodrop ND1000 (Thermo Scientif-
ic, Waltham, MA) UV-spectrophotometer. The 260/280nm ratios were measured and 
samples with ratios of  2.0 ± 0.05 were considered pure. This was followed by RNA 
integrity assessment with a 1% agarose gel imaged with the Gel doc XR system (Bio-
Rad, Hercules, CA). Samples showing clearly visible S28 and S18 ribosomal RNA bands 
were considered to be intact. cDNA synthesis of  small RNAs was performed using 
the miScript reverse transcription kit (Qiagen, Germantown, MD) according to the 
supplied protocol. Following cDNA synthesis, samples were diluted 1:10 with water. 
Quantitative real-time PCR (qRT-PCR) detection of  mature miRs was performed us-
ing the miScript SYBR green PCR kit (Qiagen, Germantown, MD) according to the 
manufacturer’s instructions. Data was normalized to U6 housekeeping gene and the 
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relative expression differences were calculated using the delta C
T
 method (Schmittgen 
and Livak, 2008). The following primer sequences were used: mature miR-338-3p for-
ward, TCCAGCATCAGTGATTTTGTTG; reverse, universal reverse primer supplied 
with the miScript PCR kit. SnoU6 forward, GCTTCGGCAGCACATATA; reverse, 
CGCTTCACGAATTTGCGT.
IUE and tissue section preparation        
IUE survival surgeries were performed as previously described (Kolk et al., 2009;Kolk 
et al., 2011). Timed pregnant (E14.5) mice were anaesthetized with 100 mg/kg Ket-
amine and 10 mg/kg Xylazine. Following laparotomy, a solution containing the plas-
mid DNA (2 μg/μl of  vector DNA of  interest co-injected with pEBFP-N1 (Clontech, 
Mountain View, CA) in Tris-buffered [pH 7.4] 0.02% Fast Green was injected through 
the uterine wall into the lateral ventricle of  each embryo. Squarewave low voltage cur-
rent pulses (5 unipolar pulses of  0.0033V, 050ms with a 950ms interval) were delivered 
across the embryonic head using Tweezertrodes (BTX, Harvard Apparatus, Holliston, 
MA). Embryos were kept hydrated, placed back into the abdomen of  the mother and 
gestation was allowed to proceed for 3 days. Brains were removed from the embryo 
and fixed in 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS), pH 7.4, 
for 1 hour. After fixation, the brains were placed in 30% sucrose overnight, and frozen 
in Shandon M-1 Embedding Medium (Thermo Scientific, Waltham, MA) on dry ice, 
and stored at -80°C. Coronal 16 µm thick cryostat sections were prepared, mounted on 
Superfrost plus slides (Thermo Scientific, Waltham, MA), air-dried and stored desiccat-
ed at -20°C. Only embryos showing effective transfection, assessed by reporter gene 
expression in the somatosensory (S1) cortex were analysed.
Immunolabeling and imaging        
Immunohistochemistry on IUE brain slices was performed as described previously by 
(Kolk et al., 2009). Slices were rehydrated in PBS and incubated in blocking buffer 
(2.5% normal donkey serum, 2.5% normal goat serum, 2.5 % normal horse serum, 
1% bovine serum albumin (BSA), 1% glycine, 0.1% lysine, 0.4% Triton X-100) for 30 
minutes at room temperature (RT). Sections were incubated in primary antibody diluted 
in blocking buffer overnight (o/n) at 4°C in humidified chambers. Then, sections were 
washed three times, each 10 min in PBS at RT. Subsequently, sections were incubated 
with species-specific Alexa-conjugated secondary antibodies diluted in blocking buffer 
for 30 minutes to 1 hour at RT. After three washes in PBS for a total of  30 min at 
RT, sections were counterstained with DAPI (Sigma–Aldrich, St. Louis, MO at 1:2000) 
in PBS, washed extensively in PBS and embedded in 90% glycerol in PBS. Primary 
antibodies used included chicken anti-GFP (Abcam, Cambridge, UK at 1:500), rabbit 
anti-GFP (Molecular Probes, Life Technologies, Grand Island, NY at 1:1000), rabbit 
anti-cleaved Caspase 3 (Cell Signaling, Danvers, MA at 1:200). Secondary antibodies 
included Alexa488 goat anti-chicken, Alexa488 goat anti-rabbit and Alexa568 goat an-
ti-rabbit (Molecular Probes, Life Technologies, Grand Island, NY at 1:500). Fluorescent 
images of  brain slices were obtained using a Leica DMRA fluorescence microscope 
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fitted with a DFC340 FX CCD camera (Leica, Wetzlar, Germany) or a Leica TCS SP2 
AOBS Confocal Laser Scanning Microscope (CLSM) (Leica, Wetzlar, Germany).
Neuronal morphology and migration analysis     
Fluorescent images were randomized and analysed in a blinded fashion. Imaging and 
analysis of  the primary somatosensory (S1) cortex IUE brain sections was performed at 
the same neuroanatomical level for all conditions. The images were loaded into Adobe 
Illustrator in which a mask was made to highlight the various cortical layers identified 
on the basis of  cell density (Nuclear staining by DAPI). The quantified number of  
electroporated cells was normalized to the total number of  cells within the intermediate 
zone (IZ) and cortical plate (CP). Neuron outlines were traced using Adobe Illustrator 
software. The digitized neuronal tracings were analysed using the NeuronJ plugin for 
ImageJ (Meijering et al., 2004). 
Statistical analysis          
Quantitative data are presented as the mean ± s.e.m. Non-paired two-tailed Student’s 
t-test was used to determine significant differences between two groups. One-way 
ANOVA with Bonferroni multiple comparison testing was used to analyse significant 
differences between multiple groups. P ≤ 0.05 was considered significant. 
Results 
Sequence-specific miR-sponge reduces endogenous miR-338 levels  
To investigate the ability of  miR-338 to modulate cortical development we used genetic 
tools to alter endogenous miR-338 expression levels. Previously, a miR-338 overexpres-
sion vector was used to enhance cellular miR-338 expression levels (Kos et al., 2012). To 
inhibit miR-338 function, we generated a miR-338 sponge, which specifically inhibits 
mature miR-338-3p. The miR-338 sponge contains four complementary miR-338-3p 
binding sites within the 3’ untranslated region (UTR) of  mCherry cDNA (Figure 1A). 
To examine the ability of  the miR-338 sponge to decrease miR-338-3p availability for its 
targets, isolated primary cortical neurons were electroporated with a mCherry control 
or the miR-338 sponge vector. qPCR revealed miR-338 expression levels at 4 days in 
vitro (DIV). The electroporation of  the miR-338 sponge resulted in a ~40% decrease 
in miR-338-3p abundance relative to the mCherry eletroporated control cells (Figure 
1B, mean 1.0 ± 0.1160 versus 0.6244 ± 0.04687 relative expression; p=0.017). These 
results show that the miR-338 sponge can effectively decrease endogenous expression 
of  miR-338 within neuronal cells.
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Figure 1. miR-338-inhibiting sponge construct. (A), The cytomegalovirus (CMV) promot-
er-driven miR-338-inhibiting sponge design. The four complementary miR-338-3p binding sites 
are depicted as green blocks within the 3’ UTR of  the mCherry gene. The sequence of  both the 
miR-338 sponge (Sp) and mature miR-338-3p is shown, containing a central bulge to increase 
the efficiency of  miR inhibition and a four nucleotide arbitrary linker sequence between each 
binding site. (B), qPCR analysis of  DIV 4 primary cortical neurons electroporated at DIV 1 
with the miR-338 sponge or a GFP control vector. Bars represent mean relative values to control 
with error bars ± s.e.m. Two-tailed unpaired student’s t test, n = 5 samples from independent 
experiments; * P < 0.05. 
In vivo modulation of  miR-338 levels affects neuronal migration in the develop-
ing cortex         
Since previous studies suggested that miR-338 might have the capacity to modulate 
axonal development in neurons, we aimed to determine the effects of  miR-338 expres-
sion changes on cortical development. To examine the expression profile of  miR-338 
during brain development, total RNA was isolated from brain tissue obtained at several 
developmental time points, namely, embryonic (E) day E10.5, E13.5, E14.5, E15.5, 
E16.5, E18.5, and at postnatal day (P) 0, followed by qRT-PCR quantification of  mature 
miR-338 levels at these time points. Levels of  mature miR-338 were elevated 16-fold 
from E10.5 to E15.5, and remained at significantly high levels at later stages (Figure 
2A). Subsequently, the role of  miR-338 in cortical development was examined by tar-
geting ventricular proliferating cells in the somatosensory cortex with either a precursor 
miR-338 vector or a miR-338 sponge vector using IUE. As controls, corresponding 
empty precursor and sponge vectors were used, for analysis purposes the controls were 
combined since no differences were found between the two control groups. 
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Figure 2. miR-338 affects neuronal migration within the developing cortex. (A) Expres-
sion level of  mature miR-338 in the whole mouse brain from embryonic day 10.5 (E10.5) up to 
postnatal day 0 (P0). Data represents the relative fold change to E10.5 ± s.e.m. One-way ANO-
VA with Bonferroni multiple comparison test, n = 3 samples collected from independently iso-
lated brains; ** P < 0.01, *** P < 0.001. (B) Outline of  the performed IUE experiment and a 
graphic illustration of  a cortical slice with the red box denoting the analysed cortical area. (C) 
Representative micrographs of  control GFP, miR-338 overexpression and miR-338 sponge in 
electroporated cortical slices with 300 µm wide masks highlighting the cortical layers ventricular 
zone (VZ); subventricular zone (SVZ); intermediate zone (IZ); subplate (SP); cortical plate (CP); 
marginal zone (MZ). The IUE targeted cells are depicted in green and DAPI nuclear staining is 
shown in blue. (D) Representative analysis of  miR-338 overexpression and inhibition compared 
to the control with each dot defining a single neuron. (E) Quantification of  IUE neurons with-
in 100 µm2 IZ and CP corrected for the total number of  cells. Bars represent mean relative 
numbers to control with error bars ± s.e.m. Two-tailed unpaired student’s t test, n = 4-5 brains 
per condition from independent experiments; * P < 0.05 and *** P < 0.001.
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Mouse embryos were electroporated with miR-338 control, overexpression or sponge 
vectors at E14.5 and sacrificed at E17.5 followed by coronal cryo-sectioning and GFP 
immuno-labeling (Figure 2B, C). The number of  fluorescently labelled cells in the in-
termediate zone (IZ) and in the cortical plate (CP) were quantified to assess the role 
of  miR-338 in modulating the radial neuronal migration (Figure 2D). This experiment 
revealed a modest increase in the number of  neurons migrating towards the IZ when 
overexpressing miR-338. In mouse embryos with an attenuated miR-338 function 
(miR-338 Sp), fewer neurons moved towards the IZ (Figure 2E). Quantification of  the 
number of  GFP-positive neurons that localized in the CP suggested a significant in-
crease in the number of  neurons overexpressing miR-338 (mean 2.840 ± 0.3756 versus 
4.188 ± 0.3788; p=0.0449), whereas sponge-mediated miR-338 repression resulted in a 
significant decrease in the number of  migrating cortical neurons towards the CP (mean 
2.840 ± 0.3756 versus 1.704 ± 0.2634; p=0.0380) (Figure 2E). This outcome raises the 
possibility that miR-338 expression can modulate the number of  neurons within the 
upper layers of  the cerebral cortex.
miR-338 affects neuronal morphologies and polarity in vivo   
During their radial migration phase, cortical neurons undergo extensive shape remodel-
ling where; while neurons within the IZ typically have a multipolar morphology, within 
the CP, they generally change to a bipolar state (Noctor et al., 2004;Volvert et al., 2014;Ye 
et al., 2014). It was previously shown that neuronal migration defects can affect the mul-
tipolar-bipolar transition of  cortical neurons which is important for correct placement 
of  these cells within the cortex (Ohtaka-Maruyama et al., 2013). Due to the finding that 
miR-338 has the capacity to influence the migration of  neurons toward the CP, we ex-
amined whether modulation of  miR-338 expression alters the morphology of  neurons 
within the CP. Using the same IUE protocol as described above, morphological analysis 
of  targeted cells was performed. This study revealed that miR-338 overexpression led 
to an increase in the total cell area (mean 98.08 ± 2.514 µm2 versus 138.3 ± 4.239 µm2; 
p<0.0001), whereas miR-338 repression decreased the cell area (mean 98.08 ± 2.514 
versus 64.20 ± 1.630; p<0.0001) (Figure 3A, B). Further analysis of  these neurons sug-
gested that miR-338-mediated changes resulted in altered neuronal polarity. miR-338 
overexpression caused significantly more multipolar neurons (mean 0.07227 ± 0.01387 
versus 0.2301 ± 0.04054; p=0.0021), with an increased number of  neurons having 4-5 
neurite endpoints (mean 0.05678 ± 0.01596 versus 0.1518 ± 0.01341; p=0.0006). miR-
338 inhibition produced more rounded, nonpolar neurons (mean miR-338 Sp, 0.1119 
± 0.03104 versus control, 0.3108 ± 0.02257; p=0.0006) exhibiting fewer process end-
points (mean 0 endpoints 0.1094 ± 0.03701 versus 0.2984 ± 0.01957; p=0.0013) (Figure 
3C, D). 
86
CHAPTER 4
A miR-338
*
*
*
miR-338 Sp
100μm
* *
*
Control
*
* *
CP
B Cell area
Co
ntr
ol
mi
R-
33
8
mi
R-
33
8 S
p
0
50
100
150
C
el
l s
iz
e 
in
µ
m
2
***
Cell polarity nonpolar
unipolar
bipolar
multipolar
C
Co
ntr
ol
mi
R-
33
8
mi
R-
33
8 S
p
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Pe
rc
en
ta
ge
 o
f c
el
ls ***
***
**
Neurite endpoints 0
1
2-3
4-5
D
Co
ntr
ol
mi
R-
33
8
mi
R-
33
8 S
p
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Pe
rc
en
ta
ge
 o
f c
el
ls ***
**
***
Figure 3. Modulation of  miR-338 levels leads to alteration of  neuronal morphologies 
within the cortical plate. (A) Representative images of  neurons electroporated at E14.5 with 
either the control, miR-338 overexpression or the miR-338-sponge vector and analysed at E17.5. 
The manipulated neurons are shown in green and the DAPI nuclear staining is shown in blue. 
Corresponding traced neurons within the CP are highlighted with a white asterisk within each 
image. (B) The total cellular area in µm2. Mean values with error bars ± s.e.m. One-way ANOVA 
with Bonferroni multiple comparison test; *** P < 0.001. (C) Neuronal polarity classified in the 
percentage of  nonpolar, unipolar, bipolar and multipolar cells. (D) The percentage of  neurons 
having no, 1, 2-3 or more number of  neurite endpoints. Graphs represent mean values with 
error bars ± s.e.m. One-way ANOVA with Bonferroni multiple comparison test, average of  150 
cells measured collected from n = 3 brains per condition from independent experiments; * P < 
0.05, ** P < 0.01 and *** P < 0.001. 
The studies further showed that the miR-338 mediated morphological differences 
in cortical neurons was not due to an increase in apoptosis, since neurons in which 
miR-338 was either overexpressed or repressed were not immune-positive for cleaved 
Caspase-3 (data not shown). Collectively, the outcome of  these studies raise the possi-
bility that miR-338 is capable of  modulating both neuronal morphologies and increases 
the number of  neurons within the CP, suggesting a regulatory role in the development 
of  the cortex.
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Discussion
There is a paucity of  information about the role played by non-coding RNAs during 
various neurodevelopmental processes. miR-338 is an evolutionarily conserved RNA 
and its expression is strongly increased at early neurodevelopmental stages. Overexpres-
sion of  miR-338 in targeted cortical cells during early mouse brain development result-
ed in an increased number of  neurons within the CP, whereas inhibition of  miR-338 
led to a reduced number of  neurons within the CP. Since neurons divide and radially 
migrate from the deeper cortical layers (VZ and SVZ), the changes in the number of  
neurons within the upper cortical layers indicate that miR-338 influences either neuro-
nal cell division or their radial migration toward the CP. Morphological analysis of  the 
targeted neurons within the CP revealed extensive morphological changes, as cortical 
neurons overexpressing miR-338 manifested a multipolar phenotype within the CP and 
an increase in the number of  neurite protrusions. Inhibition of  miR-338 resulted in the 
opposite effect, with an increase in the number of  non-polar neurons highlighted by 
a lack of  neurite processes. Moreover, these morphological changes were not due to 
changes in the apoptotic state of  the cells, since no change in the amount of  cleaved 
Caspase 3 was found.         
From embryonic day 10 onwards, a time period critical for genesis and further develop-
ment of  the cortical neuronal cell population (Gotz and Huttner, 2005;Kriegstein et al., 
2006). miR-338’s expression levels increase steadily, suggesting a role in the migration 
and further development of  cortical neurons during this neurodevelopmental period. 
Indeed, inhibition of  endogenous expression at these time points revealed that miR-338 
regulates the number of  neurons within the upper cortical layers. This observation rais-
es the possibility that miR-338 regulates downstream gene transcripts involved in the 
radial migration of  neurons from deeper cortical layers. Alternatively, miR-338 could 
affect the cell-cycle of  the neural stem cells (NSCs) within the VZ and SVZ. Enhancing 
the number of  neurons exiting the cell cycle may lead to an increase in the number of  
neurons prematurely moving up towards the upper cortical layers. Furthermore, this 
investigation suggested that an increased number of  neurons overexpressing miR-338 
maintained their multipolar morphology, while inhibition of  miR-338 resulted in neu-
rons with a non-polar appearance with few neurite extensions. During migration from 
the IZ to the CP, neurons transit from a multipolar state to a bipolar state. This multi-
polar-to-bipolar transition is important for the formation of  the various cortical layers 
and ultimately affects the proper functioning of  the cortex (Rakic et al., 2009;La Fata 
et al., 2014). Changes in morphology could be due to an altered differentiation state of  
the neurons, leading to extended maintenance of  their multipolar state under increased 
miR-338 expression. The altered differentiation state could be a direct consequence of  
the altered migration pattern of  the neurons in which miR-338 was manipulated. Indeed, 
previous studies have revealed that miRs are capable of  controlling the migration and 
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polarity of  cortical neurons through regulation of  critical downstream genes (Volvert 
et al., 2014). miR-22 and miR-124 conjointly control the expression of  components of  
the CoREST/REST transcriptional repressor complex, thereby regulating the migra-
tion and polarity of  cortical neurons (Volvert et al., 2014). Through post-transcriptional 
regulation of  the nuclear receptor TLX, miR-9 controls cell proliferation of  the NSCs 
residing within the VZ and as a result increases the number of  neurons within the CP 
(Zhao et al., 2009). Similarly, the ability for miRs to control the cell cycle of  the NSC 
population was previously shown for the miR-200 family members. This set of  miRs is 
able to promote the cell-cycle exit and subsequent differentiation of  ventral midbrain/
hindbrain neuronal progenitors (Peng et al., 2012). Furthermore, miR-134 controls the 
proliferation, migration and differentiation of  cortical neurons depending on the neu-
rodevelopmental state of  these cells through regulation of  Dcx and/or Chrdl-1 (Gaugh-
win et al., 2011). Interestingly, the above-mentioned miRs directly or indirectly control 
similar neurodevelopmental genes regulating proliferation, migration and differentia-
tion events in cortical neurons. miR-338 could post-transcriptionally induce expression 
changes in similar gene sets, and through this mechanism regulate neuronal migration 
and/or differentiation. Previous studies have identified a number of  key neurodevel-
opmental functions for miR-338 within various neural tissues. miR-338 was found to 
be expressed within oligodendrocytes of  the spinal cord (Zhao et al., 2010). Increasing 
miR-338 expression within mouse tissue promoted oligodendrocyte maturation and 
differentiation, while inhibition of  miR-338 in Zebrafish spinal cord reduced the num-
ber of  cells positive for oligodendrocyte makers (Zhao et al., 2010). Furthermore, this 
study identified the negative controllers of  oligodendrocyte differentiation Sox6 and 
Hes5 as direct miR-338 targets. Quantitative miR expression screening of  RNA isolated 
form SCG axons cultured in Campenot chambers revealed that miR-338 is abundantly 
expressed in the distal axons of  these neurons (Natera-Naranjo et al., 2010). Gain or 
loss of  function studies in rat SCG cells revealed that miR-338 has the ability to lo-
cally regulate the expression of  the nuclear-encoded mitochondrial genes CoxIV and 
Atp5g1 within the distal axon. miR-338 mediated inhibition of  these nuclear-encoded 
mitochondrial genes resulted in reduced ATP production, reduced axon outgrowth and 
diminished presynaptic function (Aschrafi et al., 2008;Aschrafi et al., 2012). Further-
more, previous studies have also shown that miR-338, encoded within the 9th intron 
of  the AATK gene, has the capacity to modulate mRNA abundance and translation 
of  its host-gene (Kos et al., 2012). AATK is highly expressed in the brain and induces 
and promotes differentiation of  human neuroblastoma cells (Raghunath et al., 2000). 
In cortical neurons, it was identified as a regulator of  axon development and dendrite 
growth (Takano et al., 2012;Takano et al., 2014). Collectively these studies show that 
miR-338 has the capacity to regulate a number of  genes critical for neurodevelopment 
and suggests that miR-338 could control a multitude of  neurodevelopmental processes 
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by regulating several underlying gene pathways.      
In conclusion, our data demonstrate a critical role for miR-338 during early cortical 
development. The finding that miR-338 affects the number of  cortical neurons within 
the upper cortical layers and subsequently their multipolar-bipolar transition suggests 
that miR-338 modulates gene expression at multiple steps of  cortical development. 
These findings support the notion that a tight spatio-temporal regulation of  this miR’s 
expression is critical for proper cortical development which could have implications for 
understanding how miRs drive early neuronal development, in particular in the context 
of  neurodevelopmental disorders.
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Abstract
MicroRNAs (miRs) are non-coding gene transcripts abundantly expressed in both the 
developing and adult mammalian brain. They act as important modulators of  com-
plex gene regulatory networks during neuronal development and plasticity. miR-181c is 
highly abundant in cerebellar cortex and its expression is increased in autism patients as 
well as in an animal model of  autism. To systematically identify putative targets of  miR-
181c, we repressed this miR in growing cortical neurons and found over 70 differential-
ly expressed target genes using transcriptome profiling. Pathway analysis showed that 
the miR-181c-modulated genes converge on signaling cascades relevant to neurite and 
synapse developmental processes. To experimentally examine the significance of  these 
data, we inhibited miR-181c during rat cortical neuronal maturation in vitro; this loss-of  
miR-181c function resulted in enhanced neurite sprouting and reduced synaptogenesis. 
Collectively, our findings suggest that miR-181c is a modulator of  gene networks asso-
ciated with cortical neuronal maturation.
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Introduction
The development of  neurons and the establishment of  mature synaptic connectivity re-
quire an intricate orchestration of  defined gene networks. Regulation of  neuronal gene 
network expression is modulated at several levels by a number of  different post-tran-
scriptional mechanisms, such as the ubiquitin-proteasome system [1], control of  mRNA 
stability [2], translation initiation [3] and elongation [4], and by non-coding microRNAs 
(miRs) [5]. miRs coordinately regulate the expression of  multiple genes coding for pro-
teins, which often have converging cellular functions [6-8]. The function(s) of  indi-
vidual miRs in neurons are beginning to emerge, and multiple lines of  evidence point 
to the widespread involvement of  miRs in various fundamental neurodevelopmental 
processes (reviewed in [9-11]). Consequently, disturbances in miR expression levels re-
sult in aberrant signaling pathways at different levels, leading to impaired intercellular 
connections and cellular functioning causing various neurodevelopmental disorders. In 
cell lines derived from autism spectrum disorder (ASD) patients, the levels of  miR-181c 
have been found to be strongly elevated [12]. Moreover, we recently observed that the 
expression of  miR-181c is altered in the amygdala of  a valproate rat model of  autism, 
and that miR-181c inhibition affects the growth of  amygdala neurons [13]. During 
retinoic acid (RA)-induced neuronal differentiation of  progenitor cells, miR-181c is 
upregulated, suggesting dynamic changes in the expression of  this miR that could be 
linked to specific neurodevelopmental stages [14]. Furthermore, miR expression profil-
ing showed that miR-181c is widely expressed in the central nervous system, including 
in cortical regions [15]. Here, we combined neuromorphological studies with whole-ge-
nome mRNA expression profiling and bioinformatic analysis to examine the impact of  
miR-181c repression on growing cortical neurons in vitro. We find a role for this small 
regulatory RNA in modulating neuronal outgrowth and synaptic formation by acting as 
a post-transcriptional regulator of  genes involved in neuronal growth and maturation.
Materials and methods 
Animals          
Wistar rats (Harlan Laboratories) embryos were used as a resource for the isolation of  
primary cortical neurons. Animals were housed 2-3 per cage with ad libitum food and 
water access with a 12hr light cycle at controlled ambient temperature (21 ± 1°C). All 
experiments were performed according to protocols approved by the Committee for 
Animal Experiments of  the Radboud University Nijmegen Medical Centre, Nijmegen, 
The Netherlands.
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Cell culture          
All media and reagents were purchased from Life Technologies. Primary cortical neu-
rons were isolated from embryonic day 18 (E18) old rat embryos brains. Pregnant rats 
were anaesthetized with isoflurane and sacrificed by cervical dislocation. Cortical region 
was isolated from E18 brains and placed in ice-cold dissection buffer (HBSS without 
Ca2+ and Mg2+, 100 U/ml penicillin, 100 μg/ml streptomycin, 1x Glutamax). Cortical 
tissue was washed two times with the dissection buffer before adding a 0.025% trypsin 
in HBSS solution followed by incubation at 37°C for 15 min. After incubation, the 
tissue was washed 3 times with the HBSS washing buffer before adding Neurobasal 
(NB) medium, supplemented with 10% FBS and 2 mmol/L GlutaMAX. The tissue 
was titrated several times with a glass Pasteur pipet, this treatment was repeated with a 
flame thinned tip glass Pasteur pipet to obtain fully dissociated cells. Separated cell were 
seeded in cell culture plates, which were overnight coated with 0.1 g/L, mol wt 70,000-
150,000 Poly-D-Lysine (PDL) (Sigma Aldrich). For the first 5 hours, the cells were 
cultured in medium containing NB medium with 10% FBS and 2 mmol/L glutaMAX. 
Afterwards, the medium was replaced with culturing medium containing NB with the 
serum free neural supplement B27 and 2 mmol/L glutaMAX. For culturing pure axonal 
fractions, microfluidic chambers were prepared by firstly ethanol cleaning the chambers. 
After the chambers were completely dry, they were placed on PDL coated coverglasses 
(Hecht Assistent). The chambers were subsequently filled with 100 µl of  NB medium 
containing 10% FBS and 2 mmol/L GlutaMAX. This was done at least one day before 
seeding the cells so that any formed bubbles will be removed. In most cases a seeding 
density of  100,000 cells per chamber was used. All the neuronal cell preparations were 
maintained at 37°C and with 5 % CO2.
Sponge-miR-181c construct        
The miR-181c-sponge vector was made by designing DNA oligonucleotides (Sigma 
Aldrich) as previously described [13,56,57]. In short, miR sponge sequences were de-
signed to contain four complementary artificial miR binding sites of  the rat miR-181c-
3p sequence, each separated by four nucleotides. The miR-181c binding site contains 
bulged sites that are non-complementary to the miR-181c, in order to enhance sponge 
efficacy. Presynthesized DNA oligonucleotides were ligated 3’ to the stop codon of  the 
cDNA encoding eGFP. For cloning miR sponges into the lentiviral pFUGW (Addgene) 
constructs the restriction sites BsrGI and EcoRI were utilized.
Transfection and virus production       
Transfection of  cortical neurons was performed using the Screenfect A transfection 
agent (Genaxxon), following the protocol provided by the manufacturer. In brief, 
Screenfect A together with either the anti-miR-181c, miR-181c mimic or non-targeting 
(NT) control were diluted in the provided buffer in order to achieve a final concentra-
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tion of  30 nM, respectively. To enable to visualize the transfection efficiency, 20 nM of  
siGlo red transfection indicator (Dharmacon) was added to the transfection mixture. 
After 20 min of  incubation, the mix was applied to the adherent primary neurons and 
left to incubate at 37°C for no longer than 24 hours.  For lentivirus production, HEK-
293T cells were transfected using the CaCl2 method. The viral particles were produced 
and purified as previously described [58]. The purified viral pellets were resuspended in 
100µl calcium and magnesium free HBSS. For infecting primary neurons, ± 0.5 µl/cm2 
of  concentrated virus was added to the cultures. If  a lower infection rate was needed 
the virus was diluted 10-20 times before adding to the primary neuronal cultures. 
RNA isolation, cDNA synthesis and qPCR       
Total RNA was isolated from primary cortical neurons using the miRNeasy kit (Qia-
gen) according to the manufacturers protocol. RNA purity was determined using the 
Nanodrop ND1000 (Thermo Scientific) UV-spectrophotometer. The 260/280 nm ra-
tios were measured and samples with ratios of  2.0±0.05 were considered pure. This 
was followed by RNA integrity assessment with a 1% agarose gel imaged with the 
Gel doc XR system (Bio-Rad). Samples showing clearly visible S28 and S18 ribosomal 
RNA bands were considered to be intact. cDNA was synthesized from isolated RNA 
according to the protocol provided with the miScript reverse transcription kit (Qia-
gen) to reverse transcribe both small RNA and mRNA. Quantitative Real-time PCR 
(QRT-PCR) detection of  mRNA transcripts was performed using the miScript SYBR 
green PCR kit (Qiagen) for the detection of  mature miRs and mRNA according to the 
manufacturers manual. The following gene-specific qPCR primers were used (in 5’ to 3’ 
direction): β-Actin forward, CCAGATCATGTTTGAGACCTTC; β-actin reverse, AG-
GATCTTCATGAGGTAGTCTG; U6 forward, GCTTCGGCAGCACATATA; U6 re-
verse, CGCTTCACGAATTTGCGT; mature rno-miR-181c, AACATTCAACCTGTC-
GGTGAGT. The data was normalized to housekeeping genes (β-actin and U6) using 
the GeNorm software [59]. 
RNA Sequencing         
RNA isolated from primary cortical neurons (at 21 DIV) infected either with control 
or sponge-miR-181c lentiviruses at 8 DIV. RNA quality was assessed using Tapestation 
analysis, which revealed RNA quality above RIN 8.0 for all samples. RNA samples from 
the same condition were processed by the HudsonAlpha Institute for Biotechnology 
(Huntsville, AL, USA). The RNA sequencing was performed in three separate flowcells 
generating a total of  45 to 50 million 50 bp reads per sample. RNA sequencing data 
analysis was carried out with the GeneSifter gene expression analysis suite (Geospiza). 
Expression data was normalized against the number of  mapped reads, and the RPKM 
threshold was set at 1. Significance was calculated using the Benjamini and Hochberg 
multiple testing correction and the level of  significance was set to 0.05.
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miR target prediction        
The miRWalk prediction database was used to identify predicted targets of  the miRs 
we found significantly dysregulated due to prenatal VPA exposure. MiRWalk combines 
the prediction data of  several databases from which we included TargetScan, miRanda, 
miRDB and miRWalk prediction lists taking into account a minimal seed length of  7 
base pairs and a p-value cut off  of  0.05 [60].
Functional classification of  miR targets      
Functional classification of  miR targets. To detect significantly enriched gene categories 
in the predicted miR target genes/mRNAs, we used the IPA software package (http://
www.ingenuity.com). This software package uses the Ingenuity Knowledge Base, which 
is based on information from the published literature as well as many other sources, 
including gene expression and gene annotation databases, to assign genes to different 
groups and categories of  functionally related genes. Each of  these categories can be 
further divided into many subcategories. Ingenuity calculates single p values for the 
enrichment of  each gene category using the right-tailed Fisher’s exact test, and taking 
into consideration both the total number of  molecules from the analysed data set and 
the total number of  molecules that is linked to the same gene category according to 
the Ingenuity Knowledge Base. Furthermore, for each gene category, a multiple testing 
corrected p value of  enrichment, calculated using the Benjamini-Hochberg correction, 
is provided. 
Immunohistochemistry        
Cultured neurons were fixed in warm (37°C) 4% paraformaldehyde and 16% sucrose 
in PBS for 30 min. After washing with PBS (3x5 min at RT) cells were incubated for 15 
min at RT with 50 mM NH
4
Cl to quench residual aldehydes. Cells were washed (3x5min 
at RT), permeabilized with 0.1% Trixon X-100 for 5 min at RT, incubated with 2% bo-
vine serum albumin (BSA, ICN Biomedicals Inc) in PBS for 30 min at RT to block non-
specific staining, and were incubated with the primary antibodies in 1% BSA in PBS. 
Incubation in primary antibodies was done overnight at 4°C. Subsequently, cells were 
washed in 2% BSA in PBS (3x5 min) and incubated in species-specific, Alexa-conjugat-
ed secondary antibodies in 1% BSA in PBS for 30-60 min at RT, washed in 2% BSA 
in PBS (3x5 min), and washed (3x5 min) in PBS containing fluorescent DAPI (Sigma, 
1:3000). The coverslips were mounted in Prolong Gold (Invitrogen). Primary antibod-
ies included chicken anti-GFP (A10262, Life Technologies, 1:500), rabbit anti-MAP2 
(ab32454, Abcam, 1:1000), mouse anti-Tau1 (MAB3420, Millipore, 1:1000). Secondary 
antibodies included goat anti-rabbit 488 (Life Technologies, 1:500), goat anti-chicken 
488 (Life Technologies, 1:500), goat anti-mouse 568 (Life Technologies, 1:500). For vi-
sualizing and measuring the axons in the microfluidic chambers, a similar protocol was 
used. After permeabilizing the neurons with 0.1% Trixon X-100 and washing with PBS 
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the cells were incubated with 100 nM Acti-stain 488 phalloidin (Cytoskeleton) in PBS 
for 30 min. After washing the cells were mounted and imaged. 
Image analysis         
Images of  neurons were captured using a Leica TCS SP2 AOBS Confocal Laser Scan-
ning Microscope (CLSM) with 20x magnification for neurite tracing or at 63x magnifi-
cation for dendritic spine imaging. For outgrowth analysis, the ImageJ plugin NeuronJ 
was used with which neurons were traced [61]. Neurites were assigned with the correct 
branch order where neurites originating from the soma were labelled as primary or first 
branch order and increasing in order values after each successive branch point. Sholl 
analysis was performed with the concentric circle ImageJ plugin to draw an overlay of  
circles (20 µm distance step size) onto the images of  neurons, followed by manual quan-
tification of  the number of  intersecting neurites with each ring. Neuronstudio software 
was used to quantify spine density by determining the amount of  spines per µm of  den-
drite followed by spine classification. Spine maturity was automatically assigned based 
on the length of  the spine and the quantified diameter of  the spine neck and head, with 
thin filopidia like spines indicated as immature and mushroom like spines indicated as 
mature [62].
Results 
Inhibition of  miR-181c alters the expression of  transcripts involved in nervous system development. 
Due to their relatively small seed regions, miRs have the potential to regulate hundreds 
of  downstream targets, and consequently, control key cellular processes [16]. To inves-
tigate which cellular pathways are controlled by miR-181c we used RNA sequencing to 
examine genome-wide gene expression changes upon inhibition of  miR-181c function 
in primary cortical neurons. To suppress miR-181c, we generated and functionally char-
acterized a competitive ‘miR-sponge’ to allow for long-term sequestering of  miR-181c 
in cortical neurons. This lentiviral based construct contains a concatemer of  four par-
tially complementary miR-181c binding sites within the 3’ untranslated region (UTR) 
of  a GFP fluorophore (Supplementary fig. 1A). To test whether the introduction of  
the miR-181c sponge into cells leads to a decrease in mature miR-181c levels, RNA 
was isolated from days in vitro (DIV) 9 cortical neurons infected at DIV 1 with the 
miR-181c sponge or a GFP control (Supplementary fig. 1B). qPCR analysis revealed 
that cells expressing the miR-181c sponge exhibited a significant decrease in miR-181c 
expression levels (mean 1.0 ± 0.0994 control versus 0.3433 ± 0.01252 miR-181c sponge 
relative miR-181c expression; p=0.0028) (Supplementary fig. 1C). Total RNA was 
isolated from DIV 21 cortical neurons infected with lentiviral particles encoding the 
miR-181c sponge or a GFP control, and subjected to RNA deep sequencing [13]. miR-
181c inhibition in cortical neurons resulted in significant expression changes of  1596 
101
MIR-181 REGULATES SYNAPTOGENESIS AND AXON GROWTH
5
transcripts, with 880 transcripts decreased and 716 transcripts increased in their expres-
sion. A 1.2 fold-change cut-off  was applied to remove marginally altered genes. This 
investigation resulted in the identification of  856 significantly differentially expressed 
genes, with 592 transcripts decreased and 264 transcripts increased in their expression 
(fig. 1A). Further analysis using the miRWalk binding site prediction algorithm on these 
856 genes showed that 70 transcripts (8.2%) contained one or more putative miR-181c 
binding sites within the 3’ UTR of  these transcript (fig. 1B). Of  these 70 genes, 16 were 
increased, while 54 genes were decreased in their expression. Since miR-181c was pre-
viously associated with ASD, we cross-compared the miR-181c regulated transcriptome 
with the set of  genes that were found to be dysregulated in cortical material from ASD 
patients in order to examine the potential impact this miR may in modulating genes pre-
viously linked with ASD [17-19]. Furthermore, an unbiased comparison suggested that 
51 genes within the transcriptomes from postmortem cortical tissue of  ASD patients 
were among the genes altered in their expression by miR-181c suppression. Among 
these 51 genes, 13 transcripts contained a binding site for miR-181c in their 3’UTR (fig. 
1B). To identify miR-181c regulated gene clusters involved in common gene networks, 
we performed an Ingenuity pathway analysis (IPA) gene ontology clustering on the 70 
genes containing a miR-181c binding site. This study revealed that within the biological 
function category “molecular and cellular functions” the top five enriched themes are 
cell-to-cell signalling and interaction, amino acid metabolism, cell death and surviv-
al, cellular assembly and organization, and cellular compromise (fig. 1C). The theme 
cell-to-cell signalling mainly contains genes involved in functions such as activation of  
neuronal cells, synaptic transmission, and cell adhesion of  neuronal cells. Examples of  
genes from this group include Apln, Ptger3, Syn2, Cast and Fbxo2. The biological func-
tion “physiological system development and function”, nervous system development 
and function was the theme with the largest number of  genes (fig. 1D). Prominent 
sub-themes of  this category are abnormal morphology of  neuronal cells, activation of  
neurons, and development of  cortical or dopaminergic neurons. Genes within these 
sub-themes are Cast, Cav1, Cyr61, Fgfr3, Lrp4, Pdgfrα, Rhoq and Syn2. Furthermore, using 
the IPA software to examine the molecular relationship among genes, we identified a 
number of  associated networks (fig. 1E), with a score of  18, meaning it has a 1E-18 
chance that the input genes are found together by random chance, containing genes 
associated with the functions behaviour, cell-to-cell signalling and interaction, and ner-
vous system development (fig. 1E and fig. 2).  This network consists of  35 genes of  
which 11 showed an increase and one a decrease in their expression upon inhibition of  
miR-181c function (fig. 2 and Supplementary table 1). 
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Figure 1: Inhibition of  miR-181c function alters the expression of  genes functionally 
involved with neurodevelopmental processes. A. Pie diagram depicts the number of  genes 
significantly (P < 0.05) increased (blue) and decreased (orange) in expression by more than 1.2 
fold. B. Venn diagram shows the overlap between the putative miR-181c targets identified with 
miRWalk (2229 molecules), the significantly altered transcripts after miR-181c inhibition using 
the sponge in cortical neurons (786 molecules) and significantly altered transcripts identified in 
cortical material from ASD patients (1067 molecules). This analysis resulted in the identification 
of  70 significantly altered transcripts containing a miR-181c binding site and 13 of  which pre-
viously found to be dysregulated in ASD. C-D. Overview of  the gene ontology study shows 70 
genes containing a miR-181c binding site in their 3’UTR, altered in their levels upon inhibition 
of  miR-181c. C. The most significant process in the category molecular and cellular functions is 
cell-to-cell signaling and interaction. D. Within the category physiological system development 
and function the process nervous system development and function has the highest number 
of  dysregulated genes. E. A list of  the top five highest scoring gene networks identified by the 
IPA. Each individual network has functions assigned to them with the highest scoring network 
involved in behavior, cell-to-cell signaling and interaction, nervous system development and 
function.
Increased expr.
Decreased expr.
264592
A B
C
D
E
Biological function Process p-value # Molecules
Cell-To-Cell Signaling and Interaction 4.24E-02 - 3.43E-03 10
Amino Acid Metabolism 3.93E-03 - 3.93E-03 1
Cell Death and Survival 4.32E-02 - 3.93E-03 3
Cellular Assembly and Organization 4.24E-02 - 3.93E-03 10
Cellular Compromise 4.24E-02 - 3.93E-03 4
Molecular and 
Cellular Functions
Biological function Process p-value # Molecules
Nervous System Development and Function 4.62E-02 - 3.43E-03 17
Cardiovascular System Development and Function 3.10E-02 - 3.93E-03 2
Embryonic Development 2.27E-02 - 3.93E-03 4
Endocrine System Development and Function 3.93E-03 - 3.93E-03 1
Organ Development 1.18E-02 - 3.93E-03 2
Physiological System 
Development and 
Function
ID Associated Network Functions Score
1 Behavior, Cell-To-Cell Signaling and Interaction, Nervous System Development and 
Function
18
2 Cell Cycle, Cellular Development, Cell Death and Survival 8
3 Cell-mediated Immune Response, Cellular Development, Cellular Function and 
Maintenance
2
4 Connective Tissue Development and Function, Skeletal and Muscular System 
Development and Function, Tissue Development
2
5 Nervous System Development and Function, Tissue Morphology, Developmental Disorder 2
Top Networks
2094 748
13
57
65
38
951
RNAseq 
181c Sponge
ASD transcripts
miRWalk miR-181c
103
MIR-181 REGULATES SYNAPTOGENESIS AND AXON GROWTH
5
Figure 2: MiR-181c control of  gene networks. Highest scoring network identified 
by IPA with genes involved in behavior, cell-to-cell signaling and interaction, nervous 
system development and function. Highlighted within the diagram are transcripts that 
are increased (red) or decreased (green) in their expression by miR-181c inhibition. 
Within the network, Huntington (Htt) connects with 16 genes, and appears to act as a 
central regulatory hub. Other central genes within the network, with nine or more con-
nections, are Dlg4, Cav1 and Hif1a. Dlg4 and Cav1 interact primarily with ion channel 
subunits or genes involved in synaptic vesicle trafficking while the transcription factor 
Hif1a activates a set of  neuronal development genes (fig. 2). Together, these results 
suggest that miR-181c inhibition in cortical neurons leads to significant changes in tran-
scripts involved in nervous system development and function (Supplemental Table 1).
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Figure 3: Inhibition of  miR-181c affects outgrowth in cortical neurons. A. Representative 
images of  DIV9 neurons infected with control or sponge-miR-181c lentiviruses. B. Quantifica-
tion of  total dendritic length. C. Graph showing the number of  branching points of  control and 
sponge-miR-181c infected neurons. D. Quantification of  the number of  branches per branch 
order. Data are shown as mean ±SEM; p-values are determined by two-tailed unpaired Student’s 
t-test. * p ≤0.05; ** p ≤0.01. E. Sholl analysis revealing dendritic arborisation of  neurons in-
fected with either control (black line) or sponge-miR-181c (grey line) lentivirus. Data are shown 
as mean ±SEM; p-values are determined by two-way ANOVA followed by Bonferroni multiple 
comparisons test. * p ≤0.05.
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MiR-181c controls the growth of  neurites and dendritic spines in developing cortical neurons.  
Our transcriptome analysis suggests that miR-181c controls the activity of  gene net-
works strongly associated with neuronal development, supporting previous findings 
that have implicated aberrant miR-181c expression with the aetiology of  neurodevel-
opmental disorders such as ASD [12,13]. This led us to evaluate whether miR-181c has 
the capacity to modulate basic neural maturation processes in cultured cortical neurons. 
Utilizing miR-181c-sponge to knock-down endogenous miR-181c levels, primary rat 
cortical neurons were infected one day after seeding and analysed at DIV 9 for dif-
ferences in neurite growth as compared to GFP-control infected neurons (fig. 3A). 
miR-181c inhibition did not result in changes in total dendritic length (mean 1.05 ± 
0.084 control versus 0.95 ± 0.09 miR-181c sponge length in percentage; p=0.44) (fig. 
3B), whereas it did enhance dendritic branching compared to control infected neurons 
(mean 1.0 ± 0.118 control versus 1.79 ± 0.206 miR-181c sponge length in percentage; 
p=0.0045) (fig. 3C). Further analysis of  the position of  the branch points showed 
that enhanced branching was mainly due to an increase in the number of  higher order 
branches (fig. 3D). Moreover, Sholl analysis showed that expression of  the miR-181c 
sponge enhanced neurite arborisation revealed by an significantly exacerbated increase 
in the number of  intersecting dendrites at 300 µm distance from the soma compared 
to control infected cells (fig. 3E). To determine whether miR-181c also affects the pro-
cess of  synapse formation, we measured the effects of  selective miR-181c repression 
on the number and shape of  dendritic spines. Accordingly, neurons were infected at 
DIV 9 with viruses driving the expression of  either GFP control or sponge-miR-181c. 
GFP-positive neurons were studied when they reached maturity at 21 DIV. Analysis 
of  the obtained images revealed that the spine density of  sponge-miR-181c infected 
cells was decreased as compared to control virus infected neurons (mean 1.0 ± 0.04973 
control versus 0.69 ± 0.04370 miR-181c sponge relative spine density; p=<0.0001) (fig. 
4A, B). Measurements of  spine width revealed that inhibiting miR-181c function re-
sults in a significant reduction in the size of  both mature and immature synapses (mean 
0.2562 ± 0.0091 control versus 0.2236 ± 0.0093 miR-181c mature spine diameter in µm; 
p=0.0147 and mean 0.1335 ± 0.0128 control versus 0.06398 ± 0.0094 miR-181c imma-
ture spine diameter in µm; p=<0.0001)  (fig. 4C). Previously, it was shown that miRs 
can be transported to distal parts of  the axon and are important for axon development 
and function [20-24]. To investigate whether miR-181c has the capacity to regulate the 
growth of  axons from young cortical neurons we made use of  microfluidic chambers, 
which allowed us to selectively study axons in compartmentalized isolation from the 
soma and dendrites (Supplementary fig. 2A, B) [25]. For modulating miR-181c in this 
setup we made use of  miR-181c mimics and locked nucleic acid (LNA) anti-miRs to 
examine how changes in miR-181c levels result in altered axonal outgrowth. 
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Figure 4: Inhibition of  miR-181c affects spine density and morphology. A. Representative 
images of  DIV21 neurons infected with either control or sponge-miR-181c at DIV8. B. Quan-
tification of  spine density of  control and sponge-miR-181c infected neurons. C. Graph showing 
the measurements of  spine head diameter of  mature (mushroom and stubby) and immature 
thin spines. Data are shown as mean ±SEM; p-values are determined by two-tailed unpaired 
Student’s t-test. * p ≤0.05 and *** p ≤0.0001.
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Figure 5: miR-181c attenuates axonal growth in cortical neurons. A. Representative images 
of  DIV 6 cortical neurons grown in microfluidic chambers transfected with NT control or miR-
181c mimic. B. Representative images of  DIV 6 cortical neurons transfected with NT control 
or anti-miR-181c inhibitor. C. Relative axonal length of  neurons overexpressing miR-181c com-
pared to the control. D. Relative axon length of  neurons transfected with the miR-181c inhibitor 
compared to the control. Data are shown as mean ±SEM; p-values are determined by two-tailed 
unpaired Student’s t-test. **p ≤0.001 and *** p ≤0.0001.
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We opted for the use of  small RNA molecules since they have the capacity to rapidly 
modulate miR levels (as opposed to the miR-sponges which act slowly), and because 
LNAs are readily transfected into primary neurons grown in compartmentalized culture 
systems (Supplementary fig. 1D). qPCR analysis revealed that transfection of  neurons 
with the miR-181c mimic lead to a significant increase of  mature miR-181c (66% in-
crease; p=0.0028) (Supplementary fig. 1E). Conversely, transfection with an anti-miR-
181c resulted in a significant decrease of  miR-181c compared to control transfected 
neurons (Supplementary fig. 1F). For the axon outgrowth experiments these synthetic 
RNAs were transfected into DIV 3 cortical neurons grown in microfluidic chambers 
and subsequently analysed at DIV 6 (fig. 5A, B). Compared to a non-targeting (NT) 
control, miR-181c overexpressing neurons exhibited an attenuated axon growth (mean 
20% decrease; p=<0.0001) (fig. 5D), whereas inhibiting miR-181c modestly but signifi-
cantly increased axon outgrowth (mean 9% increase; p=0.0054) (fig. 5E).
These findings suggest that modulation of  miR-181c expression levels in cortical neu-
rons results in altered axonal growth. We examined DIV 6 primary cells transfected 
with a miR-181c mimic at DIV 3 and found mild but no significant changes in dendrite 
length, branching and complexity compared to NT control transfected cells (fig. 6A-
D). Suggesting that miR-181c mimic overexpression does not significantly alter den-
drite formation at these developmental stages. We furthermore, transfected the miR-
181c mimic in cortical neurons to assess the effect on dendritic spine formation but 
found increased cell death when we cultured the cells overexpressing miR-181c mimic 
for extended periods of  time (Supplementary fig. 3). Together, our neuronal morpho-
logical analysis reveals that miR-181c has the capacity to critically modulate the growth 
and morphology of  cortical neurons through modulating a gene network involved in 
the development of  neurons, and synaptic activation and transmission.
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Figure 6: miR-181c overexpression has minimal impact on dendrite outgrowth. A. Repre-
sentative images of  DIV 6 cortical neurons transfected at DIV 3 with NT control or miR-181c 
mimic and stained with the dendrite marker MAP2. Quantification of  B. total dendritic length 
and C. total number of  branching points of  NT control (black bars) or miR-181c mimic (grey 
bars) transfected cells. Sholl analysis of  neurons transfected with either NT control (black line) 
or miR-181c mimic (grey line). Data are shown as mean ±SEM.
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Discussion 
Subtle changes in neurite outgrowth, synaptic development and function, and neural 
network formation underlie the etiology of  neurodevelopmental disorders and cogni-
tive dysfunction [26-30]. Here we provide evidence for a critical function for miR-181c 
in neurite growth and synaptic development. Using transcriptome profiling we show 
that inhibition of  miR-181c during development of  cortical cells altered the expression 
of  a large set of  transcripts. Gene network analysis points towards a significant enrich-
ment of  genes involved in neural development and synaptic function. Subsequent neu-
romorphological analysis of  cells in which miR-181c was knocked-down revealed a 
significant increase in dendritic branching and decreased dendritic spine size. Further-
more, cortical cells lacking miR-181c displayed longer axons, while increasing miR-181c 
expression results in shorter axons. Conversely, short-term overexpression of  miR-181c 
in young cortical neurons had negligible impact on neuronal outgrowth and branching. 
A possibility for a lack of  a clear dendrite outgrowth phenotype during overexpression 
could be that endogenous abundance of  miR-181c impeded any additional gain-of-
function by the introduction of  exogenous miR-181c. Moreover, the transient transfec-
tion was conducted between DIV 3 and 6, a time period in which this miR may not have 
critical importance for neuronal outgrowth and branching. Overexpression of  miR-
181c for an extended period of  time resulted in premature cell death of  cortical neu-
rons as illustrated by condensed nuclei and diminished PSD-95 staining. This observa-
tion suggests that long-term overexpression of  miR-181c resulted in either apoptosis or 
necrosis in these cells. Examining the extant literature we encountered recent studies 
that implicated miR-181 family members in the induction of  apoptosis. Multiple mem-
bers of  the Bcl-2 family were found to be regulated by miR-181 family members (includ-
ing miR-181c) and specific overexpression of  miR-181a increased apoptosis in primary 
astrocyte cultures [31]. Moreover, miR-181 was shown to regulate members of  the heat 
shock protein family resulting in aggravated cell injury during cellular stress, and in-
creasing the expression of  miR-181a-b exacerbated cerebral ischemia [32]. However, of  
important note, we did not see increased cell death compared to control when we trans-
fected neurons with the miR-181c mimic for 3 days.    
Collectively, the results of  our study suggest that miR-181c has the capacity to regulate 
the expression of  hundreds of  downstream transcripts, indicating a vast regulatory po-
tential for this miR during neuronal development [16]. Following long-term inhibition 
of  miR-181c function in cortical neurons, whole transcriptome analysis resulted in the 
identification of  856 genes significantly altered in their expression by 1.2-fold or more. 
More than half  of  the genes were decreased in their expression. Surprisingly, most of  
the significantly altered genes lack putative miR-181c regulation sites, suggesting that a 
large number of  these genes are possibly regulated by miR-181c in a non-canonical 
manner. It has recently become evident that miRs can indeed control gene expression 
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in an indirect manner [33,34]. Thus, within our identified gene set miR-181c may con-
trol a number of  genes in this mode of  action. Furthermore, miR-181c could indirectly 
induce expression changes of  transcripts that are downstream of  direct targets. It is 
therefore important to study miR regulation using high-throughput experimental setups 
together with prediction algorithms to chart global gene network changes.    
IPA gene ontology clustering analysis of  the genes significantly induced by the intro-
duction of  the miR-181c sponge in cortical neurons resulted in the identification of  
gene clusters involved in neuronal development. In particular, eight genes significantly 
altered by the miR-181c sponge play important roles in the development of  neurons, 
namely Cast, Cav1, Cyr61, Fgfr3, Lrp4, Pdgfra, Rhoq and Syn2 [35-40]. Furthermore, an 
enrichment of  genes involved in the activation of  neurons and regulation of  synaptic 
transmission were found, namely Apln, Ptger3, Syn2, Cast and Fbxo2 [41-43]. Together, 
these results suggest that miR-181c controls through direct or indirect interactions sev-
eral gene clusters, which modulate neuronal developmental processes and synaptic 
function.          
Due to the high degree of  sequence identity between the various miR-181 family mem-
bers (miR-181a-d) it is possible that the sponge used in this study reduced the expres-
sion of  other miR-181 family members besides miR-181c. Indeed, introduction of  a 
miR-181a LNA inhibitor into neuronal cell cultures has led to decreased expression of  
all family members [44]. Unfortunately, the currently available tools do not allow a more 
specific manipulation of  the expression of  highly conserved miR family members, such 
as the miR-181 family members. The extent of  the sequence identity among the miR-
181 family members further suggests that the members regulate similar gene networks. 
This is exemplified by the finding that when we compare predicted targets for the vari-
ous miR-181 family members we find extensive overlap between the putative targets. 
This could be indicative that the miR-181 family could cooperatively control similar 
targets. miR-181 family members sharing the same seed sequence have actually been 
found to be dysregulated in neurodevelopmental disorders or control neurodevelop-
mental processes. For example, miR-181a, miR-181a* and miR-181b were significantly 
elevated in ASD patients, similar to miR-181c. Furthermore, two independent studies 
have shown increased levels of  miR-181b in grey matter of  the dorsolateral prefrontal 
cortex and temporal cortex of  schizophrenia patients [45,46]. Finally, miR-181a acts as 
a negative regulator of  AMPA-R surface expression by direct targeting of  GluA2, re-
sulting in reduced spine development and miniature excitatory postsynaptic current 
(mEPSC) frequency in hippocampal neurons [44]. Thus, the miR-181 family controls 
overlapping downstream target genes, and potentially modulates the expression of  sim-
ilar cellular pathways. Multiple miRs from a single family sharing sequence similarities 
can indeed cooperatively control cellular processes [47,48]. For example, miR-135a/b 
control chronic stress resilience through regulation of  overlapping genes within the 
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serotonergic system [49], while miR-48, mir-84, and mir-241 family members with se-
quence similarity to let-7 cooperatively control critical developmental timing events in 
Caenorhabditis elegans [50].        
Our data indicate that miR-181c inhibition dysregulates the levels of  a number of  neu-
rodevelopmentally relevant genes, implying that disruption of  miR-181c activity during 
cortical neuron development may result in altered neuronal morphologies. We showed 
that miR-181c inhibition leads to increased dendritic branching while increasing axon 
length and the number and size dendritic spines were decreased. In a recent study, we 
showed that increased levels of  miR-30d and miR-181c were found in the amygdala of  
a VPA induced rat model for autism [13]. Additional studies showed that inhibition of  
miR-181c in neurons isolated from the amygdala resulted in a decrease in neurite growth 
and branching and fewer dendritic spines. The observed differences in the effects of  
miR-181c on neurite growth could be attributed to spatiotemporally divergent gene 
expression in amygdala cells compared to cortical cells. Alternatively, the primary cell 
cultures used in those studies contain a variety of  cell types, thus the cellular composi-
tion of  amygdala cultures could differ from those isolated from the cortex. This under-
lines the importance for investigating miR regulation in a multitude of  genetic and cel-
lular contexts.          
Previously, the involvement of  the non-coding transcriptome, including miRs, has been 
studied in the context of  neurodevelopmental disorders such as ASD, schizophrenia 
and intellectual disability disorders (ID) [12,51-55]. Expression profiling of  cell lines 
derived from ASD patients has revealed 12 differentially expressed miRs with miR-181c 
being the second most significantly elevated miR [12]. This suggests the possibility that 
altered miR expression could underlie some of  the expression changes found in ASD. 
Indeed, when we compared transcriptome changes identified in the cortex of  ASD 
patients we found a considerable overlap with the miR-181c transcriptome changes. 
This opens up the possibility that miR-181c and its family members are partially respon-
sible for the mRNA expression changes in ASD patients, which may be contributing to 
disease susceptibility and/or progression. 
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Electronic Supplemental RNA sequencing data
Accessible online:         
Cellular and Molecular Life Sciences, Epub ahead of  print, doi:10.1007/s00018-016-
2179-0 
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Gene ID Other ID Ratio Direction p-value adj. p-value
Adm 25026 2.58 Down 0.0001983 5.15E-03
Ahr 25690 1.73 Down 4.42E-05 1.50E-03
Cast 25403 1.29 Down 1.35E-05 5.73E-04
Cav1 25404 1.71 Down 0.0002832 6.76E-03
Dio2 65162 1.96 Down 1.65E-05 6.74E-04
Epas1 29452 1.44 Down 0.0005326 1.10E-02
Fbxo2 85273 1.42 Down 6.79E-05 2.10E-03
Kcnj4 116649 1.25 Up 1.11E-16 4.57E-14
Mmp14 81707 1.92 Down 2.18E-11 4.13E-09
Sepp1 29360 2.13 Down 1.77E-09 2.31E-07
Slc9a3r1 59114 1.58 Down 5.47E-05 1.77E-03
Syn2 29179 1.21 Down 0.0007638 1.45E-02
Supplement Table 1: List of  genes functioning in behavior, cell-to-cell signaling and interac-
tion, nervous system development and function.
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Supplement Figure 1: MiR-181c transduction efficiency into primary cortical neurons. A. 
Schematic overview of  the lentiviral miR-181c-sponge construct designed to continuously and 
specifically sequester miR-181c. A concatemer of  four complementary miR-181c binding sites 
is placed within the 3’ UTR of  the eGFP gene. As example, one binding site of  the sponge with 
the mature miR-181c is shown, the central mismatch is included to enhance efficiency [56,63,64]. 
B. Micrographs of  primary cortical neurons infected with the miR-181c sponge lentivirus. The 
left image shows cell nuclei visualized with DAPI (bleu), the middle panel shows GFP from the 
miR-181c sponge (green) and on the right is the DAPI and GFP overlay. C. Relative expression 
of  miR-181c in DIV 9-old primary cortical neurons expressing the GFP control or miR-181c 
sponge construct normalized to control. D. Representative images of  primary cortical neurons 
transfected with siGLO transfection indicator. The micrographs from left to right show the 
nuclear DAPI staining (blue), siGLO (red) and a DAPI with siGLO overlay. E. Relative expres-
sion of  miR-181c in DIV 6 primary cortical neurons transfected with NT control or miR-181c 
mimic, levels were normalized to control. F. Relative expression of  miR-181c in DIV 6 primary 
cortical neurons transfected with NT control or anti-miR-181c, levels were normalized to con-
trol. Data are shown as mean ±SEM; p-values are determined by two-tailed unpaired Student’s 
t-test. *p ≤0.01 and ** p ≤0.001.
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Supplement Figure 2: Growing pure axonal fractions in microfluidic chambers. A. Sche-
matic representation of  a microfluidic chamber with the soma side (grey) and the axon side 
(green) connected with microgrooves in the middle. Neurons are shown in red, which grow their 
axons through the microgrooves to the axonal side. B. An example immunostaining of  cortical 
neurons cultured in microfluidic devices. The DIC image shows the microgrooves of  the micro-
fluidic chamber, MAP2 highlights the dendrites in green and Tau1 for visualizing axons in red. 
The image on the bottom right corner shows an overlay of  DIC, MAP2 and Tau1.
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Supplement Figure 3: Mature cortical neurons transduced with miR-181c mimic have a 
necrotic phenotype. Representative micrographs of  DIV 16 primary cortical neurons trans-
fected with 30 nM NT control (upper panels) or miR-181c mimic (lower panels) and 20 nM 
SiGlo fluorescent transfection indicator at DIV 3. The panels depict micrographs of  DIV16 
neurons stained with DAPI (blue), PSD-95 (green) and the Si-Glo transfection indicator (red). 
The necrotic phenotype (condensed nuclei) in miR-181c transfected neurons was observed for 
around 90% of  the cells; this experiment was repeated three times, with similar outcomes. 
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Abstract
A steady accumulation of  experimental data argues that protein synthesis in neurons 
is not merely restricted to the somatic compartment, but also occurs in several discrete 
cellular micro-domains. Local protein synthesis is critical for the establishment of  syn-
aptic plasticity in mature dendrites and in directing the growth cones of  immature ax-
ons, and has been associated with cognitive impairment in mice and humans. Although 
in recent years a number of  important mechanisms governing this process have been 
described, it remains technically challenging to precisely monitor local protein synthesis 
in individual neuronal cell parts independent from the soma. This report presents the 
utility of  employing microfluidic chambers for the isolation and treatment of  single 
neuronal cellular compartments. Furthermore, it is demonstrated that a protein syn-
thesis assay, based on fluorescent non-canonical amino acid tagging (FUNCAT), can 
be combined with this cell culture system to label nascent proteins within a discrete 
structural and functional domain of  the neuron. Together, these techniques could be 
employed for the detection of  protein synthesis within developing and mature neur-
ites, offering an effective approach to elucidate novel mechanisms controlling synaptic 
maintenance and plasticity.
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Introduction
Translation of  synaptically localized mRNAs (local translation) plays an essential role in 
a number of  important neuronal processes, including the consolidation of  memory and 
activity-dependent forms of  synaptic plasticity [1]. Moreover, inadequate or dysregulat-
ed protein synthesis in the brain can result in a number of  neurodevelopmental disorders 
by altering synapse composition and plasticity which are suspected to be causally related 
to some of  the most devastating symptoms in schizophrenia, intellectual disability and 
autism spectrum disorders (ASD) [2, 3]. Various mechanisms ensure the rapid trans-
port of  mature mRNAs, ribosomes and translational factors (e.g. Ef1α or eif2α) that 
co-localize at distant sites of  translation [4]. Moreover, protein synthesis is a multi-step 
process controlled by a subset of  distinct processes, including non-coding microRNAs 
(miRNAs) [5, 6], many different translation factors and multiple mRNA-binding pro-
teins [7, 8]. Accumulating evidence also suggests that translation of  proteins in distant 
synapses is regulated at several levels varying from transportation of  essential factors to 
local regulation of  their activity [9, 10]. Thus, local translation is a highly flexible process 
that facilitates fast and specific changes in individual compartments, ensuring a rapid 
response to local environment changes. For example, the stabilization of  several distinct 
forms of  activity-dependent synaptic plasticity requires a wave of  postsynaptic protein 
synthesis in the dendrites of  neurons. Compelling data demonstrating the mechanisms 
connecting the processes of  synaptic plasticity and memory consolidation comes from 
recent advances in our understanding of  how neuronal protein synthesis is regulated 
by synaptic activity [11]. Moreover, recent findings suggest that growing axons depend 
on the local synthesis of  structural and cytoskeletal proteins. Extracellular cues direct 
growth cones by inducing rapid changes in local protein expression, and developing ax-
ons contain the necessary translational machinery and specific mRNAs to support local 
protein synthesis. Indeed, the proteins coordinating or comprising cytoskeletal elements 
are locally synthesized and contribute to the growth cones path finding and turning 
apparatus [12, 13]. For example, some of  the first identified functions of  axonal protein 
synthesis were intricately linked to its ability to mediate local translation of  mRNAs that 
encode the cytoskeletal proteins in growing axons [14-16]. Although important advanc-
es have been made in examining the intricate subprocesses occurring during translation 
at pre- and postsynaptic sites, direct detection of  translation inside axons or dendrites of  
living neurons, using traditional methods, is challenging. Accordingly, there is a need to 
develop novel approaches to gain quantitative insights into local translational processes 
contributing to synapse formation and function. Previous research suggested that the 
overall amount of  proteins synthesized in distal segments of  neurons is relatively low, 
and often neglected by overwhelming somal translation. Therefore, visualization of  
protein synthesis in small areas containing low numbers of  active ribosomes requires 
a highly sensitive detection method. Such an experimental approach would facilitate 
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the direct labeling of  newly synthesized proteins, enabling the examination of  func-
tionally distinct neuronal compartments with low rates of  translation. To achieve this, 
the fluorescent noncanonical amino acid tagging (FUNCAT) was developed [17, 18], a 
click chemistry reaction, which provides a powerful labeling approach to detect nascent 
proteins intracellularly [19, 20]. The concept behind this assay is the substitution of  me-
thionine with its homologue homopropargylglycine (HPG) in living cells, allowing the 
introduction of  alkyne groups into nascent protein. These alkyne groups can be azide 
linked using the catalytic click reaction. The azide may be further “flavored” by addi-
tional functional groups, such as biotins for protein affinity purification experiments, or 
to a fluorophore for direct visualization of  nascent protein synthesis using confocal or 
fluorescent microscopy [17, 21, 22]. The distribution of  the observed signal inside the 
cell may be used as a marker for active translation. Moreover, the intensity of  the signal 
can be quantified, providing an estimate of  the level of  translation at a particular loca-
tion [22]. The use of  the click reaction to visualize local translation is largely hampered 
by high level of  proteins synthesized in the somata, many of  which are transported to 
distal sites of  neurons. Thus, the utility of  microfluidic chambers to physically separate 
distal neuronal segments, such as axons from the somata and other proximal processes, 
is ideally suited to locally apply and fluidically isolate click reaction reagent to selectively 
examine local translation [23]. The combinatorial use of  mircrofluidic chambers with 
fluorescent labeling of  nascent proteins has previously been shown to allow for visu-
alization of  proteins synthesis events within distinct neuronal sub-compartments, such 
as in growing axons [22, 24]. Here, we combined the utility of  the microfluidic devices, 
to either establish neuronal connectivity between dissociated cortical neurons, or to 
selectively grow axons and dendrites in parallel rows distal from their cell bodies, with 
FUNCAT to establish a qualitative nascent protein labeling approach in cortical neu-
rons in vitro. The experimental paradigm employed here provides a versatile, and highly 
sensitive assay for the detection of  local translation in growing and mature neurons. 
Materials and Methods
Animals          
Wistar rat (Harlan laboratories B.V., Boxmeer, The Netherlands) embryos were used as 
a resource for the isolation of  primary neurons. Animals were housed 2-3 per cage us-
ing a 12 hr light cycle at controlled ambient temperature (21 ± 1°C). All animal use, care 
and experiments were performed according to protocols approved by the Committee 
for Animal Experiments of  the Radboud University Medical Centre, Nijmegen, The 
Netherlands.
128
CHAPTER 6
Culture of  primary neurons        
All media and reagents used for cell culture were purchased from Life Technologies 
(Carlsbad, CA) unless stated otherwise. Primary cortical neurons were isolated from 
embryonic day 18 (E18) old rat embryonic brains. The cortical region was isolated and 
placed in ice-cold HBSS washing buffer (Hanks’ Balanced Salt solution (HBSS) con-
taining 2 mmol/L GlutaMAX and Pen/Strep antibiotics). The tissue was washed two 
times with the HBSS buffer before adding 0.025% trypsin in HBSS solution followed 
by incubation at 37°C for 15 minutes. After incubation, the tissue was washed 3 times 
with HBSS before adding Neurobasal (NB) medium supplemented with 10% fetal bo-
vine serum (FBS) and 2 mmol/L GlutaMAX. The tissue was titrated several times 
with a glass Pasteur pipette. This treatment was repeated with a flame-thinned tip glass 
Pasteur pipette to obtain fully dissociated cells. Separated cells were seeded in cell cul-
ture plates, which were coated overnight with 0.1 g/L, Poly-D-Lysine (PDL, molecular 
weight 70,000-150,000 Da) (Sigma–Aldrich, St. Louis, MO). For the first 5 hours, the 
cells were cultured in medium containing NB medium with 10% FBS and 2 mmol/L 
glutaMAX. Afterwards, the medium was replaced with culturing medium containing 
NB with the serum free neural supplement B27 and 2 mmol/L glutaMAX. 
Microfluidic chamber assembly       
Microfluidic axon and perfusion chambers were purchased from Xona microfluidics 
(Temecula, CA) and assembled according to the protocol provided by the manufacturer. 
In-depth descriptions for assembly and maintenance of  microfluidic axon and perfu-
sion chambers are also available [25, 26]. In summary, microfluidic chambers were pre-
pared by firstly cleaning them with 70% ethanol. After the chambers were completely 
dry, they were placed bottom side down on PDL coated coverglasses (Hecht Assitent, 
Sondheim von der Rhön, Germany). The chambers were subsequently filled with 100 
µl seeding medium (NB medium containing 10% FBS and 2 mmol/L GlutaMAX). This 
was done at least one day before seeding the cells so that any formed bubbles would 
dissipate. Just before seeding the cells, all medium was removed from the wells to which 
cells are added but avoiding the removal of  medium from the channels. Primary neu-
rons were diluted to a total number of  100,000 neurons (for the axon chambers, Fig. 
3A) or 50,000 neurons (for the perfusion chambers, Fig. 4A) in 20 µl seeding medium, 
and the cells were added into one well for one channel. For the perfusion chamber, in 
both opposing channels cells were added. This would lead to axons growing from one 
channel while dendrites grow from the other resulting in synapse formation within the 
perfusion channel. After the cells have settled down (approximately 30 min after seed-
ing), 100 µl seeding medium was added to all wells. After 24 hours, the seeding medium 
was removed and replaced with 150 µl culturing medium containing NB with B27 se-
rum free neural supplement and 2 mmol/L glutaMAX. Medium was replaced every 3-4 
days depending on the rate of  evaporation. 
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Click reaction and immunostaining       
Labelling of  proteins was performed using the Click-iT HPG Alexa Fluor 594 Protein 
Synthesis Assay Kit (Life Technology), following the protocol provided by the man-
ufacturer with some minor adjustments (Fig. 1). In brief, HPG was diluted in HBSS 
(Life Technology, Carlsbad, CA) to a concentration of  2 mM. Prior to the application 
of  HPG, the culture medium was replaced with HBSS to deplete methionine from the 
cells for 30 min. During this pre-incubation, the appropriate samples were also treated 
with 100 µM cycloheximide (Sigma–Aldrich, St. Louis, MO) to inhibit protein synthesis. 
After methionine depletion, the cells were incubated with HPG in the following man-
ner: For whole cell cultures, 100 µl HPG in HBSS solution was applied for 90 min under 
normal culture conditions. Some samples were treated with 50 mM KCl for the first 10 
min of  HPG incubation to enhance translation. Then, KCl was removed to minimize 
cytotoxicity. For microfluidic axon chambers, 100 µl HPG in HBSS solution was added 
to the “axon” side of  the chamber with 200 µl HBSS on the opposite “soma” side of  
the chamber to achieve fluidic isolation of  the HPG and incubated for 120 min.  
For microfluidic perfusion chambers, HPG in HBSS was added to the perfusion well. 
In all other compartments, including the two wells next to the perfusion well, HBSS 
was added. HPG was perfused at an initial flow rate of  0.010 ml/h and was slowed to 
0.005 ml/h after 10 min to facilitate HPG uptake into the cell. HPG was perfused for 
a total of  120 min. All HPG incubations were conducted in a cell culture incubator at 
37°C and with 5 % CO
2.
 For microfluidic chambers, after HPG treatment all follow-
ing reagents were applied to the entire chamber. After HPG incubation, the cells were 
washed 3 times with pre-warmed PBS. Cells were then fixed by incubating them with 
4% paraformaldehyde (PFA; Sigma–Aldrich, St. Louis, MO) and 16% sucrose in PBS 
for 15 min at room temperature (RT). After fixation, cells were washed with PBS and 
incubated with 0.5% Triton-X 100 (Sigma–Aldrich, St. Louis, MO) in PBS for 10 min at 
RT. Permeabilized cells were washed before the fluorophore Alexa-594 coupled azide 
containing click-reaction-cocktail was prepared according to the instructions of  the 
assay kit provider. The reaction cocktail was added to the cells for 30 min at RT. The 
remaining click-reaction-cocktail was removed by washing the cells with PBS followed 
by removal of  the silicone chambers. Samples were treated with 4% bovine serum albu-
min (BSA; ICN Biomedicals, Santa Ana, CA) in PBS blocking solution for 30 min at RT. 
Then, primary antibodies were diluted in blocking solution and added to the samples 
for an overnight incubation at 4°C. The next day, samples were washed with blocking 
solution and incubated with the Alexa-conjugated secondary antibodies diluted in 4% 
BSA-PBS for 30 min at RT. The samples were washed with PBS followed by washing 
with distilled water in order to reduce the amount of  potentially fluorescent salts in the 
samples. 
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Figure 1. Protein labeling using the click reaction. (A) A scheme showing the copper-catalyzed 
click reaction in which two molecules containing either an alkyne (blue) or azide (red) group are 
covalently bound to form a stable triazole conjugate. (B) Click reaction workflow for labeling 
nascent proteins in neuronal cultures. First, the cells will be methionine (brown dots) depleted 
and the medium replaced with HBSS buffer. HPG is added to the cells and incorporated into 
newly synthesized proteins (blue hexagons). The incorporated HPG is labeled with Alexa-594 
containing a azide moiety (red hexagons). Thereafter, cells can be subjected to immunostaining 
to label specific neuronal components. 
Finally, the samples were mounted in ProLong Gold antifade reagent (Life Technolo-
gies, Carlsbad, CA) and allowed to dry for at least 24 h before image acquisition. The 
following primary antibodies were employed in the study: mouse anti-tau1 (MAB3420, 
Millipore, Billerica, MA at 1:1000); rabbit anti-MAP2 (ab32454, Abcam, Cambridge, UK 
at 1:2000); mouse anti-PSD95 (MA1-045, Thermo Scientific, Waltham, MA at 1:2000). 
Goat anti-rabbit-Alexa 405 (Molecular Probes, Life Technologies, Grand Island, NY at 
1:250), goat anti-mouse-Alexa 488 (Molecular Probes, Life Technologies, Grand Island, 
NY at 1:500) were used as secondary antibodies.
RNA isolation and reverse transcription polymerase chain reaction (RT-PCR)   
Total RNA from microfluidic axon chambers was isolated as previously described [27]. 
RNA was isolated with the RNAeasy extraction kit (Qiagen, Germantown, MD), ac-
cording to the manufacturer’s manual. RNA purity was determined using the Nanodrop 
ND1000 (Thermo Scientific, Waltham, MA) UV-spectrophotometer. The 260/280 nm 
ratios were measured and samples with ratios of  2.0 ± 0.05 were considered pure. 
cDNA was synthesized using the RevertAid RT reverse transcription kit (ThermoFish-
er Scientific) from isolated RNA according to the protocol provided by the supplier. 
RT-PCR detection of  mRNA transcripts (using 50 PCR cycles) was performed using 
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the SensiFAST SYBR No-ROX kit (Bioline, London, United Kingdom). The following 
gene specific primers were used: rat Scn3b, forward 5’- TGTGGTGTGACTTGAG-
GTGAT, rat Scn3b, reverse 5’- TGTTGGCTCTTCGGTTCAGG, rat RragB forward 
5’- AAAGAACAGCGAGATGCCCA, rat RragB reverse 5’- GCTGCAGAAGGAAT-
GGATGG.
Microscopy and image analysis       
Images were analysed using the Fiji image processing software [28]. All images from a 
single experiment ware taken using the same microscope settings to allow subsequent 
quantitative analysis of  the fluorescent intensities. In all experiments, any residual back-
ground signal measured after blocking translation, was subtracted from the data. For 
experiments performed in whole neuronal cultures (24 well), MAP2 staining was used 
to either define the somata or single neurites before the intensity of  the HPG signal was 
measured. For the quantification of  the HPG signal in dendrites or axons, MAP2 and 
Tau antibodies were used, respectively. The same selection threshold was used between 
images from the same experiment. In whole cell preparations, samples incubated with 
no HPG treatment served as a background control.  The specificity of  the click reaction 
in the absence of  specific ligation azide binding partners and was used to determine 
the baseline signal. Protein labelling in axons was quantified by measuring the average 
intensity of  the HPG signal inside regions of  interest as selected based on Tau staining. 
For measuring the HPG signal in axon, the Tau staining was used as a mask to select 
the region of  interest, the same selection threshold was applied between images from 
the same experiment. For the microfluidic perfusion chambers, regions of  interest were 
defined within the perfusion channel to measure the intensity of  the HPG signal. For 
quantifying protein labelling in synapses, the average intensity of  HPG was measured 
determining the fraction of  HPG signal overlapping with the PSD-95 signal. This value 
was subsequently normalized for the area that was threshold selected for analysis. The 
same selection threshold was used between images from the same experiment. Fluores-
cent images of  the axons were obtained using a Leica DMRA fluorescence microscope 
fitted with a DFC340 FX CCD camera (Leica, Wetzlar, Germany). A Leica TCS SP2 
AOBS Confocal Laser Scanning Microscope (CLSM) (Leica, Wetzlar, Germany) was 
used to capture fluorescent images of  whole neuronal cultures and of  the microfluidic 
perfusion chambers.  
Statistical analysis         
Quantitative data are presented as the mean ± SEM. Non-paired two-tailed Student’s 
t-test was used to determine significant differences between two groups. One-way 
ANOVA with Bonferroni’s multiple comparison testing was used to analyse significant 
differences between multiple groups. P ≤ 0.05 was considered significant.
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Results
Labelling of  nascent proteins in primary neuronal cultures   
To examine protein synthesis in distal cellular compartments, such as axons and den-
drites, we first confirmed that the click reaction can be used for the detection of  na-
scent proteins in cortical neurons. Toward this end, days in vitro (DIV) 14 rat primary 
cortical neurons were methionine-depleted and treated with HPG (Fig. 1). After HPG 
labelling, neurons were subjected to Tau and MAP2 staining to visualize axons and 
dendrites, respectively (Fig. 2A). Neurons treated with HPG alone showed a fluorescent 
signal representative of  the baseline rate of  translation in cortical neurons. To examine 
whether HPG incorporation is dependent on translation, we co-incubated HPG-treated 
cells with the protein synthesis inhibitor cycloheximide (CHX), which selectively inhib-
its eukaryotic translation elongation [29]. Translation inhibition resulted in a significant 
reduction of  HPG incorporation, suggesting that HPG incorporation is specifically 
dependent on active mRNA translation (mean 1.913 ± 0.2035 HPG versus 0.8657 ± 
0.1142 CHX relative intensity; p=0.0013). Furthermore, translation was strongly en-
hanced after neurons were depolarized with the addition of  50 mM KCl during the 
initial 10 min of  HPG incubation. This increase could be blocked in cells treated with 
CHX (mean 4.421 ± 0.3565 KCl versus 0.8624 ± 0.0917 KCl + CHX relative intensi-
ty; p=<0.0001) (Fig. 2B). Using MAP2 and Tau immunocytochemistry, selective HPG 
incorporation in the dendrites and axons of  cortical neurons was detected, respectively. 
The results of  this investigation revealed that KCl depolarization strongly enhanced 
the intensity of  the HPG signal both in dendrites (mean 0.1401 ± 0.0486 HPG versus 
0.8106 ± 0.1319 KCl relative intensity; p=<0.0001) and in the axons (mean 0.2885 ± 
0.1535 HPG versus 1.509 ± 0.2817 KCl relative intensity; p <0.0001). This increase in 
translation could be completely blocked by the inclusion of  CHX in dendrites (mean 
0.8106 ± 0.1319 KCl versus 0.1486 ± 0.0385 KCl + CHX relative intensity; p <0.0001) 
and axons (mean 1.509 ± 0.2817 KCl versus 0.4866 ± 0.1388 KCl + CHX relative 
intensity; p=<0.0041) (Fig. 2C, D). These findings show the specificity of  HPG and 
azide binding as demonstrated by the general low background signal in the control and 
inhibited groups. However, under these conditions, it is not clear whether this signal is 
related to local protein synthesis in the neurites or whether it represents proteins that 
were produced in the somata and subsequently transported throughout the neuron. 
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Figure 2. HPG incorporation into neurons is dependent on translational activity. (A) Repre-
sentative images of  HPG signal (inverted greyscale and red) in DIV 14 cortical neurons. Trans-
lation was stimulated by KCl-mediated neuronal potentiation and reduced by pre-incubation 
with the translation inhibitor cycloheximide (CHX). Immunostaining with anti-Tau (green) and 
anti-MAP2 (blue) distinguishes between axons and dendrites, respectively. (B) Quantification of  
the relative changes in somatic HPG signal intensity after treatment with CHX, KCl or CHX 
and KCl. (C-D) Shows the relative intensity of  HPG in the (C) MAP2 positive dendrites and 
(D) Tau positive axons after treatment with CHX, KCl or CHX and KCl. Data represents the 
mean ± SEM and single values shown for n=11-15 samples collected from three independent 
experiments. DIV, days in vitro; HPG, homopropargylglycine; MAP2, microtubule-associated 
protein 2. One-way ANOVA with Bonferroni multiple comparison test. **. p < 0.01 and ***, p 
< 0.001. Scale 50 µm.
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Labelling of  newly synthesised proteins in growing axons   
Local translation in growing axons is essential for rapidly supplying the demand for 
newly synthesized proteins in these distal neuronal compartments. To visualize the frac-
tion of  proteins locally synthesised within distal neuronal compartments, we made use 
of  microfluidic chambers allowing for fluidic isolation of  growing axons [23]. Aiming 
at labelling locally synthesized proteins in growing axons, compounds were applied and 
fluidically isolated to the axonal compartment. Cortical neurons were cultured in micro-
fluidic chambers in the “soma” compartment until their corresponding axons reached 
the adjacent unoccupied “axon” compartment (Fig. 3A). An absence of  MAP2 within 
the axon compartment, using immunocytochemistry, suggested that this area is devoid 
of  dendrites (Fig. 3B). Detection and quantification of  HPG incorporation revealed 
that newly-synthesized proteins can be detected in growing axons and that application 
of  the translation inhibitor CHX significantly reduced the signal (mean 0.5238 ± 0.1515 
HPG versus 0.0 ± 0.07834 CHX relative intensity; p=0.0050) (Fig. 3B, C). To demon-
strate the absence of  somata within the axon compartment, the purity of  the RNA 
samples prepared from the distal axons was assessed by RT-PCR, using gene-specific 
primer sets for mRNAs present in neuronal cell somata only. As shown in Fig. 3D, am-
plicons for Sodium Channel, Voltage Gated, Type III Beta Subunit (SCN3B) and Gly-
cine Receptor, Beta (GLRB), were readily detected in RNA prepared from the neurons 
present in compartment harbouring parental cell somata and proximal axons, but were 
not observed in RNA obtained from distal axons. These genes were selected as mark-
ers, because in a recent investigation using microarray and qPCR analyses of  soma and 
axon RNAs, we found that SCN3B and GLRB mRNAs were present in the somata, but 
were not localized in the axons (unpublished microarray data). To investigate that local 
treatment of  axon compartment with HPG selectively incorporates this compound into 
axonal proteins without being introduced into parental cell soma proteins, we examined 
HPG incorporation into the parental somata compartment. Little HPG incorporation 
was detected in the parental somata of  axons treated with this reagent. Moreover, the 
weak HPG signal detected in the somata was insensitive to CHX treatment (Fig. 3E, F). 
Images from the somatic area were captured at the centre of  the compartment, approx-
imately 200 µm away from the 450 µm long microgroove barrier. These observations 
further demonstrate the feasibility of  in situ tagging and detection of  relatively low 
abundant, locally synthesized proteins in growing axons using microfluidic chambers.
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Figure 3.  Nascent protein tagging in axon of  cortical neurons growing in microfluidic cham-
bers. (A) Schematic representation of  a compartmentalized microfluidic chamber with the grey 
channel holding the cells from which the axons will originate. These will grow through the 
middle microgrooves towards the axon chamber (green). On the right a representative micro-
graph of  growing axons from DIV 7 cortical neurons stained with phalloidin (green) and DAPI 
(blue). The white insert denotes the typical area in which the axonal HPG signal was measured. 
(B) Representative images of  axons treated with HPG alone or combined with the translation 
inhibitor CHX, these compounds were added to the axon compartment and fluidically isolated. 
Neurons were stained for Tau (green) and HPG incorporation (inverted greyscale and red) and 
the overlay of  the two fluorofores. (C) Quantification of  the HPG signal in immature axons 
relative to axons treated with CHX. (D) Agarose gel electropherogram of  the soma enriched 
genes Scn3b and Glrb after RT-PCR amplification of  RNA samples isolated from the soma or 
axon compartment including a H2O negative RT-PCR control. (E) Representative images of  
cells within the soma compartment of  the axon chamber in which only the axon compartment 
was treated with HPG. Neurons were stained for Tau (green) and HPG incorporation (inverted 
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greyscale and red). (F) Quantification of  the HPG signal in the soma compartment compared 
to cells treated with CHX. Data represents the mean ± SEM and single values shown for n=6-9 
chambers collected from three independent experiments. CHX, cycloheximide; DIV, days in vi-
tro; HPG, homopropargylglycine. p-values are determined by two-tailed unpaired Students t-test. 
**, p < 0.01. Scale (A, B and E) 50 µm.
Detection of  nascent proteins in postsynaptic densities   
The ability to detect relatively small amounts of  newly produced proteins in defined 
cellular compartments, such as in growing neurites, led us to evaluate whether nascent 
proteins within synapses of  mature neurons could be examined using click chemistry. 
Toward this end, the microfluidic perfusion chamber was utilized enabling the local 
perfusion of  compounds through a channel in which neuronal synapses are formed 
(Fig. 4A). Cortical neurons were cultured in perfusion chambers for 14-16 days to allow 
formation and maturation of  synapses inside the perfusion chamber. HPG alone or 
in combination with CHX was applied locally by pumping the solutions for 120 min 
through the perfusion channels harbouring mature synapses (Fig. 4B, C). Quantification 
of  incorporated HPG was performed to evaluate whether newly synthesised proteins 
could be imaged within the perfusion channel. This resulted in the detection of  labelled 
HPG in the perfused area of  the chamber. Importantly, the HPG signal was significant-
ly diminished when translation was repressed by CHX (mean 0.4293 ± 0.09 HPG ver-
sus 0.0 ± 0.045 CHX relative intensity; p=0.0052) (Fig. 4D). We also examined whether 
perfusion of  HPG resulted in its incorporation within the parental soma proteins. We 
chose to examine HPG incorporation in cell somata in the lateral compartment, which 
is connected to the perfusion chamber via the shorter microgroove barrier, enabling 
dendrites to project toward the central perfusion chamber. Investigation of  HPG in-
corporation into the cell somata located in this compartment suggested that only a very 
small amount of  HPG is incorporated in the parental cell somata of  the postsynaptic 
compartment (Fig. 4E and F). Images were taken central of  the dendrite generating 
somatic compartment, at an approximate 200 µm away from the 75 µm long micro-
grooves. To demonstrate that the perfused area of  the chamber can be employed to 
label nascent proteins within mature synapses, we performed PSD-95 immunolabelling 
to mark the postsynaptic compartment of  neurons grown in microfluidic perfusion 
chambers (Fig. 5A). The quantification of  newly synthesised, labelled proteins colocal-
izing with postsynaptic densities visualized local translation on this site, which exhibited 
significant reduction in HPG signal once CHX was applied (mean 0.3325 ± 0.03586 
HPG versus 0.0 ± 0.04146 CHX relative intensity; p=<0.0001) (Fig. 5B). In addition, 
a significant amount of  HPG signal was observed outside of  the postsynaptic regions, 
indicating that nascent proteins are synthesized along the dendrite lengths. 
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Figure 4. Imaging of  protein synthesis in neurons grown in microfluidic perfusion chambers. 
(A) Schematic overview of  a microfluidic perfusion chamber with a zoom in (insert of  the per-
fusion channel on the right). On the left side of  the chamber there are three reservoirs. The two 
outer green wells contain a buffer to hold the perfusate inside the perfusion chamber preventing 
it from entering the microgrooves. The middle red well contains the desired perfusate. The lower 
red cells generate the axons growing towards the perfusion channel (presynaptic compartment), 
while the blue upper cells generate the dendrites (postsynaptic compartment). (B) and (C) Rep-
resentative confocal images of  the HPG signal (red and greyscale) and Tau (blue) within the 
perfusion channel of  chambers in which mature cortical neurons (DIV 14-16) were cultured. 
The neurons were treated locally within the perfusion channel with HPG alone or combined 
with CHX. (C) Magnifications of  the white square inserts depicted in (B) with the HPG shown 
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in red and inverted greyscale. (D) Quantification of  the relative intensity of  the HPG signal in-
side the perfusion channel compared to neurons treated with CHX. (E) Representative confocal 
images of  cells within dendrite side (postsynaptic compartment) of  the perfusion chamber with 
Tau (blue) and the HPG signal (greyscale). (F) Quantification of  the relative intensity of  the 
HPG signal of  cells cultured on the dendrite side of  the perfusion chamber. Data represents the 
mean ± SEM and single values shown for n = 4 independent experiments. CHX, cycloheximide; 
DIV, days in vitro; HPG, homopropargylglycine. p-values are determined by two-tailed unpaired 
Students t-test.  **, p < 0.01. Scale (B and E) 50 µm and (C) 5 µm.
Collectively, these results demonstrate that the microfluidic perfusion chamber can be 
utilized to label and visualize nascent proteins in defined synaptic entities. Furthermore, 
these finding suggest that HPG can label translation in discrete neuronal compartments, 
demonstrating its general usefulness for investigating local translation.
139
MONITORING MRNA TRANSLATION
6
A BHPG HPG OverlayPSD95
H
PG
C
H
X
***
HP
G
CH
X
-0.2
0.0
0.2
0.4
0.6
R
el
at
iv
e 
in
te
ns
ity
Figure 5. Visualization of  nascent protein synthesis in postsynaptic densities from neurons 
grown in microfluidic perfusion chambers. (A) Representative confocal images of  the perfusion 
channel from microfluidic perfusion chambers in which DIV 14-16 primary cortical neurons 
were grown. Neurons were treated with HPG alone or in combination with CHX and stained 
for HPG incorporation (inverted greyscale and red) or PSD-95 (green), the overlay shows the 
overlap between these two signals. (B) Quantified relative HPG signals inside PSD-95 puncta of  
neurons treated HPG alone or in which translation was inhibited using CHX, normalized for the 
total selected PSD-95-positive-area. Data represents the mean ± SEM and single values shown 
for n=10-11 culture chambers collected from three independent experiments. CHX, cyclohexi-
mide; DIV, days in vitro; HPG, homopropargylglycine; PSD-95, postsynaptic density protein 95. 
p-values are determined by two-tailed unpaired Students t-test.  *** p < 0.0001. Scale (A) 5 µm.
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Discussion
Previously, the majority of  research to visualize local translation had been performed 
using genetic fluorophore labeling techniques, allowing for the visualisation of  specific 
individual proteins. This approach, however, is limited to monitoring only a few pro-
teins at the same time. Here, it is demonstrated that the combination of  amino acid 
tagging with microfluidic chambers can be harnessed for the labelling of  the proteome 
within specific neuronal sub-compartments. This technique allowed for the detection 
of  relatively low basal levels of  nascent proteins synthesized within axons and synapses 
of  neurons grown in microfluidic devices using the click amino acid labeling assay.  
To achieve metabolic labeling of  nascent proteins, HPG or azidohomoalanine (AHA) 
have been successfully employed as methionine analogs. Both molecules efficiently and 
abundantly label nascent proteins within the soma and neurites of  neurons [17]. It is im-
portant to note that both methionine surrogates have slightly different charging rates by 
methionyl-tRNA synthetase, with AHA incorporating faster into nascent polypeptides 
than HPG. This difference in incorporation rates can be harnessed for sequential pulse 
labeling of  different protein populations within a single experiment. As demonstrated 
previously, during protein tagging, an initial pulse with HPG, followed by incubation 
with AHA offer the most optimal incorporation rates [17].    
Studying localized production of  proteins within neuronal compartments is important 
for understanding processes such as axon development or synaptic plasticity. The com-
binatorial use of  amino acid labeling and microfluidic cell culture chambers has been 
reported previously and facilitated the study of  local regulation of  gene expression 
within neuronal processes [22, 24]. For example, combining this technique with the 
induction of  long-tern potentiation (LTP) or depression (LTD) enabled the investi-
gation of  the role of  local translation in these physiological processes within synapses 
in vitro [26]. These forms of  synaptic plasticity could either be achieved using specific 
pharmacological compounds such as DHPG, an agonist for the glutamate receptors 
Glu1 and Glu5 that induces LTD [30], or by the application of  alternative system like 
the genetic introduction of  opsins for the optogenetic control of  depolarization [31]. 
The advantage of  this system is that the design of  the perfusion chamber would permit 
the investigator to express the opsins exclusively in one cell population. In this manner, 
individual (sub-) populations could be stimulated in order to conjointly quantify trans-
lation activity in neurons [32, 33]. Furthermore, this technique could also be applied to 
study the effect of  the non-coding RNAs, such as miRNA, on global protein output 
within restricted neuronal compartments. For example, miR-16 was shown to locally 
control axonal eIF2B2 and eIF4G2 mRNA expression impacting the axonal transla-
tion machinery [34]. In our experiments, we could detect nascent proteins under basal 
translation activity in cortical neurons. Our experiments furthermore showed that the 
click chemistry is sensitive enough to detect relatively low amounts of  locally produced 
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proteins in growing axons and within synaptic densities. Previous reports showed simi-
lar findings in which neuronal stimulation resulted in enhanced mRNA translation. For 
example, neuronal stimulation using brain-derived neurotrophic factor (BDNF) result-
ed in a substantial enhancement of  translation activity in the dendrites of  hippocampal 
neurons [17]. Furthermore, it was shown that LTD induction in microfluidic perfusion 
chambers by locally applying DHPG increased Arc levels within the stimulated synapse 
[26]. The detection of  significant amounts of  labeled proteins during basal translation 
suggests that in growing axons substantial local translation takes place during the ex-
perimental procedure without depolarization of  the cells or addition of  growth factors. 
The benefit of  using microfluidic chambers is that it allows for the isolated labeling and 
detection of  proteins in axons and synapses while in traditional neuronal culture the 
subtle translation activity within these neuronal components is possibly masked by vast 
amount of  protein synthesis in the soma. Furthermore, our experiments showed that 
local application of  the click chemistry did not lead to substantial labeling of  nascent 
proteins within the somatic compartment. This suggests that a relatively short incuba-
tion period used during our experiments does not lead to intracellular diffusion of  the 
HPG. However, it bears mention that we cannot exclude the possibility of  diffusion oc-
curring when longer incubation periods or higher concentrations of  HPG are applied. 
Although CHX is a selective protein synthesis inhibitor, previous reports have shown 
that it can induce apoptosis when exposed to cells over extended periods of  time [35]. 
In our experiments we exposed cells to CHX only for a short periods of  time and did 
not observe any apoptosis or necrosis in the neurons exposed to CHX.    
In conclusion, here we report on the use of  fluorescent amino acid labeling in micro-
fluidic chambers to detect nascent locally translated proteins in neuronal cultures. The 
premise of  the presented technology is that it might help to identify novel regulatory 
mechanism of  local translation at nerve endings and will facilitate the illumination of  
novel pathways involved in neuronal development and synaptic plasticity.
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The brain is a highly organized organ consisting of  numerous regions, each having a 
specific structure and function. It is no surprise that small changes in this cellular orga-
nization will have consequences for the functioning of  the brain. Indeed, a number of  
brain disorders are due to abnormal development of  the brain, such as autism spectrum 
disorders (ASD), schizophrenia, fragile X syndrome and intellectual disability [1]. The 
development of  the various cellular structures within the brain is a tightly regulated pro-
cess controlled by a plethora of  genetic and epigenetic mechanisms. One such regulato-
ry mechanism is mediated by microRNAs (miRs), which have the capacity to post-tran-
scriptionally modulate mRNA and protein homeostasis. miRs are small non-coding 
RNA molecules of  approximately 22 nucleotides long that interact with downstream 
mRNA transcripts through binding with complementary sequences. These interactions 
result in either translational repression or degradation of  the targeted mRNA transcript. 
Initial experiments using animal knock-outs of  Dicer, a key enzyme for the formation 
of  mature miR, have highlighted the critical role of  miRs in cortical development [2,3]. 
Moreover, specific miRs have been implicated in a number of  neurodevelopmental pro-
cesses such as neurogenesis [4], neuronal differentiation [5], neurite growth [6,7], and 
synapse formation [8] and plasticity [9-11]. 
One of  the prominent regions within the brain is the cerebral cortex, playing a key role 
in sensory perception, cognitive function, working memory and attention. Upon closer 
inspection, the cortex consists of  numerous layers each densely packed with highly 
specialized cells which generate complex circuitries allowing for the directed flow of  
information. In light of  the involvement of  specific miRs in the etiology of  a number 
of  brain disorders, we aimed to deepen our understanding of  how individual miRs can 
control cortical development and identify the downstream gene networks. In this thesis, 
I focused on unraveling the role of  two brain-enriched miRs, namely miR-338 and miR-
181c. Previous studies have identified miR-338 as an axon growth regulator in sympa-
thetic neurons and it has been found to control oligodendrocyte development [12]. 
miR-338 is encoded within the 7th intron of  the apoptosis-associated tyrosine kinase (AATK) 
gene. In chapter 2 we found that miR-338 can regulate the expression of  the AATK 
host gene through its binding to regions within the 3’ UTR. In chapter 3 we altered 
the expression levels of  miR-338 by genetic modification of  cortical cells in cell culture 
systems and in chapter 4 within intact developing embryonic brains. These studies 
demonstrated a critical role of  miR-338 during neurite development and migration of  
cortical neurons. Furthermore, a miR-338 target screening revealed that miR-338 con-
trols a subset of  transcripts involved in the axonal guidance machinery and identified 
roundabout guidance receptor 2 (Robo2) as one of  the direct targets. miR-181c has previously 
been found to be upregulated in an autism rat model [13]. In chapter 5 systematic 
target identification and pathway analysis revealed miR-181c as a modulator of  genes 
relevant for neurite and synapse developmental processes. Furthermore, changing the 
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levels of  miR-181c during the development of  cortical cells affected their neurite and 
synapse development. Since our studies identified miRs that can regulate the growth 
and development of  neurites, we developed a method, described in chapter 6, which 
allowed us to monitor the production of  locally produced nascent proteins within these 
distal processes of  cortical cells.
Intronically encoded miR-338, a potential regulator of  its host gene AATK 
Although most miRs are encoded by intergenic regions, miR genes are also found in 
introns or exons of  non-coding RNA genes, or within introns of  protein-coding genes. 
miR-338 is an intronic miR encoded within the 7th intron of  the AATK host gene 
(chapter 2). Like many of  the intronically encoded miRs, miR-338 lacks a promoter 
and is under the regulatory control of  the AATK gene promoter. Previous reports 
have shown that most intronic miRs display coordinated expression with its host gene 
[14,15]. Thus, transcription and splicing of  the AATK gene may lead to synchronized 
expression of  AATK mRNA and a pre-miR-338 transcript. However, our initial investi-
gation analyzing the expression of  miR-338 and its host-gene AATK during maturation 
of  hippocampal neurons revealed that the expression patterns of  AATK and miR-
338 are different. Since the majority of  miR targets are eventually degraded upon miR 
binding [16,17], increased miR expression likely leads to downregulation of  its mRNA 
targets. Reasoning along this line, using paired analysis of  miR and putative target gene 
expression levels approximately 20% of  intragenic miRs was predicted to have the ca-
pacity to target their host mRNA transcript [18]. Because of  the uncorrelated expres-
sion of  miR-338 and its host gene AATK, we screened the AATK gene for potential 
miR-338-3p binding sites and found multiple sites within the 3’ UTR of  its host gene. 
This led us to hypothesize that miR-338 could bind to and regulate these sites within 
the AATK mRNA. Subsequent experiments in which we upregulated miR-338 showed 
that miR-338-3p, but not miR-338-5p, mildly decreases AATK mRNA quantity. Fur-
thermore, fusion of  the AATK 3’ UTR to a luciferase reporter gene allowed regulation 
by miR-338-3p. The results collectively indicate that miR-338 has indeed the capacity 
to regulate its host gene, which is restricted to the miR-338-3p strand. The regulation 
of  AATK by miR-338 is in agreement with the target site prediction analysis which 
showed one poorly conserved binding site in the mouse ortholog of  the AATK gene. 
Overexpression of  miR-338 in neuroblastoma cells induced a modest repression of  
AATK mRNA. This is in line with previous reports that miRs generally act as fine-tun-
ers of  mRNA stability and translation rather than being regulatory switches [19]. Initial 
reports demonstrated enhanced AATK expression upon growth arrest and apoptosis 
in myeloid precursor cells [20]. Similar effects were later shown in cerebellar granule 
neurons, in which induction of  apoptosis was associated with an increase in AATK 
expression [21]. Furthermore, AATK mRNA and protein expression increases during 
postnatal brain development, and elevated levels of  AATK have been demonstrated to 
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enhance neurite outgrowth [22]. More recent studies in cortical neurons showed that 
AATK is activated by cyclin-dependent kinase 5 (CDK5) phosphorylation and subse-
quently regulates axon and dendritic growth acting via Ras-related protein RAB11A 
[23,24]. Collectively, the observations suggest that specific levels of  AATK may be 
important for proper neuronal growth and development. The capacity of  miR-338 to 
modulate the mRNA levels and translation of  AATK suggests that miR-338 could con-
trol axon and dendrite development as well as neuronal differentiation (partially) though 
the regulation of  AATK. Indeed, in vitro and in vivo modulation of  miR-338 resulted in 
changes in axon and dendritic growth in similar fashion previously identified for AATK 
[22-24], and miR-338 may be important for maintaining specific homeostatic levels of  
AATK within the cell to properly execute its cellular functions. 
A few studies have suggested a functional relationship between miR host genes and pu-
tative targets of  corresponding intronic miRs. The miRs encoded within the host genes 
were found to support the host gene either by synergistic or antagonistic regulatory ef-
fects [25,26]. This notion is supported by reports investigating the regulatory programs 
of  individual intronic miRs. For example, the intron of  the schizophrenia-susceptibility 
gene glutamate receptor, ionotropic, delta 1 (GRID1) encodes miR-346 which is down-regu-
lated in schizophrenia, and based on target prediction algorithms preferentially targets 
genes which may be involved in the schizophrenia pathophysiology [27]. Furthermore, 
the CTD small phosphatase 2 (Ctdsp2) gene is a repressor of  neuronal differentiation genes 
and hosts the intronic miR-26b, in neuronal stem cells the biogenesis of  pre-miR-26b 
is inhibited. Interestingly, during neuronal differentiation the miR-26b processing block 
is relieved, resulting in repression of  Ctdsp2 mRNA by miR-26b [28]. The regulation 
of  AATK by miR-338 could influence the neurodevelopmental role of  AATK and fine 
tuning its mRNA stability and translation. Furthermore, in chapters 3 and 4 we show 
that miR-338 functions as a regulator of  neurite growth and development within the 
cortex by controlling the expression of  a set of  neurodevelopmental genes, such as 
Robo2 and Rho-Associated, Coiled-Coil Containing Protein Kinase 2 (Rock2), with a converging 
role in axon guidance and development. These findings suggest that miR-338 functions 
synergistically with AATK in regulating neurite development in cortical neurons.
Regulation of  cortical development by miR-338     
Previous stdies have shown that miR-338 has the capacity to modulate the growth of  
axons in dorsal root ganglion neurons and it was suggested that it does so through reg-
ulating a number of  mitochondrial genes [29,30]. In the spinal cord however, miR-338 
was found to induce oligodendrocyte differentiation and maturation through regulation 
of  the transcription factors sex determining region Y-Box 6 (Sox6) and hes family BHLH 
transcription factor 5 (Hes5) [12]. Based on previous studies and our own (chapters 3 and 
4) we know that miR-338 is also abundantly expressed in cortical tissue [31]. Expression 
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profiling of  miR-338 in isolated cortical neurons revealed a dynamic expression pat-
tern, with expression peaks at 3 and 18 days in culture, time points generally associated 
with neurite growth and synaptic development, respectively. In chapter 3 we therefore 
decided to modulate miR-338 expression in cortical cells during these early stages of  
development and analyze the effects on neurite development and growth. This revealed 
that miR-338 inhibition leads to a decrease in dendritic complexity and a mild change 
in spine morphology while axon growth was enhanced. The changes in neurite growth 
suggest that miR-338 could alter the polarization of  cortical neurons, whereby cells 
lacking miR-338 function tend to enhance the growth of  their axons, while dendritic 
development is decreased. In utero manipulation of  miR-338 levels in chapter 4 addi-
tionally revealed that there were fewer cells within the upper cortical layers when miR-
338 was inhibited and furthermore exhibited loss of  neuronal polarity. Taken together, 
these results suggest a key role for miR-338 in regulating neurite growth and develop-
ment in the cortex. 
Regulation of  axon guidance genes by miR-338    
In chapter 3 and 4 we demonstrated that miR-338 controls neurite development and 
polarization of  cortical neurons, processes highly dependent on remodelling of  the 
cytoskeleton and membrane trafficking [32]. Since miRs enforce their effects through 
regulation of  multiple downstream mRNA targets we expected miR-338 to target a 
number of  genes that directly or indirectly involved in these neurodevelopmental pro-
cesses. Large scale screening for miR-338 targets using transcriptomics after miR-338 
inhibition identified a large number of  genes differentially expressed as described in 
chapter 3 [33,34]. Gene ontology analysis revealed an enrichment of  genes involved 
in neurite growth and development. In particular, canonical pathway analysis revealed 
a significant enrichment of  a number of  genes involved in the axon guidance pathway 
of  which a large number was confirmed via qPCR to be significantly upregulated upon 
miR-338 inhibition. Putative binding site analysis and subsequent luciferase reporter as-
says revealed Robo2 as one of  the direct targets of  miR-338. This suggests that the ma-
jority of  expression changes induced by miR-338 are due to indirect regulatory effects. 
A large body of  research has shown that miRs can target transcription factors [34,35], 
components of  the nonsense mediated decay pathway [36], and factors regulating the 
splicing process [37,38]. Such regulatory pathways exemplify that the contribution of  
indirect changes by miRs in downstream gene networks can be substantial. The benefit 
of  adopting whole transcriptome and proteome screening, in combination with miR 
binding site algorithms and luciferase gene reporter assays, is that it offers insight into 
both the direct and indirect changes induced by miRs. Importantly, the majority of  miR 
target identification algorithms limit their analysis for putative binding sites on the 3’ 
UTR of  mRNA transcripts. The first miR regulatory elements have indeed primarily 
been identified within the 3’ UTR [39,40]. Recent high-throughput identification of  
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miR regulation sites has revealed that miR binding sites residing outside the boundaries 
of  the 3’ UTR are common [41,42]. However, within the set of  axon guidance genes we 
did not identify regulatory elements outside the 3’ UTR, although we cannot exclude the 
existence non-canonical binding sites. Due to the lack of  miR-338 binding sites within 
many of  the significantly altered transcripts we expect that the majority of  transcrip-
tional changes are due to indirect regulation. The consequences of  non-canonical miR 
binding and subsequent regulation are currently poorly understood. While recent work 
suggests that miR binding in coding regions of  mRNA transcripts results in translation 
inhibition and destabilization [43,44], a few reports have shown noncanonical binding 
could lead to translational upregulation [45,46]. Interestingly, a luciferase reporter assay 
did show that addition of  one of  the miR-338 bindings sites within the 3’ UTR of  
Rock2 led to an enhanced luciferase activity. Further research will be needed to deter-
mine whether this is caused by translational upregulation, increased mRNA stability or 
enhanced protein levels due to other downstream effects. Collectively, our data suggests 
that through direct regulation of  a relatively few mRNA transcripts, miR-338 modula-
tion indirectly leads to significant changes in the expression of  cellular pathways gov-
erning neurodevelopmental processes such as axon guidance. 
Regulation of  cortical development by miR-181 family members  
ASD constitute a heterogeneous group of  neurodevelopmental disorders with a strong 
genetic predisposition and involvement of  multiple environmental factors [47]. Little is 
known about the miR expression changes occurring in Autism and their involvement 
the disorder. Previously, using a valproic acid (VPA)-induced autism rat model to iden-
tify miR expression changes, it was revealed that miR-181c is one of  two miRs altered 
in its expression [13]. In an effort to reveal the role of  miR-181c in the development of  
cortical neurons we assessed in chapter 5 the effects of  miR-181c expression changes 
on cortical cells at the level of  the transcriptome, neurite outgrowth and synaptogenesis. 
Neurodevelopment and the miR-181 family     
The miR-181 family consists of  four members, namely miR-181a/b/c/d, and express 
three mature miR transcripts with similar sequences. The expression of  this family is 
highly abundant within the brain, with miR-181a generally being the most prominently 
expressed of  the four members, while miR-181b and c are the second most abundantly 
expressed transcripts [31]. A number of  studies have revealed that distinct miR-181 
family members play a role in neuronal development and function, and found asso-
ciations with neurological disorders. Saba and others have shown that miR-181a in-
hibits the translation of  glutamate receptor, ionotropic, AMPA 2 (GluA2) and negatively 
regulates the surface expression of  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid receptor (AMPAR), consequently reducing spine formation and miniature excit-
atory postsynaptic currents (mEPSCs) in hippocampal neurons [48]. Upon induction 
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of  long-term potentiation (LTP) and long-term depression (LTD), miR-181b rapidly 
increases in expression in hippocampal neurons [49]. Furthermore, miR-181b showed 
increased expression levels in grey matter of  the dorsolateral prefrontal cortex and tem-
poral cortex of  schizophrenia patients [50,51]. In cell lines derived from autism patients, 
miR-181c was the second most significantly upregulated of  the total of  12 deregulated 
miRs, which included miR-181a, miR-181a* (also known as miR-181a-5p) and miR-
181b [52]. More recently, Olde Loohuis and others have screened for miR expression 
changes in the VPA-induced autism model and found miR-30d and miR-181c to be 
significantly upregulated. Subsequent inhibition of  miR-181c function in cells isolated 
from the amygdala led to significant expression changes in gene networks involved in 
neurodevelopmental processes, resulting in decreased neurite growth and branching 
and fewer dendritic spines [53]. These findings indicate that the miR-181 family may 
play a role in the onset of  neurodevelopmental disorders such as autism and schizo-
phrenia possibly by regulating key aspects in the correct development of  neurons.
miR-181c-regulated gene networks control neurodevelopment   
The association of  miR-181c with autism led us to study in chapter 5 the role of  miR-
181c in cortical development. In our initial experiments we performed a transcriptom-
ics analysis of  cells lacking miR-181c function. This analysis revealed that miR-181c has 
the capacity to alter the expression of  a large number of  genes involved in neurodevel-
opmental processes. Screening the pool of  significantly changed transcripts for miR-
181c binding sites showed that a relatively small portion contained a putative binding 
site (approximately 8%), indicating that miR-181c changes gene expression primarily in 
an indirect fashion, similar to what was found for miR-338 (chapter 3). Further gene 
clustering analysis of  the set of  70 binding site-containing genes with altered transcript 
levels upon miR-181c inhibition, uncovered an enrichment of  12 genes involved in be-
havior, cell-to-cell signaling and interaction, nervous system development and function, 
which includes eight genes that have a known role in the development of  neurons and 
five of  these regulate synaptic development and transmission. The results are indicative 
of  a potential role of  miR-181c in neurodevelopment. Indeed, when we studied the 
significance of  the miR-181c-induced gene expression changes we found that inhibition 
of  miR-181c during neuronal development leads to enhanced dendritic branching, low-
er number of  dendritic spines and increased axon growth (chapter 5). The effects on 
dendrite and axon growth in cortical neurons demonstrate the potential of  miR-181c to 
control neuronal development though modulation of  gene networks governing neurite 
and synapse development. However, the miR-181 family members are experimentally 
difficult to distinguish due to their high sequence identity; for example, the sequences 
of  miR-181a and miR-181c differ only in one nucleotide. The difficulties in distinguish-
ing between miR family members with similar sequences is exemplified by the finding 
that introduction of  anti-miR-181a locked nucleic acid (LNA) inhibitors resulted in a 
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decrease in the availability of  all miR-181 family members [54]. Thus, even with the 
enhanced specificities of  the LNA probes compared to traditional RNA oligonucle-
otides, it is not possible to specifically target individual miR-181 family members, which 
have few sequence differences. A tool such as the miR-181 sponge used in our study 
(chapter 5) will likely also bind and inactivate other miR-181 family members besides 
miR-181c. Taking this into account, we cannot delineate the physiological role of  each 
miR-181 family member. Since binding of  a miR is dictated by its nucleotide sequence, 
the high similarity between family members also implies that they control overlapping 
downstream targets. Such regulatory miR modules, where a miR family cooperatively 
controls similar gene networks, have been demonstrated previously [55-58]. 
Regulation of  local translation by miRs     
Neuronal growth and development is dependent on the steady supply of  new proteins 
to fuel these processes. The majority of  proteins are produced near the nucleus of  the 
cell, in the soma. However, since the discovery of  polyribosomes in the dendrites and 
axons of  neurons it is known that translation can also take place in distal compartments 
of  the neuron [59]. Just like translation in the soma, distal protein synthesis in synapses 
and axons can be regulated by miRs. A number of  expression profiling studies have 
revealed that there is abundant miR expression in both the axons and dendrites [60]. 
An expanding number of  miRs appears to be capable of  controlling the expression 
of  proteins in the axon, dendrites and synapses of  neurons [61,62]. In the studies de-
scribed in chapters 3-5 we found that the neurodevelopment modulators miR-338 and 
miR-181 are abundantly expressed in the axons of  sympathetic neurons and in nucleus 
accumbens synapses [54,60]. Thus, these miRs may control their targets locally. Modu-
lation of  the levels of  miR-338 in axons indeed controlled the translation of  its target 
cytochrome c oxidase subunit IV (COXIV) [30]. To label and visualize proteins produced in 
distinct neuronal compartments. We developed a combination of  two techniques, mi-
crofluidic neuronal cell culture chambers and fluorescent labeling of  nascent proteins, 
to tag locally produced protein within axonal and synaptic neuronal compartments 
(chapter 6). 
Visualization of  local translation in neuronal cultures    
To investigate local translation, most classical studies have used genetically encoded 
fluorescent labels, allowing for a limited number of  proteins to be examined at the same 
time. To overcome this limitation, a technique has been developed and optimized to la-
bel and visualize global protein synthesis, making use of  the incorporation of  modified 
amino acids followed by selective fluorescent tagging via click-chemistry [63]. Applying 
this technique and combining it with microfluidic chambers, we aimed to label proteins 
in specific neuronal compartments (chapter 6). We demonstrated the potential of  using 
microfluidic chambers to locally label nascent proteins in axons and synaptic densities 
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of  neurons under basal conditions. Microfluidic chambers allow for the fluidic isolation 
of  compounds, making it possible to specifically and locally treat the neurons cultured 
in these devices. A number of  studies have revealed the capacity for miR to control 
axon growth and synapse formation, and function by locally regulating specific targets 
within the axon and synapse. One of  the first examples was miR-134 that translation-
ally represses LIM domain kinase 1 (Limk1) at the synapse and as such is able to control 
spine development [8]. Furthermore, several studies have shown regulation by miRs in 
axon terminals, such as the control of  microtubule-associated protein 1B (Map1b) by miR-9 
affecting the growth and development of  the axons of  cortical neurons [6]. The ax-
on-enriched miR-16 has been shown to modulate the activity of  the protein synthesis 
machinery by regulation of  elongation factors in the axons of  sympathetic neurons 
[60,64]. The technique to label nascent proteins in microfluidic chambers presented in 
chapter 6 can be used to study the impact of  miR regulation on protein synthesis in 
axonal or synaptic compartments. By applying compounds to modulate synaptic activ-
ity one could study the effect of  LTP or LTD induction on miR activity and its effect 
on translational regulation. Furthermore, due to the design of  the microfluidic cham-
bers one can specifically manipulate miR expression in either the pre- or post-synaptic 
compartment. This could be used to delineate the impact of  synaptic activity on miR 
activation and regulation within these defined neuronal compartments. For example, 
recent studies have shown the capacity of  the schizophrenia- and intellectual disabil-
ity-associated miR-137 to regulate important genes at the opposite end of  the hippo-
campal synapse [65,66], and these regulatory processes could offer insight into its role 
in neurological disorders. 
Future prospects        
Our functional studies on miR-338 (chapters 3 and 4) and miR-181 (chapter 5) point 
to an important role for these miRs in the regulation of  gene networks controlling 
neurodevelopmental (Figure 1). The multi-disciplinary work described in chapters 3 
and 4 indicates that miR-338 controls neurite development and neuronal polarization 
by altering the expression of  a number of  axon guidance genes, with Robo2 being one 
of  the direct miR-338 targets. Since Robo2 has previously been shown to control neu-
rite development and neuronal polarization in the cortex [67-69], we hypothesise that 
Robo2 is a candidate miR-338 target which controls part of  the observed phenotypes. To 
study this hypothesis, a number of  additional rescue experiments should be performed. 
For example, in cultured neurons and/or during in utero brain development a construct 
containing the Robo2 open-reading frame could be co-expressed in cells overexpressing 
miR-338. Furthermore, if  Robo2 is indeed responsible for the miR-338-induced neu-
rodevelopmental defects, one would expect that cells expressing the miR-338-inhibit-
ing sponge and co-injected with a Robo2-inhibiting siRNA to reduce Robo2 expression 
to basal levels would rescue the observed neurodevelopmental defects such as altered 
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neurite growth, neuronal polarization and neuronal placement within cortical layers. 
However, we expect that a return to normal Robo2 expression levels will only partially 
rescue the neurodevelopmental defects induced by miR-338, since Robo2 is just one 
of  several gene targets affected by miR-338 expression changes. Modulation of  miR-
338 levels within the developing cortex induced neuronal polarity and changes in the 
number of  neurons within the upper cortical layers (chapter 4). Changes in neuro-
nal placement could indicate that miR-338 enhances the radial migration of  neurons 
during early cortical development. Alternatively, miR-338 could affect the cell-cycle of  
the neural stem cells (NSCs) within the deeper cortical layers, namely the ventricular 
zone (VZ) and subventricular zone (SVZ). Increasing the expression of  miR-338 could 
enhance the number of  cells exiting the cell cycle which may lead to an increase in the 
number of  cells prematurely moving up towards the upper cortical layers. Furthermore, 
during neuronal migration from the intermediate zone (IZ) to the cortical plate (CP), 
neurons transit from a multipolar state to a bipolar state. This multipolar-to-bipolar 
transition is important for the formation of  the various cortical layers and ultimately 
affects the proper functioning of  the cortex [72,73]. Changes in morphology could 
be due to an altered differentiation state of  the cells leading to extended maintenance 
of  their multipolar state under increased miR-338 expression. Previously, it has been 
shown that ROBO2 is involved in the neurogenesis of  neuronal progenitors [70]. To 
examine the role in neurogenesis in more detail, cells could be stained for proliferative 
markers to quantify the cell-cycle state of  cells in which miR-338 is altered. In chapter 
5 we showed miR-181 regulation of  gene networks controlling neuronal development 
and function, and found that miR-181 inhibition results in altered dendrite, axon and 
spine development. Furthermore, we expect that the majority of  the expression chang-
es are due to indirect regulation by miR-181, because these genes lack a miR-181 bind-
ing site in their transcripts. Further experiments employing luciferase reporter assays 
could pinpoint direct targets among the transcripts containing a miR-181c-binding site. 
Initial experiments have revealed miR-181c upregulation in autism patients and in the 
amygdala of  the VPA rat autism model [13,71]. It is currently unknown what the func-
tional influence is of  the increased miR-181c expression. To further delineate this, the 
expression of  miR-181c could be virally inhibited in the rat VPA model to see whether 
a decrease in miR-181c exacerbates or ameliorates the autistic phenotype. At the same 
time, analysis of  the effects of  manipulating miR-181 levels could offer insights into 
in vivo neurodevelopmental defects and whether there are differences between brain re-
gions. Alternatively, a miR-181 family (conditional) knock-out model could be generat-
ed to see whether the absence of  miR-181 would result in neurodevelopmental defects, 
in particular alterations in dendrite, axon and synapse formation and ultimately probe its 
role in learning and memory behaviours. The entire miR-181 family is that it consists of  
four family members with miR-181a and miR-181b having two gene copies at different 
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chromosomal locations, implying the deletion of  six genetic loci for full removal of  
miR-181. Knock-out mice lacking specific miR-181 clusters have been generated, how-
ever the effect of  such specific miR-181 family member deletions on brain development 
and function is currently unknown [72-74]. 
miR-338 miR-181c
Neurodevelopmental 
disorders
Axon growth Axon growth
Dendrite development
Cortical plate neurons
Neuronal polarity
Spine width and length Spine density
Dendrite development
Axon guidance genes
(including
Robo2 and AATK)
Neurite and synapse
 development genes
Misexpression
Figure 1. Overview of  the findings presented in this thesis. Inhibition of  miR-338 (chapter 
3) and miR-181c (chapter 5) in cortical neurons results in substantial changes of  a large number 
of  downstream transcripts. Gene ontology analysis of  the altered transcripts identified gene 
clusters involved in critical neurodevelopmental pathways. miR-338 regulates the abundance of  
transcripts involved in axon development, while miR-181c modulates genes involved in neurite 
and synapse development. Dysregulation of  miR-181c expression is associated with ASD both 
in patients and animal models. Of  the collection of  miR-338-induced transcript changes, Robo2 
(chapter 3) and AATK (chapter 2) are direct downstream targets of  this miR. In cortical neu-
rons miR-338 (chapter 3) and miR-181c (chapter 5) regulate axon growth, dendrite and spine 
development in vitro. In vivo, miR-338 increases the number of  neurons within the cortical plate 
and enhances the number of  multipolar cells within this cortical layer (chapter 4). The arrows 
denote whether the process is positively (up) or negatively (down) regulated by the correspond-
ing miR, respectively. 
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While this thesis mostly focused on delineating the role of  gene regulation by miRs on 
neuronal development, the impact of  the observed effects on the electrophysiology of  
cells overexpressing or lacking either miR-338 or miR-181 is currently unknown. We 
hypothesise that since neurite development and synapse formation are key processes in 
the formation of  functional neuronal networks, miR-338 and miR-181 could potentially 
alter neuronal function which could be studied by performing electrical recordings on in 
vitro or in vivo manipulated cells to assess the physiological impact of  either overexpress-
ing or repressing miR-181 or miR-338. Performing electrophysiological experiments 
on miR-manipulated cells could further unravel the mechanisms behind the observed 
neurodevelopmental changes induced by the miRs studied in this thesis. 
MiRs as biomarkers and therapeutic targets for neurodevelopmental disorders 
MiR-338 is one of  the miRs displaying increased expression in multiple sclerosis (MS) 
and amyotrophic lateral sclerosis (ALS) patient material [75-77], and, as mentioned 
above, increased miR-181c expression is associated with autism. The perturbations in 
the expression of  miR-338 and miR-181c in brain-associated disorders could suggest 
that they play a role in the etiology and progression of  these diseases. The emerging 
role of  miR modulation in brain disorders such as neurodevelopmental disorders have 
sparked great interest in the use of  miRs for clinical applications. One such avenue is 
to use miR expression levels as biomarker for the identification or monitoring of  (neu-
rodevelopmental) disorders. For a number of  neurodevelopmental disorders such ef-
forts have been undertaken. For example, miR expression profiles have been identified 
for schizophrenia and ASD [78]. However, little overlap was found among the various 
reported miR expression profiles, possibly due to differences in the isolation of  the 
patient material or in the methods used to quantify miR expression levels. Furthermore, 
the treatment history of  the patient can greatly influence gene expression profiles. A 
current challenge is to identify consistent disease markers, which is daunting due to the 
heterogeneity of  the patient population. There is a need for better characterisation of  
patients and increased standardisation of  the methods used.
Besides their use as biomarkers, miRs are interesting therapeutic targets due to their 
impact on neurological disorders and their capacity to regulate gene networks by target-
ing multiple transcripts at the same time. While initially neurodevelopmental disorders 
were thought to be irreversible in adults, a number of  studies using animal models 
have shown that the adult brain remains plastic enough to partially overcome these 
disorders by targeting the underlying molecular machineries (for review, see [79]). In 
animal studies, the RNA interference system can be used to knock-down specific gene 
targets involved in disease. For example, in a mouse model for Huntington’s disease it 
was shown that intraventricular infusion of  RNA oligonucleotides targeting mutant 
Huntington decreased mutant Huntington protein within the brain [79]. Interestingly, in 
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the same study, introducing stabilizing modifications within the RNA oligonucleotides 
(which are normally rapidly degraded) enhanced degradation resistance and specificity 
of  the oligonucleotides. Similar miR mimics can be designed to temporarily enhance 
miR function within the brain. Furthermore, silencing of  miR-134 using antagomirs has 
been found to decrease the number of  epileptic seizures in mice [80]. A more recent 
study showed that miR-16 and its family members are potential candidate therapeutic 
targets in Alzheimer’s disease, in which they were shown to control a number of  genes 
involved in the progression of  the disease [81]. Collectively, these studies highlight the 
potential of  miR-based therapies in animals and depending on whether increasing or 
decreasing miR levels is necessary, miR antagomirs or mimics can be applied. In hu-
mans, a number of  promising clinical trials involving miR-based treatment strategies for 
various diseases are ongoing [82].
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Summary 
The brain is an intricate organ and serves as the centre of  the nervous system, respon-
sible for receiving and processing information. It is made up of  a plethora of  differ-
ent cell types, strictly organized into specialized areas fulfilling specific functions. The 
numerous neural cells within the brain form intricate networks through the outgrowth 
of  axons and dendrites, which have extensive ramifications that are engaged in neural 
connectivity through synaptic connections. One of  the largest specialized areas within 
the brain is the cerebral cortex, which is responsible for a number of  crucial cognitive 
functions including memory, perception, awareness and consciousness. The correct 
formation of  this brain area is critically important for its ability of  properly execut-
ing its functions. Indeed, malformations of  the cortex are associated with a range of  
neurodevelopmental disorders such as intellectual disability, schizophrenia and autism 
spectrum disorders. To understand these disorders one needs to understand the under-
lying regulatory molecular networks responsible for the formation, maintenance and 
plasticity of  the cortex. One critical group of  regulatory genes are microRNAs (miRs). 
An increasing body of  evidence have implicated miR expression changes with a number 
of  neurodevelopmental disorders. miRs are non-coding genes that generate short RNA 
molecules, which can regulate translational repression and mRNA destabilization upon 
binding to complementary sequences within mRNA transcripts. Due to the critical im-
pact of  miR regulation on cortical development we aimed in the current thesis to iden-
tify miRs which have the capacity to control key aspects of  cortical neurodevelopment 
such as axon, dendrite growth and synapse development.
In chapter 1, I discuss the history, biogenesis, general function of  miRs and subse-
quently their importance for normal neurodevelopment and physiology and their role in 
neurodevelopmental disorders. miR genes produce a class of  small non-conding RNA 
molecules and their functional mature form is incorporated into the RNA-induced si-
lencing complex (RISC). This RISC complex containing the miR binds to, and subse-
quently regulates target mRNA transcripts. Due to their relative short sequence size, 
miRs can have a vast regulatory potential where a single miR can potentially regulate 
many mRNA transcripts and a single mRNA transcript can be controlled by multiple 
miRs, establishing them as key gene network regulators. 
A number of  studies have previously provided evidence for a role of  miR-338 in axon 
development of  sympathetic neurons. Furthermore, modulation of  miR-338 levels in 
oligodendrocytes has shown the ability of  this miR to regulate the development and 
maturation of  these cells. While these studies provided convincing evidence that miR-
338 is a key modulator of  development of  the peripheral nervous system, this miR is 
also highly expressed within the central nervous system including the cortex. This led 
us to explore, in the first part of  this thesis (chapters 2-4), the effects of  the disruption 
of  the brain-enriched miR-338 on cortical neurodevelopment. miR-338 is encoded in 
the 7th intron of  the AATK gene, a gene previously identified as a regulator of  axon and 
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dendrite development. In chapter 2 I describe that miR-338 has the capacity to regulate 
the mRNA stability and translation of  its host-gene AATK. The regulation of  AATK 
by miR-338 is likely important for the fine-tuning of  AATKs function during neuronal 
development. miR-338 could partially exert its neurodevelopmental function in axon 
growth and dendrite formation through the control of  AATK. 
This resulted prompted me to further explore the impact of  miR-338 manipulation 
during the development of  cortical cells (chapter 3). I could demonstrate that miR-
338 controls dendrite sprouting and branching, dendritic spine morphology and axon 
growth. Subsequent large-scale transcriptome analysis after miR-338 inhibition, com-
bined with miR-338 binding site analysis to identify potential down-stream targets re-
sponsible for the observed neurodevelopmental effects, revealed a large number of  
genes to be involved in neurite development. A particularly significant enrichment of  
genes was found playing a role in axon guidance and development. Further validation 
of  the set of  axon development genes resulted in the identification of  Robo2 as one of  
the direct targets of  miR-338, a gene which was previously shown to regulate neurite 
development and could explain some of  the neuromorphological phenotypes we ob-
served in the cortical neurons after miR-338 manipulation. These results show that the 
brain-enriched miR-338 has the ability to regulate multiple neurodevelopmental genes 
at the same time, controlling cellular pathways involved in neurite and synapse devel-
opment. 
Next, I studied the impact of  miR-338 overexpression or inhibition at an early stage of  
the developing embryonic cortex by means of  in utero electroporation (chapter 4). The 
modulation of  miR-338 expression levels during early cortical development revealed 
that miR-338 overexpression resulted in an increase in the number of  neurons within 
the upper cortical layers and an increase in the number of  multipolar neuronal cell 
types. Conversely, inhibition of  miR-338 decreased the number of  neurons within the 
upper cortical layer and resulted in an increase in the number of  nonpolar cells. On the 
basis of  the results described in chapters 3 and 4 we concluded that miR-338 acts as 
a regulator of  neurite development, cortical neuronal placement and polarity through 
(direct or indirect) regulation of  a number of  axon guidance genes of  which Robo2 is a 
direct miR-338 target. 
miR-181c is abundantly expressed within the central nervous system. Its expression is 
increased in a valproic acid-induced autism animal model. In chapter 5 we investigated 
the effect of  miR-181c inhibition in developing cortical neurons. Comparison of  tran-
scriptome of  normal cortical cells and cells lacking miR-181c revealed an enrichment 
of  changed transcripts involved in nervous system development due to the lack of  
miR-181c. Neuromorphological analysis of  cortical cells in which miR-181c expression 
levels were inhibited revealed significant changes in dendrite development and axon 
growth. To further study the underlying (local) regulatory mechanisms of  miR-338 and 
miR-181, we pioneered a method combining the use of  microfluidic chambers and 
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modified amino acid incorporation into nascent proteins, which may present an inter-
esting tool for investigating local regulation of  miR targets within axonal or synaptic 
neuronal compartments (chapter 6).
In chapter 7 the results of  this thesis have been re-evaluated and extensively discussed. 
In addition, a number of  follow-up studies are proposed to address the questions which 
have arisen from the presented results. 
Collectively, the findings presented in this thesis show the enormous impact of  miRs on 
the regulation of  key neurodevelopmental processes by directly or indirectly controlling 
large numbers of  genes involved in neuronal development. I have shown that the inves-
tigated miRs have the capacity to regulate key processes for the formation of  functional 
cortical networks. Furthermore, my research has significantly contributed to our knowl-
edge of  the mechanisms by which miR mis-expression contributes to the development 
and progression of  neurodevelopmental disorders. Further unraveling the function of  
these miRs and the downstream molecular machineries they control contributes to the 
understanding of  neurodevelopmental disorders and offer insights into novel clinical 
treatment possibilities.  
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Samenvatting
Het brein is een complex orgaan dat als centrum van het zenuwstelsel dient en is ver-
antwoordelijk voor het ontvangen en verwerken van de informatie die binnenkomt. Het 
brein bestaat uit veel verschillende soorten cellen, welke in gespecialiseerde hersenge-
bieden georganiseerd zijn die elk een eigen specifieke functie hebben. De vele hersen-
cellen in het brein ontwikkelen complexe neuronale netwerken van axonen en dendriten 
die connecties vormen via synaptische verbinding. Eén van de grootste hersengebieden 
binnen het brein is de cortex en is verantwoordelijk voor een aantal cruciale cognitieve 
functies zoals geheugen, waarnemen en bewustzijn. Het is belangrijk dat de cortex op 
de juiste manier gevormd wordt zodat het zijn functie op een correcte manier kan uitvo-
eren. Een abnormale ontwikkeling van de cortex kan leiden tot verschillende neuronale 
ontwikkelingsstoornissen, zoals intellectuele stoornissen, schizofrenie en autisme. Om 
deze ontwikkelingsstoornissen beter te begrijpen is het van belang om de onderliggende 
regulatoire netwerken te onderzoeken, die een rol spelen bij de ontwikkeling, het onder-
houden en plasticiteit van de cortex. MicroRNAs (miR’s) zijn een belangrijke groep reg-
ulatie genen die in staat zijn andere genen aan te sturen. Er is een groeiende hoeveelheid 
studies die aantonen dat miR expressie veranderingen een rol spelen bij het ontstaan van 
neuronale ontwikkelingsstoornissen. Deze niet-coderende genen vormen korte RNA 
moleculen die aan complementaire sequenties van mRNA transcripten kunnen binden. 
De interactie tussen een miR en mRNA transcript kan leiden tot inhibitie van translatie 
of  destabilisatie van het mRNA transcript en vertegenwoordigen dus een cruciale groep 
genen die post-translationeel de productie van eiwitten beïnvloeden. Door de essentiële 
rol die miR’s spelen in de ontwikkeling van de cortex was het doel van het onderzoek, 
beschreven in dit proefschrift, het identificeren van specifieke miR’s die belangrijke as-
pecten van corticale neuronale ontwikkeling reguleren, zoals axon en dendriet groei en 
synaps ontwikkeling. 
In hoofstuk 1 bespreek ik de geschiedenis, biogenese en algemene functie van miR’s. 
Vervolgens beschrijf  ik het belang van deze groep genen in neuronale ontwikkelingss-
toornissen. miR genen produceren een groep niet-coderende RNA moleculen die in hun 
functionele vorm in het RNA-geïnduceerd stiltecomplex (RISC) worden opgenomen. 
Dit RISC complex met daarin de miR, gaat de interactie aan met mRNA transcripten 
waarna regulatie plaatsvindt. Vanwege hun korte sequentie, kunnen miR’s aan meerdere 
mRNA transcripten binden. Dit zorgt ervoor dat miR’s een zeer grote regulatie poten-
tie hebben, waarbij een enkel mRNA transcript door meerdere miR’s gereguleerd kan 
worden en een enkele miR meerdere mRNAs tegelijk kan reguleren. Hierdoor staan 
miR’s centraal in het aansturen van gen netwerken binnen de cel. 
Een aantal studies hebben aangetoond dat miR-338 in staat is de axon groei van sym-
pathische zenuwcellen te vertragen. Verder zijn er aanwijzingen dat miR-338 de ontwik-
keling en maturatie van oligodendrocyten kan beïnvloeden. Ook al geven deze studies 
belangrijke informatie over de rol van miR-338 in het perifere zenuwstelsel, is er weinig 
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bekend over zijn rol in de cortex, een breinregio waar deze miR hoog tot expressie 
komt. Dit was de aanleiding om in het eerste deel van deze thesis (hoofdstuk 2-4) de 
rol van miR-338 in de ontwikkeling van de cortex beter in kaart te brengen. miR-338 is 
gecodeerd in het 7e intron van het AATK gen, een gen dat is betrokken bij de ontwik-
keling van axonen en dendrieten. Tijdens het bestuderen van het expressie patroon van 
miR-338 vonden we in hoofdstuk 2 dat miR-338 in staat is de translatie en stabiliteit van 
AATK mRNA kan reguleren. Dit kan er mogelijk op duiden dat miR-338 gedeeltelijk 
de ontwikkeling van axonen en dendrieten kan beïnvloeden via de regulatie van AATK. 
In hoofdstuk 3 hebben we de rol van miR-338 in neuronale ontwikkeling verder onder-
zocht. Hierbij manipuleerden we de expressie van miR-338 in corticale neuronen tijdens 
hun ontwikkeling. Dit toonde aan dat deze miR in corticale neuronen de vorming en 
vertakking van dendrieten bevordert, de morfologie van synapsen beïnvloedt en de 
groei van axonen verstoort. Gebruikmakend van RNA sequencing brachten we het ge-
hele transcriptome in kaart van neuronen waarin we de expressie van miR-338 hadden 
onderdrukt. Door de differentieel tot expressie komende mRNA transcripten te analy-
seren op mogelijke bindingsplaatsen voor miR-338, vonden we een grote groep genen 
die potentieel door miR-338 gereguleerd kunnen worden. Door deze groep genen 
functioneel te classificeren vonden we een significante groep genen die een rol spelen 
bij neurite ontwikkeling. Verder vonden we een opvallende verrijking voor een groep 
genen die axon groei en ontwikkeling beïnvloeden. Door deze bevindingen verder te 
onderzoeken, identificeerden we Robo2 als één van de genen die miR-338 rechtstreeks 
kan reguleren. Op basis van recente studies hebben we kunnen concluderen dat Robo2 
mogelijk een aantal van de geobserveerde miR-338 geïnduceerde fenotypes kan verk-
laren. Deze resultaten laten zien dat miR-338 in staat is gelijktijdig meerdere mRNA 
transcripten direct en indirect te beïnvloeden. Hierdoor kan deze miR cellulaire gen-
netwerken reguleren die neuriet en synapse ontwikkeling aansturen. 
Vervolgens wilden we de impact van miR-338 overexpressie of  inhibitie tijdens de 
vroege ontwikkeling van de embryonale cortex onderzoeken, waarbij we gebruik maak-
ten van in utero elektroporatie (hoofdstuk 4). Dit toonde aan dat het verhogen van de 
miR-338 expressie niveaus in neuronen tijdens de vroege ontwikkeling van de cortex 
leidde tot een verhoging in het aantal neuronen in de bovenste corticale laag en ook 
meer multipolaire cellen. Wanneer miR-338 geblokkeerd werd in zijn functie, zagen 
we het tegenovergestelde, vermindering van de hoeveelheid neuronen in de bovenste 
corticale laag en een verhoging van het aantal niet-polaire cellen. Op basis van de re-
sultaten, beschreven in hoofdstukken 3 en 4, kunnen we concluderen dat miR-338 een 
belangrijke rol speelt in de vorming van neuriten, migratie van corticale neuronen en het 
bepalen van de polariteit van deze cellen. miR-338 is in staat deze processen te contr-
oleren door de expressie van een aantal axon ontwikkelingsgenen (direct of  indirect) te 
beïnvloeden, waarvan miR-338 het gen Robo2 rechtstreeks kan reguleren. 
miR-181c komt hoog tot expressie in het centrale zenuwstelsel en recent is aangetoond 
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dat de expressie van deze miR omhoog gaat in een valproaat geïnduceerd diermodel 
voor autisme. In hoofdstuk 5 onderzochten we de effecten van het verlagen van de 
expressie van miR-181c tijdens de ontwikkeling van corticale neuronen. Door het tran-
scriptome in kaart te brengen van neuronen met een vermindering van miR-181c verge-
leken met normale corticale neuronen konden we aantonen dat er een significante verri-
jking is in het aantal genen die betrokken zijn bij de ontwikkeling van het zenuwstelsel. 
Morfologische analyse van neuronen waarin de functie van miR-181c is geblokkeerd, 
toonde aan dat deze cellen complexere dendrieten met een lagere synapse dichtheid en 
langere axonen hebben. Samen laten deze resultaten zien dan miR-181c de ontwikkeling 
van corticale neuronen kan aansturen via de regulatie van gen netwerken die betrokken 
zijn bij de ontwikkeling van neuriten en synapsen. 
Om verder de onderliggende (lokale) regulatie mechanismen van miR-338 en miR-181 
te bestuderen hebben we een methode opgezet die ons in staat stelt om de productie 
van nieuwe eiwitten te visualiseren in de axonen en synapsen van neuronen (hoofd-
stuk 6). Hierbij maken we gebruik van microvloeistof  celkweek kamers in combinatie 
met een techniek waarbij gemodificeerde aminozuren in nieuwe eiwitten opgenomen 
worden. Deze combinatie van technieken kan gebruikt worden om de lokale miR regu-
latie van genen te bestuderen in specifieke neuronale compartimenten.   
In hoofdstuk 7 zijn de resultaten van dit onderzoek verder bediscussieerd en worden 
er een aantal vervolg studies voorgesteld om de mogelijke vragen te beantwoorden die 
zijn voortgekomen uit ons werk. 
Concluderend benadrukken de resultaten van dit onderzoek de centrale rol die miR’s 
spelen in de regulatie van belangrijke neuronale ontwikkelingsprocessen. Ze zijn hier-
toe in staat door direct of  indirect meerdere genen tegelijk aan te sturen die betrokken 
zijn bij neuronale ontwikkeling. De onderzochte miR’s hebben dus de capaciteit om 
specifieke cruciale gennetwerken aan te sturen die belangrijk zijn voor de formatie van 
corticale neuronale netwerken. Deze bevindingen zijn relevant voor het onderzoek naar 
potentiele foutieve expressie van miR’s tijdens de ontwikkeling van het brein, welke 
kunnen bijdragen aan het ontstaan en progressie van neurologische aandoeningen. Het 
verder uitdiepen van de miR functie en de moleculaire mechanismen die ze aansturen 
draagt bij aan het beter begrijpen van neurologische aandoeningen en kan mogelijk 
leiden tot nieuwe therapeutische interventie strategieën. 
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Lieve Zlata, ik leerde je kennen ongeveer halverwege mijn promotie en ik prijs mij 
daarin zeer gelukkig. Je was er altijd voor me, vooral tijdens de stressvolle momenten, 
en dan kon je me altijd weer opbeuren. Ik hoop dat ik nog lang van je steun, vertrouwen 
en liefde mag genieten. Ik hou van je. 
Aron
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